id	sid	tid	token	lemma	pos
aiua-10141	1	1	stesura	stesura	PROPN
aiua-10141	1	2	seveso	seveso	PROPN
aiua-10141	1	3	archivio	archivio	PROPN
aiua-10141	1	4	italiano	italiano	X
aiua-10141	1	5	di	di	X
aiua-10141	1	6	urologia	urologia	PROPN
aiua-10141	1	7	e	e	PROPN
aiua-10141	1	8	andrologia	andrologia	NOUN
aiua-10141	1	9	2021	2021	NUM
aiua-10141	1	10	;	;	PUNCT
aiua-10141	1	11	93	93	NUM
aiua-10141	1	12	,	,	PUNCT
aiua-10141	1	13	4460	4460	NUM
aiua-10141	1	14	original	original	ADJ
aiua-10141	1	15	paper	paper	NOUN
aiua-10141	1	16	no	no	DET
aiua-10141	1	17	conflict	conflict	NOUN
aiua-10141	1	18	of	of	ADP
aiua-10141	1	19	interest	interest	NOUN
aiua-10141	1	20	declared	declare	VERB
aiua-10141	1	21	.	.	PUNCT
aiua-10141	2	1	pelvic	pelvic	ADJ
aiua-10141	2	2	ganglia	ganglia	NOUN
aiua-10141	2	3	to	to	PART
aiua-10141	2	4	smooth	smooth	VERB
aiua-10141	2	5	muscles	muscle	NOUN
aiua-10141	2	6	and	and	CCONJ
aiua-10141	2	7	the	the	DET
aiua-10141	2	8	endothelial	endothelial	ADJ
aiua-10141	2	9	cells	cell	NOUN
aiua-10141	2	10	of	of	ADP
aiua-10141	2	11	the	the	DET
aiua-10141	2	12	corpora	corpora	NOUN
aiua-10141	2	13	cavernosa	cavernosa	NOUN
aiua-10141	2	14	(	(	PUNCT
aiua-10141	2	15	4	4	NUM
aiua-10141	2	16	)	)	PUNCT
aiua-10141	2	17	.	.	PUNCT
aiua-10141	3	1	low	low	ADJ
aiua-10141	3	2	testosterone	testosterone	NOUN
aiua-10141	3	3	levels	level	NOUN
aiua-10141	3	4	are	be	AUX
aiua-10141	3	5	associated	associate	VERB
aiua-10141	3	6	with	with	ADP
aiua-10141	3	7	decreased	decrease	VERB
aiua-10141	3	8	libido	libido	NOUN
aiua-10141	3	9	,	,	PUNCT
aiua-10141	3	10	ed	ed	NOUN
aiua-10141	3	11	,	,	PUNCT
aiua-10141	3	12	decreased	decrease	VERB
aiua-10141	3	13	energy	energy	NOUN
aiua-10141	3	14	,	,	PUNCT
aiua-10141	3	15	depressive	depressive	ADJ
aiua-10141	3	16	symptoms	symptom	NOUN
aiua-10141	3	17	,	,	PUNCT
aiua-10141	3	18	and	and	CCONJ
aiua-10141	3	19	fatigue	fatigue	NOUN
aiua-10141	3	20	(	(	PUNCT
aiua-10141	3	21	5	5	NUM
aiua-10141	3	22	)	)	PUNCT
aiua-10141	3	23	.	.	PUNCT
aiua-10141	4	1	changes	change	NOUN
aiua-10141	4	2	in	in	ADP
aiua-10141	4	3	testosterone	testosterone	NOUN
aiua-10141	4	4	levels	level	NOUN
aiua-10141	4	5	after	after	SCONJ
aiua-10141	4	6	covid-19	covid-19	PROPN
aiua-10141	4	7	may	may	AUX
aiua-10141	4	8	not	not	PART
aiua-10141	4	9	only	only	ADV
aiua-10141	4	10	increase	increase	VERB
aiua-10141	4	11	the	the	DET
aiua-10141	4	12	severity	severity	NOUN
aiua-10141	4	13	of	of	ADP
aiua-10141	4	14	ed	ed	NOUN
aiua-10141	4	15	but	but	CCONJ
aiua-10141	4	16	also	also	ADV
aiua-10141	4	17	cause	cause	VERB
aiua-10141	4	18	ed	ed	NOUN
aiua-10141	4	19	alone	alone	ADV
aiua-10141	4	20	(	(	PUNCT
aiua-10141	4	21	6	6	NUM
aiua-10141	4	22	)	)	PUNCT
aiua-10141	4	23	.	.	PUNCT
aiua-10141	5	1	the	the	DET
aiua-10141	5	2	relationship	relationship	NOUN
aiua-10141	5	3	between	between	ADP
aiua-10141	5	4	covid-19	covid-19	PROPN
aiua-10141	5	5	and	and	CCONJ
aiua-10141	5	6	testosterone	testosterone	NOUN
aiua-10141	5	7	is	be	AUX
aiua-10141	5	8	based	base	VERB
aiua-10141	5	9	on	on	ADP
aiua-10141	5	10	contracting	contract	VERB
aiua-10141	5	11	the	the	DET
aiua-10141	5	12	disease	disease	NOUN
aiua-10141	5	13	,	,	PUNCT
aiua-10141	5	14	the	the	DET
aiua-10141	5	15	severity	severity	NOUN
aiua-10141	5	16	of	of	ADP
aiua-10141	5	17	the	the	DET
aiua-10141	5	18	disease	disease	NOUN
aiua-10141	5	19	and	and	CCONJ
aiua-10141	5	20	progression	progression	NOUN
aiua-10141	5	21	of	of	ADP
aiua-10141	5	22	the	the	DET
aiua-10141	5	23	disease	disease	NOUN
aiua-10141	5	24	.	.	PUNCT
aiua-10141	6	1	covid-19	covid-19	PROPN
aiua-10141	6	2	makes	make	VERB
aiua-10141	6	3	use	use	NOUN
aiua-10141	6	4	of	of	ADP
aiua-10141	6	5	transmembrane	transmembrane	ADJ
aiua-10141	6	6	protease	protease	NOUN
aiua-10141	6	7	serine	serine	NOUN
aiua-10141	6	8	2	2	NUM
aiua-10141	6	9	(	(	PUNCT
aiua-10141	6	10	tmprss2	tmprss2	ADV
aiua-10141	6	11	)	)	PUNCT
aiua-10141	6	12	to	to	PART
aiua-10141	6	13	penetrate	penetrate	VERB
aiua-10141	6	14	into	into	ADP
aiua-10141	6	15	the	the	DET
aiua-10141	6	16	host	host	NOUN
aiua-10141	6	17	cell	cell	NOUN
aiua-10141	6	18	and	and	CCONJ
aiua-10141	6	19	androgen	androgen	NOUN
aiua-10141	6	20	receptors	receptor	NOUN
aiua-10141	6	21	are	be	AUX
aiua-10141	6	22	transcription	transcription	NOUN
aiua-10141	6	23	supportive	supportive	ADJ
aiua-10141	6	24	for	for	ADP
aiua-10141	6	25	tmprss2	tmprss2	PROPN
aiua-10141	6	26	.	.	PUNCT
aiua-10141	7	1	the	the	PRON
aiua-10141	7	2	higher	high	ADJ
aiua-10141	7	3	the	the	DET
aiua-10141	7	4	testosterone	testosterone	NOUN
aiua-10141	7	5	level	level	NOUN
aiua-10141	7	6	,	,	PUNCT
aiua-10141	7	7	the	the	PRON
aiua-10141	7	8	easier	easy	ADJ
aiua-10141	7	9	it	it	PRON
aiua-10141	7	10	is	be	AUX
aiua-10141	7	11	for	for	SCONJ
aiua-10141	7	12	covid-19	covid-19	PROPN
aiua-10141	7	13	to	to	PART
aiua-10141	7	14	penetrate	penetrate	VERB
aiua-10141	7	15	into	into	ADP
aiua-10141	7	16	the	the	DET
aiua-10141	7	17	host	host	NOUN
aiua-10141	7	18	via	via	ADP
aiua-10141	7	19	this	this	DET
aiua-10141	7	20	mechanism	mechanism	NOUN
aiua-10141	7	21	(	(	PUNCT
aiua-10141	7	22	7	7	NUM
aiua-10141	7	23	)	)	PUNCT
aiua-10141	7	24	.	.	PUNCT
aiua-10141	8	1	besides	besides	ADV
aiua-10141	8	2	,	,	PUNCT
aiua-10141	8	3	tmprss2	tmprss2	ADV
aiua-10141	8	4	is	be	AUX
aiua-10141	8	5	up	up	ADV
aiua-10141	8	6	-	-	PUNCT
aiua-10141	8	7	regulated	regulate	VERB
aiua-10141	8	8	in	in	ADP
aiua-10141	8	9	prostate	prostate	NOUN
aiua-10141	8	10	cancer	cancer	NOUN
aiua-10141	8	11	where	where	SCONJ
aiua-10141	8	12	it	it	PRON
aiua-10141	8	13	supports	support	VERB
aiua-10141	8	14	tumor	tumor	NOUN
aiua-10141	8	15	progression	progression	NOUN
aiua-10141	8	16	,	,	PUNCT
aiua-10141	8	17	thus	thus	ADV
aiua-10141	8	18	these	these	DET
aiua-10141	8	19	patients	patient	NOUN
aiua-10141	8	20	may	may	AUX
aiua-10141	8	21	have	have	VERB
aiua-10141	8	22	a	a	DET
aiua-10141	8	23	higher	high	ADJ
aiua-10141	8	24	risk	risk	NOUN
aiua-10141	8	25	of	of	ADP
aiua-10141	8	26	sars	sar	NOUN
aiua-10141	8	27	-	-	PUNCT
aiua-10141	8	28	cov-2	cov-2	NOUN
aiua-10141	8	29	infection	infection	NOUN
aiua-10141	8	30	.	.	PUNCT
aiua-10141	9	1	tmprss2	tmprss2	SCONJ
aiua-10141	9	2	inhibitors	inhibitor	NOUN
aiua-10141	9	3	may	may	AUX
aiua-10141	9	4	be	be	AUX
aiua-10141	9	5	useful	useful	ADJ
aiua-10141	9	6	for	for	ADP
aiua-10141	9	7	the	the	DET
aiua-10141	9	8	treatment	treatment	NOUN
aiua-10141	9	9	or	or	CCONJ
aiua-10141	9	10	prevention	prevention	NOUN
aiua-10141	9	11	of	of	ADP
aiua-10141	9	12	covid-19	covid-19	PROPN
aiua-10141	9	13	(	(	PUNCT
aiua-10141	9	14	8)	8)	NUM
aiua-10141	9	15	.	.	PUNCT
aiua-10141	10	1	on	on	ADP
aiua-10141	10	2	the	the	DET
aiua-10141	10	3	contrary	contrary	NOUN
aiua-10141	10	4	,	,	PUNCT
aiua-10141	10	5	some	some	DET
aiua-10141	10	6	other	other	ADJ
aiua-10141	10	7	studies	study	NOUN
aiua-10141	10	8	have	have	AUX
aiua-10141	10	9	reported	report	VERB
aiua-10141	10	10	that	that	SCONJ
aiua-10141	10	11	low	low	ADJ
aiua-10141	10	12	testosterone	testosterone	NOUN
aiua-10141	10	13	levels	level	NOUN
aiua-10141	10	14	are	be	AUX
aiua-10141	10	15	associated	associate	VERB
aiua-10141	10	16	with	with	ADP
aiua-10141	10	17	acute	acute	ADJ
aiua-10141	10	18	respiratory	respiratory	ADJ
aiua-10141	10	19	distress	distress	NOUN
aiua-10141	10	20	syndrome	syndrome	NOUN
aiua-10141	10	21	(	(	PUNCT
aiua-10141	10	22	ards	ard	NOUN
aiua-10141	10	23	)	)	PUNCT
aiua-10141	10	24	by	by	ADP
aiua-10141	10	25	increasing	increase	VERB
aiua-10141	10	26	proinflammatory	proinflammatory	ADJ
aiua-10141	10	27	cytokines	cytokine	NOUN
aiua-10141	10	28	and	and	CCONJ
aiua-10141	10	29	they	they	PRON
aiua-10141	10	30	intensify	intensify	VERB
aiua-10141	10	31	covid-19	covid-19	PROPN
aiua-10141	10	32	infection	infection	NOUN
aiua-10141	10	33	in	in	ADP
aiua-10141	10	34	elderly	elderly	ADJ
aiua-10141	10	35	men	man	NOUN
aiua-10141	10	36	(	(	PUNCT
aiua-10141	10	37	9	9	NUM
aiua-10141	10	38	)	)	PUNCT
aiua-10141	10	39	.	.	PUNCT
aiua-10141	11	1	ed	ed	NOUN
aiua-10141	11	2	which	which	PRON
aiua-10141	11	3	is	be	AUX
aiua-10141	11	4	caused	cause	VERB
aiua-10141	11	5	by	by	ADP
aiua-10141	11	6	covid-19	covid-19	PROPN
aiua-10141	11	7	appears	appear	VERB
aiua-10141	11	8	to	to	PART
aiua-10141	11	9	be	be	AUX
aiua-10141	11	10	associated	associate	VERB
aiua-10141	11	11	with	with	ADP
aiua-10141	11	12	both	both	CCONJ
aiua-10141	11	13	vascular	vascular	ADJ
aiua-10141	11	14	endothelial	endothelial	ADJ
aiua-10141	11	15	damage	damage	NOUN
aiua-10141	11	16	and	and	CCONJ
aiua-10141	11	17	reduction	reduction	NOUN
aiua-10141	11	18	in	in	ADP
aiua-10141	11	19	testosterone	testosterone	NOUN
aiua-10141	11	20	level	level	NOUN
aiua-10141	11	21	.	.	PUNCT
aiua-10141	12	1	even	even	ADV
aiua-10141	12	2	though	though	SCONJ
aiua-10141	12	3	the	the	DET
aiua-10141	12	4	studies	study	NOUN
aiua-10141	12	5	in	in	ADP
aiua-10141	12	6	the	the	DET
aiua-10141	12	7	last	last	ADJ
aiua-10141	12	8	year	year	NOUN
aiua-10141	12	9	mostly	mostly	ADV
aiua-10141	12	10	focused	focus	VERB
aiua-10141	12	11	on	on	ADP
aiua-10141	12	12	primary	primary	ADJ
aiua-10141	12	13	disease	disease	NOUN
aiua-10141	12	14	due	due	ADP
aiua-10141	12	15	to	to	ADP
aiua-10141	12	16	the	the	DET
aiua-10141	12	17	pandemic	pandemic	NOUN
aiua-10141	12	18	,	,	PUNCT
aiua-10141	12	19	in	in	ADP
aiua-10141	12	20	some	some	DET
aiua-10141	12	21	studies	study	NOUN
aiua-10141	12	22	,	,	PUNCT
aiua-10141	12	23	covid-19	covid-19	PROPN
aiua-10141	12	24	and	and	CCONJ
aiua-10141	12	25	its	its	PRON
aiua-10141	12	26	effects	effect	NOUN
aiua-10141	12	27	on	on	ADP
aiua-10141	12	28	sexual	sexual	ADJ
aiua-10141	12	29	life	life	NOUN
aiua-10141	12	30	have	have	AUX
aiua-10141	12	31	begun	begin	VERB
aiua-10141	12	32	to	to	PART
aiua-10141	12	33	be	be	AUX
aiua-10141	12	34	revealed	reveal	VERB
aiua-10141	12	35	and	and	CCONJ
aiua-10141	12	36	suggestions	suggestion	NOUN
aiua-10141	12	37	are	be	AUX
aiua-10141	12	38	made	make	VERB
aiua-10141	12	39	in	in	ADP
aiua-10141	12	40	terms	term	NOUN
aiua-10141	12	41	of	of	ADP
aiua-10141	12	42	sexual	sexual	ADJ
aiua-10141	12	43	health	health	NOUN
aiua-10141	12	44	,	,	PUNCT
aiua-10141	12	45	especially	especially	ADV
aiua-10141	12	46	through	through	ADP
aiua-10141	12	47	andrology	andrology	NOUN
aiua-10141	12	48	associations	association	NOUN
aiua-10141	12	49	(	(	PUNCT
aiua-10141	12	50	10	10	NUM
aiua-10141	12	51	)	)	PUNCT
aiua-10141	12	52	,	,	PUNCT
aiua-10141	12	53	but	but	CCONJ
aiua-10141	12	54	the	the	DET
aiua-10141	12	55	results	result	NOUN
aiua-10141	12	56	on	on	ADP
aiua-10141	12	57	effects	effect	NOUN
aiua-10141	12	58	of	of	ADP
aiua-10141	12	59	covid-19	covid-19	PROPN
aiua-10141	12	60	infection	infection	NOUN
aiua-10141	12	61	on	on	ADP
aiua-10141	12	62	the	the	DET
aiua-10141	12	63	male	male	ADJ
aiua-10141	12	64	reproductive	reproductive	ADJ
aiua-10141	12	65	system	system	NOUN
aiua-10141	12	66	are	be	AUX
aiua-10141	12	67	currently	currently	ADV
aiua-10141	12	68	insufficient	insufficient	ADJ
aiua-10141	12	69	as	as	SCONJ
aiua-10141	12	70	they	they	PRON
aiua-10141	12	71	are	be	AUX
aiua-10141	12	72	based	base	VERB
aiua-10141	12	73	on	on	ADP
aiua-10141	12	74	a	a	DET
aiua-10141	12	75	small	small	ADJ
aiua-10141	12	76	number	number	NOUN
aiua-10141	12	77	of	of	ADP
aiua-10141	12	78	patients	patient	NOUN
aiua-10141	12	79	and	and	CCONJ
aiua-10141	12	80	therefore	therefore	ADV
aiua-10141	12	81	are	be	AUX
aiua-10141	12	82	often	often	ADV
aiua-10141	12	83	contradictory	contradictory	ADJ
aiua-10141	12	84	(	(	PUNCT
aiua-10141	12	85	11	11	NUM
aiua-10141	12	86	)	)	PUNCT
aiua-10141	12	87	.	.	PUNCT
aiua-10141	13	1	our	our	PRON
aiua-10141	13	2	study	study	NOUN
aiua-10141	13	3	aimed	aim	VERB
aiua-10141	13	4	to	to	PART
aiua-10141	13	5	figure	figure	VERB
aiua-10141	13	6	out	out	ADP
aiua-10141	13	7	the	the	DET
aiua-10141	13	8	factors	factor	NOUN
aiua-10141	13	9	which	which	PRON
aiua-10141	13	10	may	may	AUX
aiua-10141	13	11	play	play	VERB
aiua-10141	13	12	a	a	DET
aiua-10141	13	13	role	role	NOUN
aiua-10141	13	14	in	in	ADP
aiua-10141	13	15	the	the	DET
aiua-10141	13	16	development	development	NOUN
aiua-10141	13	17	of	of	ADP
aiua-10141	13	18	ed	ed	NOUN
aiua-10141	13	19	in	in	ADP
aiua-10141	13	20	our	our	PRON
aiua-10141	13	21	patients	patient	NOUN
aiua-10141	13	22	with	with	ADP
aiua-10141	13	23	covid-19	covid-19	PROPN
aiua-10141	13	24	and	and	CCONJ
aiua-10141	13	25	the	the	DET
aiua-10141	13	26	effect	effect	NOUN
aiua-10141	13	27	of	of	ADP
aiua-10141	13	28	testosterone	testosterone	NOUN
aiua-10141	13	29	level	level	NOUN
aiua-10141	13	30	on	on	ADP
aiua-10141	13	31	the	the	DET
aiua-10141	13	32	prognosis	prognosis	NOUN
aiua-10141	13	33	of	of	ADP
aiua-10141	13	34	covid-19	covid-19	PROPN
aiua-10141	13	35	.	.	PUNCT
aiua-10141	14	1	materials	material	NOUN
aiua-10141	14	2	and	and	CCONJ
aiua-10141	14	3	methods	method	NOUN
aiua-10141	14	4	study	study	NOUN
aiua-10141	14	5	design	design	NOUN
aiua-10141	14	6	and	and	CCONJ
aiua-10141	14	7	patients	patient	NOUN
aiua-10141	14	8	our	our	PRON
aiua-10141	14	9	study	study	NOUN
aiua-10141	14	10	has	have	AUX
aiua-10141	14	11	been	be	AUX
aiua-10141	14	12	designed	design	VERB
aiua-10141	14	13	after	after	ADP
aiua-10141	14	14	being	be	AUX
aiua-10141	14	15	approved	approve	VERB
aiua-10141	14	16	by	by	ADP
aiua-10141	14	17	the	the	DET
aiua-10141	14	18	republic	republic	PROPN
aiua-10141	14	19	of	of	ADP
aiua-10141	14	20	turkey	turkey	PROPN
aiua-10141	14	21	ministry	ministry	PROPN
aiua-10141	14	22	of	of	ADP
aiua-10141	14	23	health	health	PROPN
aiua-10141	14	24	and	and	CCONJ
aiua-10141	14	25	the	the	DET
aiua-10141	14	26	local	local	ADJ
aiua-10141	14	27	ethics	ethic	NOUN
aiua-10141	14	28	committee	committee	PROPN
aiua-10141	14	29	(	(	PUNCT
aiua-10141	14	30	ethical	ethical	ADJ
aiua-10141	14	31	committe	committe	NOUN
aiua-10141	14	32	approval	approval	NOUN
aiua-10141	14	33	number	number	NOUN
aiua-10141	14	34	:	:	PUNCT
aiua-10141	14	35	1303/27.01.2021	1303/27.01.2021	NUM
aiua-10141	14	36	)	)	PUNCT
aiua-10141	14	37	and	and	CCONJ
aiua-10141	14	38	210	210	NUM
aiua-10141	14	39	patients	patient	NOUN
aiua-10141	14	40	who	who	PRON
aiua-10141	14	41	were	be	AUX
aiua-10141	14	42	admitted	admit	VERB
aiua-10141	14	43	objective	objective	ADJ
aiua-10141	14	44	:	:	PUNCT
aiua-10141	14	45	we	we	PRON
aiua-10141	14	46	aimed	aim	VERB
aiua-10141	14	47	to	to	PART
aiua-10141	14	48	investigate	investigate	VERB
aiua-10141	14	49	the	the	DET
aiua-10141	14	50	relationship	relationship	NOUN
aiua-10141	14	51	between	between	ADP
aiua-10141	14	52	covid-19	covid-19	PROPN
aiua-10141	14	53	and	and	CCONJ
aiua-10141	14	54	erectile	erectile	ADJ
aiua-10141	14	55	dysfunction	dysfunction	NOUN
aiua-10141	14	56	(	(	PUNCT
aiua-10141	14	57	ed	ed	NOUN
aiua-10141	14	58	)	)	PUNCT
aiua-10141	14	59	and	and	CCONJ
aiua-10141	14	60	the	the	DET
aiua-10141	14	61	effect	effect	NOUN
aiua-10141	14	62	of	of	ADP
aiua-10141	14	63	serum	serum	NOUN
aiua-10141	14	64	testosterone	testosterone	NOUN
aiua-10141	14	65	level	level	NOUN
aiua-10141	14	66	on	on	ADP
aiua-10141	14	67	the	the	DET
aiua-10141	14	68	disease	disease	NOUN
aiua-10141	14	69	prognosis	prognosis	NOUN
aiua-10141	14	70	.	.	PUNCT
aiua-10141	15	1	methods	method	NOUN
aiua-10141	15	2	:	:	PUNCT
aiua-10141	15	3	between	between	ADP
aiua-10141	15	4	april	april	PROPN
aiua-10141	15	5	-	-	PUNCT
aiua-10141	15	6	december	december	PROPN
aiua-10141	15	7	2020	2020	NUM
aiua-10141	15	8	,	,	PUNCT
aiua-10141	15	9	70	70	NUM
aiua-10141	15	10	patients	patient	NOUN
aiua-10141	15	11	who	who	PRON
aiua-10141	15	12	were	be	AUX
aiua-10141	15	13	admitted	admit	VERB
aiua-10141	15	14	with	with	ADP
aiua-10141	15	15	a	a	DET
aiua-10141	15	16	complaint	complaint	NOUN
aiua-10141	15	17	of	of	ADP
aiua-10141	15	18	ed	ed	NOUN
aiua-10141	15	19	after	after	ADP
aiua-10141	15	20	having	have	VERB
aiua-10141	15	21	covid-19	covid-19	PROPN
aiua-10141	15	22	and	and	CCONJ
aiua-10141	15	23	whose	whose	DET
aiua-10141	15	24	serum	serum	NOUN
aiua-10141	15	25	testosterone	testosterone	NOUN
aiua-10141	15	26	level	level	NOUN
aiua-10141	15	27	was	be	AUX
aiua-10141	15	28	checked	check	VERB
aiua-10141	15	29	for	for	ADP
aiua-10141	15	30	varicocele	varicocele	NOUN
aiua-10141	15	31	,	,	PUNCT
aiua-10141	15	32	premature	premature	ADJ
aiua-10141	15	33	ejaculation	ejaculation	NOUN
aiua-10141	15	34	,	,	PUNCT
aiua-10141	15	35	and	and	CCONJ
aiua-10141	15	36	infertility	infertility	NOUN
aiua-10141	15	37	reasons	reason	NOUN
aiua-10141	15	38	before	before	ADP
aiua-10141	15	39	covid-19	covid-19	PROPN
aiua-10141	15	40	.	.	PUNCT
aiua-10141	16	1	the	the	DET
aiua-10141	16	2	patients	patient	NOUN
aiua-10141	16	3	filled	fill	VERB
aiua-10141	16	4	the	the	DET
aiua-10141	16	5	international	international	ADJ
aiua-10141	16	6	index	index	NOUN
aiua-10141	16	7	of	of	ADP
aiua-10141	16	8	erectile	erectile	NOUN
aiua-10141	16	9	function	function	NOUN
aiua-10141	16	10	(	(	PUNCT
aiua-10141	16	11	iief-5	iief-5	NUM
aiua-10141	16	12	)	)	PUNCT
aiua-10141	16	13	and	and	CCONJ
aiua-10141	16	14	their	their	PRON
aiua-10141	16	15	testosterone	testosterone	NOUN
aiua-10141	16	16	level	level	NOUN
aiua-10141	16	17	was	be	AUX
aiua-10141	16	18	checked	check	VERB
aiua-10141	16	19	.	.	PUNCT
aiua-10141	17	1	the	the	DET
aiua-10141	17	2	questionnaire	questionnaire	NOUN
aiua-10141	17	3	was	be	AUX
aiua-10141	17	4	arranged	arrange	VERB
aiua-10141	17	5	to	to	PART
aiua-10141	17	6	assess	assess	VERB
aiua-10141	17	7	the	the	DET
aiua-10141	17	8	first	first	ADJ
aiua-10141	17	9	month	month	NOUN
aiua-10141	17	10	before	before	ADP
aiua-10141	17	11	covid-19	covid-19	PROPN
aiua-10141	17	12	and	and	CCONJ
aiua-10141	17	13	after	after	ADP
aiua-10141	17	14	covid-19	covid-19	PROPN
aiua-10141	17	15	.	.	PUNCT
aiua-10141	17	16	testosterone	testosterone	NOUN
aiua-10141	17	17	levels	level	NOUN
aiua-10141	17	18	of	of	ADP
aiua-10141	17	19	the	the	DET
aiua-10141	17	20	patients	patient	NOUN
aiua-10141	17	21	before	before	ADP
aiua-10141	17	22	and	and	CCONJ
aiua-10141	17	23	after	after	SCONJ
aiua-10141	17	24	covid-19	covid-19	PROPN
aiua-10141	17	25	were	be	AUX
aiua-10141	17	26	compared	compare	VERB
aiua-10141	17	27	.	.	PUNCT
aiua-10141	18	1	the	the	DET
aiua-10141	18	2	relationship	relationship	NOUN
aiua-10141	18	3	between	between	ADP
aiua-10141	18	4	testosterone	testosterone	NOUN
aiua-10141	18	5	levels	level	NOUN
aiua-10141	18	6	and	and	CCONJ
aiua-10141	18	7	hospitalization	hospitalization	NOUN
aiua-10141	18	8	in	in	ADP
aiua-10141	18	9	the	the	DET
aiua-10141	18	10	intensive	intensive	ADJ
aiua-10141	18	11	care	care	NOUN
aiua-10141	18	12	was	be	AUX
aiua-10141	18	13	evaluated	evaluate	VERB
aiua-10141	18	14	.	.	PUNCT
aiua-10141	19	1	results	result	NOUN
aiua-10141	19	2	:	:	PUNCT
aiua-10141	19	3	it	it	PRON
aiua-10141	19	4	was	be	AUX
aiua-10141	19	5	revealed	reveal	VERB
aiua-10141	19	6	that	that	SCONJ
aiua-10141	19	7	testosterone	testosterone	NOUN
aiua-10141	19	8	levels	level	NOUN
aiua-10141	19	9	and	and	CCONJ
aiua-10141	19	10	iief-5	iief-5	NUM
aiua-10141	19	11	scores	score	NOUN
aiua-10141	19	12	after	after	ADP
aiua-10141	19	13	covid-19	covid-19	PROPN
aiua-10141	19	14	in	in	ADP
aiua-10141	19	15	all	all	DET
aiua-10141	19	16	patients	patient	NOUN
aiua-10141	19	17	were	be	AUX
aiua-10141	19	18	statisticaly	statisticaly	ADJ
aiua-10141	19	19	and	and	CCONJ
aiua-10141	19	20	significantly	significantly	ADV
aiua-10141	19	21	different	different	ADJ
aiua-10141	19	22	compared	compare	VERB
aiua-10141	19	23	to	to	ADP
aiua-10141	19	24	the	the	DET
aiua-10141	19	25	period	period	NOUN
aiua-10141	19	26	before	before	ADP
aiua-10141	19	27	covid-19	covid-19	PROPN
aiua-10141	19	28	(	(	PUNCT
aiua-10141	19	29	p	p	X
aiua-10141	19	30	<	<	X
aiua-10141	19	31	0.05	0.05	NUM
aiua-10141	19	32	)	)	PUNCT
aiua-10141	19	33	.	.	PUNCT
aiua-10141	20	1	testosterone	testosterone	NOUN
aiua-10141	20	2	levels	level	NOUN
aiua-10141	20	3	of	of	ADP
aiua-10141	20	4	patients	patient	NOUN
aiua-10141	20	5	in	in	ADP
aiua-10141	20	6	need	need	NOUN
aiua-10141	20	7	of	of	ADP
aiua-10141	20	8	intensive	intensive	ADJ
aiua-10141	20	9	care	care	NOUN
aiua-10141	20	10	were	be	AUX
aiua-10141	20	11	significantly	significantly	ADV
aiua-10141	20	12	higher	high	ADJ
aiua-10141	20	13	than	than	ADP
aiua-10141	20	14	those	those	PRON
aiua-10141	20	15	without	without	ADP
aiua-10141	20	16	any	any	DET
aiua-10141	20	17	need	need	NOUN
aiua-10141	20	18	of	of	ADP
aiua-10141	20	19	intensive	intensive	ADJ
aiua-10141	20	20	care	care	NOUN
aiua-10141	20	21	(	(	PUNCT
aiua-10141	20	22	p	p	X
aiua-10141	20	23	<	<	X
aiua-10141	20	24	0.05	0.05	NUM
aiua-10141	20	25	)	)	PUNCT
aiua-10141	20	26	.	.	PUNCT
aiua-10141	21	1	conclusions	conclusion	NOUN
aiua-10141	21	2	:	:	PUNCT
aiua-10141	21	3	our	our	PRON
aiua-10141	21	4	study	study	NOUN
aiua-10141	21	5	has	have	AUX
aiua-10141	21	6	presented	present	VERB
aiua-10141	21	7	that	that	SCONJ
aiua-10141	21	8	covid-19	covid-19	PROPN
aiua-10141	21	9	may	may	AUX
aiua-10141	21	10	cause	cause	VERB
aiua-10141	21	11	ed	ed	NOUN
aiua-10141	21	12	and	and	CCONJ
aiua-10141	21	13	high	high	ADJ
aiua-10141	21	14	testosterone	testosterone	NOUN
aiua-10141	21	15	levels	level	NOUN
aiua-10141	21	16	increase	increase	VERB
aiua-10141	21	17	the	the	DET
aiua-10141	21	18	rate	rate	NOUN
aiua-10141	21	19	of	of	ADP
aiua-10141	21	20	hospitalization	hospitalization	NOUN
aiua-10141	21	21	in	in	ADP
aiua-10141	21	22	the	the	DET
aiua-10141	21	23	intensive	intensive	ADJ
aiua-10141	21	24	care	care	NOUN
aiua-10141	21	25	by	by	ADP
aiua-10141	21	26	intensifying	intensify	VERB
aiua-10141	21	27	the	the	DET
aiua-10141	21	28	disease	disease	NOUN
aiua-10141	21	29	.	.	PUNCT
aiua-10141	22	1	key	key	ADJ
aiua-10141	22	2	words	word	NOUN
aiua-10141	22	3	:	:	PUNCT
aiua-10141	22	4	covid-19	covid-19	PROPN
aiua-10141	22	5	;	;	PUNCT
aiua-10141	22	6	erectile	erectile	ADJ
aiua-10141	22	7	dysfunction	dysfunction	NOUN
aiua-10141	22	8	;	;	PUNCT
aiua-10141	22	9	testosterone	testosterone	NOUN
aiua-10141	22	10	.	.	PUNCT
aiua-10141	22	11	submitted	submit	VERB
aiua-10141	22	12	18	18	NUM
aiua-10141	22	13	september	september	PROPN
aiua-10141	22	14	2021	2021	NUM
aiua-10141	22	15	;	;	PUNCT
aiua-10141	22	16	accepted	accept	VERB
aiua-10141	22	17	9	9	NUM
aiua-10141	22	18	october	october	NOUN
aiua-10141	22	19	2021	2021	NUM
aiua-10141	22	20	introduction	introduction	NOUN
aiua-10141	22	21	the	the	DET
aiua-10141	22	22	global	global	ADJ
aiua-10141	22	23	coronavirus	coronavirus	NOUN
aiua-10141	22	24	disease	disease	NOUN
aiua-10141	22	25	(	(	PUNCT
aiua-10141	22	26	covid-19	covid-19	PROPN
aiua-10141	22	27	)	)	PUNCT
aiua-10141	22	28	results	result	NOUN
aiua-10141	22	29	in	in	ADP
aiua-10141	22	30	a	a	DET
aiua-10141	22	31	cytokine	cytokine	ADJ
aiua-10141	22	32	storm	storm	NOUN
aiua-10141	22	33	that	that	PRON
aiua-10141	22	34	leads	lead	VERB
aiua-10141	22	35	to	to	ADP
aiua-10141	22	36	the	the	DET
aiua-10141	22	37	development	development	NOUN
aiua-10141	22	38	of	of	ADP
aiua-10141	22	39	microthrombosis	microthrombosis	NOUN
aiua-10141	22	40	and	and	CCONJ
aiua-10141	22	41	diffuse	diffuse	VERB
aiua-10141	22	42	intravascular	intravascular	ADJ
aiua-10141	22	43	coagulation	coagulation	NOUN
aiua-10141	22	44	(	(	PUNCT
aiua-10141	22	45	dic	dic	ADJ
aiua-10141	22	46	)	)	PUNCT
aiua-10141	22	47	(	(	PUNCT
aiua-10141	22	48	1	1	NUM
aiua-10141	22	49	)	)	PUNCT
aiua-10141	22	50	.	.	PUNCT
aiua-10141	23	1	despite	despite	SCONJ
aiua-10141	23	2	the	the	DET
aiua-10141	23	3	fact	fact	NOUN
aiua-10141	23	4	that	that	SCONJ
aiua-10141	23	5	lungs	lung	NOUN
aiua-10141	23	6	are	be	AUX
aiua-10141	23	7	the	the	DET
aiua-10141	23	8	organs	organ	NOUN
aiua-10141	23	9	which	which	PRON
aiua-10141	23	10	are	be	AUX
aiua-10141	23	11	primarily	primarily	ADV
aiua-10141	23	12	targeted	target	VERB
aiua-10141	23	13	in	in	ADP
aiua-10141	23	14	cytokine	cytokine	NOUN
aiua-10141	23	15	storm	storm	NOUN
aiua-10141	23	16	,	,	PUNCT
aiua-10141	23	17	the	the	DET
aiua-10141	23	18	cardiovascular	cardiovascular	ADJ
aiua-10141	23	19	system	system	NOUN
aiua-10141	23	20	is	be	AUX
aiua-10141	23	21	also	also	ADV
aiua-10141	23	22	affected	affect	VERB
aiua-10141	23	23	.	.	PUNCT
aiua-10141	24	1	the	the	DET
aiua-10141	24	2	autopsies	autopsy	NOUN
aiua-10141	24	3	which	which	PRON
aiua-10141	24	4	were	be	AUX
aiua-10141	24	5	performed	perform	VERB
aiua-10141	24	6	showed	show	VERB
aiua-10141	24	7	that	that	SCONJ
aiua-10141	24	8	there	there	PRON
aiua-10141	24	9	were	be	VERB
aiua-10141	24	10	signs	sign	NOUN
aiua-10141	24	11	of	of	ADP
aiua-10141	24	12	endothelial	endothelial	ADJ
aiua-10141	24	13	damage	damage	NOUN
aiua-10141	24	14	,	,	PUNCT
aiua-10141	24	15	pulmonary	pulmonary	ADJ
aiua-10141	24	16	embolism	embolism	NOUN
aiua-10141	24	17	,	,	PUNCT
aiua-10141	24	18	bleeding	bleed	VERB
aiua-10141	24	19	at	at	ADP
aiua-10141	24	20	multiple	multiple	ADJ
aiua-10141	24	21	levels	level	NOUN
aiua-10141	24	22	including	include	VERB
aiua-10141	24	23	alveolar	alveolar	ADJ
aiua-10141	24	24	,	,	PUNCT
aiua-10141	24	25	microangiopathy	microangiopathy	ADJ
aiua-10141	24	26	,	,	PUNCT
aiua-10141	24	27	and	and	CCONJ
aiua-10141	24	28	vascular	vascular	ADJ
aiua-10141	24	29	dysfunctions	dysfunction	NOUN
aiua-10141	24	30	in	in	ADP
aiua-10141	24	31	the	the	DET
aiua-10141	24	32	form	form	NOUN
aiua-10141	24	33	of	of	ADP
aiua-10141	24	34	vasculitis	vasculitis	PROPN
aiua-10141	24	35	(	(	PUNCT
aiua-10141	24	36	2	2	NUM
aiua-10141	24	37	)	)	PUNCT
aiua-10141	24	38	.	.	PUNCT
aiua-10141	25	1	the	the	DET
aiua-10141	25	2	relationship	relationship	NOUN
aiua-10141	25	3	between	between	ADP
aiua-10141	25	4	erectile	erectile	ADJ
aiua-10141	25	5	dysfunction	dysfunction	NOUN
aiua-10141	25	6	(	(	PUNCT
aiua-10141	25	7	ed	ed	NOUN
aiua-10141	25	8	)	)	PUNCT
aiua-10141	25	9	and	and	CCONJ
aiua-10141	25	10	covid-19	covid-19	PROPN
aiua-10141	25	11	develops	develop	VERB
aiua-10141	25	12	due	due	ADJ
aiua-10141	25	13	to	to	ADP
aiua-10141	25	14	vasculogenic	vasculogenic	ADJ
aiua-10141	25	15	and	and	CCONJ
aiua-10141	25	16	hormonal	hormonal	ADJ
aiua-10141	25	17	causes	cause	NOUN
aiua-10141	25	18	which	which	PRON
aiua-10141	25	19	were	be	AUX
aiua-10141	25	20	caused	cause	VERB
aiua-10141	25	21	by	by	ADP
aiua-10141	25	22	the	the	DET
aiua-10141	25	23	primary	primary	ADJ
aiua-10141	25	24	disease	disease	NOUN
aiua-10141	25	25	.	.	PUNCT
aiua-10141	26	1	the	the	DET
aiua-10141	26	2	vasculogenic	vasculogenic	ADJ
aiua-10141	26	3	damage	damage	NOUN
aiua-10141	26	4	and	and	CCONJ
aiua-10141	26	5	ed	ed	NOUN
aiua-10141	26	6	are	be	AUX
aiua-10141	26	7	also	also	ADV
aiua-10141	26	8	seen	see	VERB
aiua-10141	26	9	as	as	ADP
aiua-10141	26	10	predictors	predictor	NOUN
aiua-10141	26	11	of	of	ADP
aiua-10141	26	12	a	a	DET
aiua-10141	26	13	cardiovascular	cardiovascular	ADJ
aiua-10141	26	14	pathology	pathology	NOUN
aiua-10141	26	15	which	which	PRON
aiua-10141	26	16	may	may	AUX
aiua-10141	26	17	be	be	AUX
aiua-10141	26	18	observed	observe	VERB
aiua-10141	26	19	in	in	ADP
aiua-10141	26	20	patients	patient	NOUN
aiua-10141	26	21	in	in	ADP
aiua-10141	26	22	the	the	DET
aiua-10141	26	23	future	future	NOUN
aiua-10141	26	24	(	(	PUNCT
aiua-10141	26	25	3	3	NUM
aiua-10141	26	26	)	)	PUNCT
aiua-10141	26	27	.	.	PUNCT
aiua-10141	27	1	testosterone	testosterone	NOUN
aiua-10141	27	2	,	,	PUNCT
aiua-10141	27	3	which	which	PRON
aiua-10141	27	4	is	be	AUX
aiua-10141	27	5	the	the	DET
aiua-10141	27	6	most	most	ADV
aiua-10141	27	7	important	important	ADJ
aiua-10141	27	8	hormone	hormone	NOUN
aiua-10141	27	9	in	in	ADP
aiua-10141	27	10	male	male	ADJ
aiua-10141	27	11	erection	erection	NOUN
aiua-10141	27	12	,	,	PUNCT
aiua-10141	27	13	modulates	modulate	VERB
aiua-10141	27	14	almost	almost	ADV
aiua-10141	27	15	every	every	PRON
aiua-10141	27	16	component	component	NOUN
aiua-10141	27	17	involved	involve	VERB
aiua-10141	27	18	in	in	ADP
aiua-10141	27	19	erectile	erectile	ADJ
aiua-10141	27	20	function	function	NOUN
aiua-10141	27	21	,	,	PUNCT
aiua-10141	27	22	from	from	ADP
aiua-10141	27	23	the	the	DET
aiua-10141	27	24	erectile	erectile	ADJ
aiua-10141	27	25	dysfunction	dysfunction	NOUN
aiua-10141	27	26	and	and	CCONJ
aiua-10141	27	27	testosterone	testosterone	NOUN
aiua-10141	27	28	levels	level	NOUN
aiua-10141	27	29	prior	prior	ADV
aiua-10141	27	30	to	to	ADP
aiua-10141	27	31	covid-19	covid-19	PROPN
aiua-10141	27	32	disease	disease	NOUN
aiua-10141	27	33	:	:	PUNCT
aiua-10141	27	34	what	what	PRON
aiua-10141	27	35	is	be	AUX
aiua-10141	27	36	the	the	DET
aiua-10141	27	37	relationship	relationship	NOUN
aiua-10141	27	38	?	?	PUNCT
aiua-10141	28	1	kadir	kadir	PROPN
aiua-10141	28	2	karkin	karkin	PROPN
aiua-10141	28	3	,	,	PUNCT
aiua-10141	28	4	ergün	ergün	VERB
aiua-10141	28	5	alma	alma	PROPN
aiua-10141	28	6	department	department	PROPN
aiua-10141	28	7	of	of	ADP
aiua-10141	28	8	urology	urology	NOUN
aiua-10141	28	9	,	,	PUNCT
aiua-10141	28	10	health	health	PROPN
aiua-10141	28	11	sciences	sciences	PROPN
aiua-10141	28	12	university	university	PROPN
aiua-10141	28	13	,	,	PUNCT
aiua-10141	28	14	adana	adana	PROPN
aiua-10141	28	15	city	city	PROPN
aiua-10141	28	16	training	training	NOUN
aiua-10141	28	17	and	and	CCONJ
aiua-10141	28	18	research	research	NOUN
aiua-10141	28	19	hospital	hospital	NOUN
aiua-10141	28	20	,	,	PUNCT
aiua-10141	28	21	adana	adana	PROPN
aiua-10141	28	22	,	,	PUNCT
aiua-10141	28	23	turkey	turkey	PROPN
aiua-10141	28	24	.	.	PUNCT
aiua-10141	29	1	doi	doi	NOUN
aiua-10141	29	2	:	:	PUNCT
aiua-10141	29	3	10.4081	10.4081	NUM
aiua-10141	29	4	/	/	SYM
aiua-10141	29	5	aiua.2021.4.460	aiua.2021.4.460	PROPN
aiua-10141	29	6	summary	summary	NOUN
aiua-10141	29	7	461archivio	461archivio	PROPN
aiua-10141	29	8	italiano	italiano	NOUN
aiua-10141	29	9	di	di	X
aiua-10141	29	10	urologia	urologia	PROPN
aiua-10141	29	11	e	e	PROPN
aiua-10141	29	12	andrologia	andrologia	NOUN
aiua-10141	29	13	2021	2021	NUM
aiua-10141	29	14	;	;	PUNCT
aiua-10141	29	15	93	93	NUM
aiua-10141	29	16	,	,	PUNCT
aiua-10141	29	17	4	4	NUM
aiua-10141	29	18	erectile	erectile	NOUN
aiua-10141	29	19	dysfunction	dysfunction	NOUN
aiua-10141	29	20	and	and	CCONJ
aiua-10141	29	21	testosterone	testosterone	NOUN
aiua-10141	29	22	in	in	ADP
aiua-10141	29	23	covid-19	covid-19	PROPN
aiua-10141	29	24	to	to	ADP
aiua-10141	29	25	our	our	PRON
aiua-10141	29	26	clinic	clinic	NOUN
aiua-10141	29	27	with	with	ADP
aiua-10141	29	28	a	a	DET
aiua-10141	29	29	complaint	complaint	NOUN
aiua-10141	29	30	of	of	ADP
aiua-10141	29	31	ed	ed	NOUN
aiua-10141	29	32	between	between	ADP
aiua-10141	29	33	aprildecember	aprildecember	PROPN
aiua-10141	29	34	2020	2020	NUM
aiua-10141	29	35	were	be	AUX
aiua-10141	29	36	evaluated	evaluate	VERB
aiua-10141	29	37	prospectively	prospectively	ADV
aiua-10141	29	38	.	.	PUNCT
aiua-10141	30	1	written	write	VERB
aiua-10141	30	2	consent	consent	NOUN
aiua-10141	30	3	forms	form	NOUN
aiua-10141	30	4	were	be	AUX
aiua-10141	30	5	obtained	obtain	VERB
aiua-10141	30	6	from	from	ADP
aiua-10141	30	7	all	all	DET
aiua-10141	30	8	patients	patient	NOUN
aiua-10141	30	9	who	who	PRON
aiua-10141	30	10	participated	participate	VERB
aiua-10141	30	11	in	in	ADP
aiua-10141	30	12	the	the	DET
aiua-10141	30	13	study	study	NOUN
aiua-10141	30	14	.	.	PUNCT
aiua-10141	31	1	in	in	ADP
aiua-10141	31	2	order	order	NOUN
aiua-10141	31	3	to	to	PART
aiua-10141	31	4	figure	figure	VERB
aiua-10141	31	5	out	out	ADP
aiua-10141	31	6	the	the	DET
aiua-10141	31	7	erectile	erectile	NOUN
aiua-10141	31	8	conditions	condition	NOUN
aiua-10141	31	9	of	of	ADP
aiua-10141	31	10	the	the	DET
aiua-10141	31	11	patients	patient	NOUN
aiua-10141	31	12	,	,	PUNCT
aiua-10141	31	13	the	the	DET
aiua-10141	31	14	iief-5	iief-5	NUM
aiua-10141	31	15	questionnaire	questionnaire	NOUN
aiua-10141	31	16	,	,	PUNCT
aiua-10141	31	17	fiveitem	fiveitem	PROPN
aiua-10141	31	18	short	short	ADJ
aiua-10141	31	19	version	version	NOUN
aiua-10141	31	20	of	of	ADP
aiua-10141	31	21	the	the	DET
aiua-10141	31	22	international	international	ADJ
aiua-10141	31	23	index	index	NOUN
aiua-10141	31	24	of	of	ADP
aiua-10141	31	25	erectile	erectile	NOUN
aiua-10141	31	26	function	function	NOUN
aiua-10141	31	27	(	(	PUNCT
aiua-10141	31	28	iief	iief	NOUN
aiua-10141	31	29	-	-	PUNCT
aiua-10141	31	30	ef	ef	NOUN
aiua-10141	31	31	)	)	PUNCT
aiua-10141	31	32	,	,	PUNCT
aiua-10141	31	33	was	be	AUX
aiua-10141	31	34	used	use	VERB
aiua-10141	31	35	.	.	PUNCT
aiua-10141	32	1	this	this	DET
aiua-10141	32	2	questionnaire	questionnaire	NOUN
aiua-10141	32	3	was	be	AUX
aiua-10141	32	4	designed	design	VERB
aiua-10141	32	5	in	in	ADP
aiua-10141	32	6	a	a	DET
aiua-10141	32	7	form	form	NOUN
aiua-10141	32	8	assessing	assess	VERB
aiua-10141	32	9	the	the	DET
aiua-10141	32	10	first	first	ADJ
aiua-10141	32	11	month	month	NOUN
aiua-10141	32	12	before	before	ADP
aiua-10141	32	13	covid-19	covid-19	PROPN
aiua-10141	32	14	infection	infection	NOUN
aiua-10141	32	15	and	and	CCONJ
aiua-10141	32	16	the	the	DET
aiua-10141	32	17	period	period	NOUN
aiua-10141	32	18	after	after	ADP
aiua-10141	32	19	covid-19	covid-19	PROPN
aiua-10141	32	20	.	.	PUNCT
aiua-10141	33	1	according	accord	VERB
aiua-10141	33	2	to	to	ADP
aiua-10141	33	3	this	this	DET
aiua-10141	33	4	form	form	NOUN
aiua-10141	33	5	,	,	PUNCT
aiua-10141	33	6	scores	score	NOUN
aiua-10141	33	7	between	between	ADP
aiua-10141	33	8	5	5	NUM
aiua-10141	33	9	-	-	SYM
aiua-10141	33	10	7	7	NUM
aiua-10141	33	11	were	be	AUX
aiua-10141	33	12	considered	consider	VERB
aiua-10141	33	13	as	as	ADP
aiua-10141	33	14	severe	severe	ADJ
aiua-10141	33	15	,	,	PUNCT
aiua-10141	33	16	8	8	NUM
aiua-10141	33	17	-	-	SYM
aiua-10141	33	18	17	17	NUM
aiua-10141	33	19	as	as	ADP
aiua-10141	33	20	moderate	moderate	ADJ
aiua-10141	33	21	,	,	PUNCT
aiua-10141	33	22	17	17	NUM
aiua-10141	33	23	-	-	SYM
aiua-10141	33	24	21	21	NUM
aiua-10141	33	25	as	as	ADV
aiua-10141	33	26	mild	mild	ADJ
aiua-10141	33	27	and	and	CCONJ
aiua-10141	33	28	22	22	NUM
aiua-10141	33	29	-	-	SYM
aiua-10141	33	30	25	25	NUM
aiua-10141	33	31	as	as	ADP
aiua-10141	33	32	no	no	DET
aiua-10141	33	33	ed	ed	NOUN
aiua-10141	33	34	.	.	PUNCT
aiua-10141	34	1	male	male	ADJ
aiua-10141	34	2	patients	patient	NOUN
aiua-10141	34	3	with	with	ADP
aiua-10141	34	4	an	an	DET
aiua-10141	34	5	elapsed	elapse	VERB
aiua-10141	34	6	time	time	NOUN
aiua-10141	34	7	at	at	ADP
aiua-10141	34	8	least	least	ADV
aiua-10141	34	9	six	six	NUM
aiua-10141	34	10	months	month	NOUN
aiua-10141	34	11	after	after	ADP
aiua-10141	34	12	covid-19	covid-19	PROPN
aiua-10141	34	13	and	and	CCONJ
aiua-10141	34	14	who	who	PRON
aiua-10141	34	15	did	do	AUX
aiua-10141	34	16	not	not	PART
aiua-10141	34	17	have	have	VERB
aiua-10141	34	18	ed	ed	NOUN
aiua-10141	34	19	according	accord	VERB
aiua-10141	34	20	to	to	ADP
aiua-10141	34	21	the	the	DET
aiua-10141	34	22	iief-5	iief-5	NUM
aiua-10141	34	23	score	score	NOUN
aiua-10141	34	24	before	before	ADP
aiua-10141	34	25	covid-19	covid-19	PROPN
aiua-10141	34	26	infection	infection	NOUN
aiua-10141	34	27	,	,	PUNCT
aiua-10141	34	28	and	and	CCONJ
aiua-10141	34	29	whose	whose	DET
aiua-10141	34	30	testosterone	testosterone	NOUN
aiua-10141	34	31	level	level	NOUN
aiua-10141	34	32	was	be	AUX
aiua-10141	34	33	measured	measure	VERB
aiua-10141	34	34	for	for	ADP
aiua-10141	34	35	varicocele	varicocele	NOUN
aiua-10141	34	36	,	,	PUNCT
aiua-10141	34	37	premature	premature	ADJ
aiua-10141	34	38	ejaculation	ejaculation	NOUN
aiua-10141	34	39	,	,	PUNCT
aiua-10141	34	40	infertility	infertility	NOUN
aiua-10141	34	41	reasons	reason	NOUN
aiua-10141	34	42	in	in	ADP
aiua-10141	34	43	the	the	DET
aiua-10141	34	44	last	last	ADJ
aiua-10141	34	45	year	year	NOUN
aiua-10141	34	46	were	be	AUX
aiua-10141	34	47	included	include	VERB
aiua-10141	34	48	in	in	ADP
aiua-10141	34	49	our	our	PRON
aiua-10141	34	50	study	study	NOUN
aiua-10141	34	51	.	.	PUNCT
aiua-10141	35	1	furthermore	furthermore	ADV
aiua-10141	35	2	,	,	PUNCT
aiua-10141	35	3	beck	beck	PROPN
aiua-10141	35	4	depression	depression	PROPN
aiua-10141	35	5	scale	scale	NOUN
aiua-10141	35	6	was	be	AUX
aiua-10141	35	7	used	use	VERB
aiua-10141	35	8	to	to	PART
aiua-10141	35	9	determine	determine	VERB
aiua-10141	35	10	the	the	DET
aiua-10141	35	11	current	current	ADJ
aiua-10141	35	12	depressive	depressive	ADJ
aiua-10141	35	13	states	state	NOUN
aiua-10141	35	14	of	of	ADP
aiua-10141	35	15	the	the	DET
aiua-10141	35	16	patients	patient	NOUN
aiua-10141	35	17	.	.	PUNCT
aiua-10141	36	1	patients	patient	NOUN
aiua-10141	36	2	with	with	ADP
aiua-10141	36	3	minimal	minimal	ADJ
aiua-10141	36	4	depression	depression	NOUN
aiua-10141	36	5	(	(	PUNCT
aiua-10141	36	6	0	0	NUM
aiua-10141	36	7	-	-	SYM
aiua-10141	36	8	9	9	NUM
aiua-10141	36	9	)	)	PUNCT
aiua-10141	36	10	according	accord	VERB
aiua-10141	36	11	to	to	ADP
aiua-10141	36	12	this	this	DET
aiua-10141	36	13	scale	scale	NOUN
aiua-10141	36	14	were	be	AUX
aiua-10141	36	15	included	include	VERB
aiua-10141	36	16	in	in	ADP
aiua-10141	36	17	the	the	DET
aiua-10141	36	18	study	study	NOUN
aiua-10141	36	19	.	.	PUNCT
aiua-10141	37	1	the	the	DET
aiua-10141	37	2	patients	patient	NOUN
aiua-10141	37	3	who	who	PRON
aiua-10141	37	4	had	have	VERB
aiua-10141	37	5	comorbidities	comorbiditie	NOUN
aiua-10141	37	6	before	before	ADP
aiua-10141	37	7	covid-19	covid-19	PROPN
aiua-10141	37	8	such	such	ADJ
aiua-10141	37	9	as	as	ADP
aiua-10141	37	10	obesity	obesity	NOUN
aiua-10141	37	11	,	,	PUNCT
aiua-10141	37	12	hypertension	hypertension	NOUN
aiua-10141	37	13	,	,	PUNCT
aiua-10141	37	14	diabetes	diabetes	NOUN
aiua-10141	37	15	or	or	CCONJ
aiua-10141	37	16	heart	heart	NOUN
aiua-10141	37	17	disease	disease	NOUN
aiua-10141	37	18	,	,	PUNCT
aiua-10141	37	19	the	the	DET
aiua-10141	37	20	patients	patient	NOUN
aiua-10141	37	21	who	who	PRON
aiua-10141	37	22	have	have	AUX
aiua-10141	37	23	used	use	VERB
aiua-10141	37	24	drugs	drug	NOUN
aiua-10141	37	25	(	(	PUNCT
aiua-10141	37	26	such	such	ADJ
aiua-10141	37	27	as	as	ADP
aiua-10141	37	28	beta	beta	NOUN
aiua-10141	37	29	blocker	blocker	NOUN
aiua-10141	37	30	)	)	PUNCT
aiua-10141	37	31	that	that	PRON
aiua-10141	37	32	can	can	AUX
aiua-10141	37	33	cause	cause	VERB
aiua-10141	37	34	ed	ed	NOUN
aiua-10141	37	35	during	during	ADP
aiua-10141	37	36	and	and	CCONJ
aiua-10141	37	37	after	after	ADP
aiua-10141	37	38	covid-19	covid-19	PROPN
aiua-10141	37	39	,	,	PUNCT
aiua-10141	37	40	the	the	DET
aiua-10141	37	41	patients	patient	NOUN
aiua-10141	37	42	with	with	ADP
aiua-10141	37	43	who	who	PRON
aiua-10141	37	44	had	have	VERB
aiua-10141	37	45	an	an	DET
aiua-10141	37	46	increase	increase	NOUN
aiua-10141	37	47	in	in	ADP
aiua-10141	37	48	smoking	smoking	NOUN
aiua-10141	37	49	and	and	CCONJ
aiua-10141	37	50	alcohol	alcohol	NOUN
aiua-10141	37	51	use	use	NOUN
aiua-10141	37	52	after	after	ADP
aiua-10141	37	53	covid-19	covid-19	PROPN
aiua-10141	37	54	,	,	PUNCT
aiua-10141	37	55	the	the	DET
aiua-10141	37	56	patients	patient	NOUN
aiua-10141	37	57	with	with	ADP
aiua-10141	37	58	an	an	DET
aiua-10141	37	59	elapsed	elapse	VERB
aiua-10141	37	60	time	time	NOUN
aiua-10141	37	61	of	of	ADP
aiua-10141	37	62	less	less	ADJ
aiua-10141	37	63	than	than	ADP
aiua-10141	37	64	6	6	NUM
aiua-10141	37	65	months	month	NOUN
aiua-10141	37	66	after	after	ADP
aiua-10141	37	67	covid-19	covid-19	PROPN
aiua-10141	37	68	,	,	PUNCT
aiua-10141	37	69	the	the	DET
aiua-10141	37	70	patients	patient	NOUN
aiua-10141	37	71	whose	whose	DET
aiua-10141	37	72	testosterone	testosterone	NOUN
aiua-10141	37	73	levels	level	NOUN
aiua-10141	37	74	were	be	AUX
aiua-10141	37	75	not	not	PART
aiua-10141	37	76	known	know	VERB
aiua-10141	37	77	before	before	ADP
aiua-10141	37	78	covid-19	covid-19	PROPN
aiua-10141	37	79	,	,	PUNCT
aiua-10141	37	80	the	the	DET
aiua-10141	37	81	patients	patient	NOUN
aiua-10141	37	82	who	who	PRON
aiua-10141	37	83	did	do	AUX
aiua-10141	37	84	not	not	PART
aiua-10141	37	85	have	have	VERB
aiua-10141	37	86	a	a	DET
aiua-10141	37	87	minimal	minimal	ADJ
aiua-10141	37	88	depression	depression	NOUN
aiua-10141	37	89	level	level	NOUN
aiua-10141	37	90	according	accord	VERB
aiua-10141	37	91	to	to	ADP
aiua-10141	37	92	the	the	DET
aiua-10141	37	93	beck	beck	NOUN
aiua-10141	37	94	depression	depression	PROPN
aiua-10141	37	95	scale	scale	NOUN
aiua-10141	37	96	,	,	PUNCT
aiua-10141	37	97	the	the	DET
aiua-10141	37	98	patients	patient	NOUN
aiua-10141	37	99	with	with	ADP
aiua-10141	37	100	an	an	DET
aiua-10141	37	101	iief-5	iief-5	NUM
aiua-10141	37	102	score	score	NOUN
aiua-10141	37	103	of	of	ADP
aiua-10141	37	104	21	21	NUM
aiua-10141	37	105	and	and	CCONJ
aiua-10141	37	106	below	below	ADV
aiua-10141	37	107	,	,	PUNCT
aiua-10141	37	108	the	the	DET
aiua-10141	37	109	patients	patient	NOUN
aiua-10141	37	110	who	who	PRON
aiua-10141	37	111	had	have	VERB
aiua-10141	37	112	treatment	treatment	NOUN
aiua-10141	37	113	for	for	ADP
aiua-10141	37	114	ed	ed	NOUN
aiua-10141	37	115	before	before	ADP
aiua-10141	37	116	covid-19	covid-19	PROPN
aiua-10141	37	117	,	,	PUNCT
aiua-10141	37	118	whose	whose	DET
aiua-10141	37	119	detailed	detailed	ADJ
aiua-10141	37	120	medical	medical	ADJ
aiua-10141	37	121	history	history	NOUN
aiua-10141	37	122	could	could	AUX
aiua-10141	37	123	not	not	PART
aiua-10141	37	124	be	be	AUX
aiua-10141	37	125	taken	take	VERB
aiua-10141	37	126	and	and	CCONJ
aiua-10141	37	127	who	who	PRON
aiua-10141	37	128	did	do	AUX
aiua-10141	37	129	not	not	PART
aiua-10141	37	130	have	have	VERB
aiua-10141	37	131	education	education	NOUN
aiua-10141	37	132	level	level	NOUN
aiua-10141	37	133	enough	enough	ADV
aiua-10141	37	134	to	to	PART
aiua-10141	37	135	fill	fill	VERB
aiua-10141	37	136	in	in	ADP
aiua-10141	37	137	iief-5	iief-5	NUM
aiua-10141	37	138	form	form	NOUN
aiua-10141	37	139	were	be	AUX
aiua-10141	37	140	not	not	PART
aiua-10141	37	141	included	include	VERB
aiua-10141	37	142	in	in	ADP
aiua-10141	37	143	the	the	DET
aiua-10141	37	144	study	study	NOUN
aiua-10141	37	145	.	.	PUNCT
aiua-10141	38	1	after	after	ADP
aiua-10141	38	2	being	be	AUX
aiua-10141	38	3	evaluated	evaluate	VERB
aiua-10141	38	4	according	accord	VERB
aiua-10141	38	5	to	to	ADP
aiua-10141	38	6	the	the	DET
aiua-10141	38	7	exclusion	exclusion	NOUN
aiua-10141	38	8	criteria	criterion	NOUN
aiua-10141	38	9	,	,	PUNCT
aiua-10141	38	10	our	our	PRON
aiua-10141	38	11	study	study	NOUN
aiua-10141	38	12	was	be	AUX
aiua-10141	38	13	carried	carry	VERB
aiua-10141	38	14	on	on	ADP
aiua-10141	38	15	with	with	ADP
aiua-10141	38	16	70	70	NUM
aiua-10141	38	17	patients	patient	NOUN
aiua-10141	38	18	.	.	PUNCT
aiua-10141	39	1	the	the	DET
aiua-10141	39	2	ages	age	NOUN
aiua-10141	39	3	of	of	ADP
aiua-10141	39	4	the	the	DET
aiua-10141	39	5	patients	patient	NOUN
aiua-10141	39	6	,	,	PUNCT
aiua-10141	39	7	their	their	PRON
aiua-10141	39	8	results	result	NOUN
aiua-10141	39	9	of	of	ADP
aiua-10141	39	10	covid-19	covid-19	PROPN
aiua-10141	39	11	polymerase	polymerase	NOUN
aiua-10141	39	12	chain	chain	NOUN
aiua-10141	39	13	reaction	reaction	NOUN
aiua-10141	39	14	(	(	PUNCT
aiua-10141	39	15	pcr	pcr	NOUN
aiua-10141	39	16	)	)	PUNCT
aiua-10141	39	17	test	test	NOUN
aiua-10141	39	18	,	,	PUNCT
aiua-10141	39	19	testosterone	testosterone	NOUN
aiua-10141	39	20	level	level	NOUN
aiua-10141	39	21	,	,	PUNCT
aiua-10141	39	22	reports	report	VERB
aiua-10141	39	23	consistent	consistent	ADJ
aiua-10141	39	24	with	with	ADP
aiua-10141	39	25	covid-19	covid-19	PROPN
aiua-10141	39	26	observed	observe	VERB
aiua-10141	39	27	in	in	ADP
aiua-10141	39	28	thoracic	thoracic	NOUN
aiua-10141	39	29	computed	compute	VERB
aiua-10141	39	30	tomography	tomography	NOUN
aiua-10141	39	31	(	(	PUNCT
aiua-10141	39	32	ct	ct	PROPN
aiua-10141	39	33	)	)	PUNCT
aiua-10141	39	34	and	and	CCONJ
aiua-10141	39	35	the	the	DET
aiua-10141	39	36	presence	presence	NOUN
aiua-10141	39	37	of	of	ADP
aiua-10141	39	38	hospitalization	hospitalization	NOUN
aiua-10141	39	39	in	in	ADP
aiua-10141	39	40	intensive	intensive	ADJ
aiua-10141	39	41	care	care	NOUN
aiua-10141	39	42	unit	unit	NOUN
aiua-10141	39	43	were	be	AUX
aiua-10141	39	44	recorded	record	VERB
aiua-10141	39	45	.	.	PUNCT
aiua-10141	40	1	the	the	DET
aiua-10141	40	2	patients	patient	NOUN
aiua-10141	40	3	were	be	AUX
aiua-10141	40	4	evaluated	evaluate	VERB
aiua-10141	40	5	after	after	ADP
aiua-10141	40	6	being	be	AUX
aiua-10141	40	7	classified	classify	VERB
aiua-10141	40	8	under	under	ADP
aiua-10141	40	9	three	three	NUM
aiua-10141	40	10	different	different	ADJ
aiua-10141	40	11	groups	group	NOUN
aiua-10141	40	12	according	accord	VERB
aiua-10141	40	13	to	to	ADP
aiua-10141	40	14	their	their	PRON
aiua-10141	40	15	ages	age	NOUN
aiua-10141	40	16	.	.	PUNCT
aiua-10141	41	1	the	the	DET
aiua-10141	41	2	patients	patient	NOUN
aiua-10141	41	3	aged	age	VERB
aiua-10141	41	4	between	between	ADP
aiua-10141	41	5	20	20	NUM
aiua-10141	41	6	-	-	SYM
aiua-10141	41	7	40	40	NUM
aiua-10141	41	8	were	be	AUX
aiua-10141	41	9	recorded	record	VERB
aiua-10141	41	10	in	in	ADP
aiua-10141	41	11	group	group	NOUN
aiua-10141	41	12	1	1	NUM
aiua-10141	41	13	,	,	PUNCT
aiua-10141	41	14	the	the	DET
aiua-10141	41	15	ones	one	NOUN
aiua-10141	41	16	aged	age	VERB
aiua-10141	41	17	between	between	ADP
aiua-10141	41	18	40	40	NUM
aiua-10141	41	19	-	-	SYM
aiua-10141	41	20	60	60	NUM
aiua-10141	41	21	were	be	AUX
aiua-10141	41	22	recorded	record	VERB
aiua-10141	41	23	in	in	ADP
aiua-10141	41	24	group	group	NOUN
aiua-10141	41	25	2	2	NUM
aiua-10141	41	26	and	and	CCONJ
aiua-10141	41	27	the	the	DET
aiua-10141	41	28	ones	one	NOUN
aiua-10141	41	29	aged	age	VERB
aiua-10141	41	30	60	60	NUM
aiua-10141	41	31	or	or	CCONJ
aiua-10141	41	32	over	over	ADV
aiua-10141	41	33	were	be	AUX
aiua-10141	41	34	recorded	record	VERB
aiua-10141	41	35	in	in	ADP
aiua-10141	41	36	group	group	NOUN
aiua-10141	41	37	3	3	NUM
aiua-10141	41	38	.	.	PUNCT
aiua-10141	42	1	the	the	DET
aiua-10141	42	2	levels	level	NOUN
aiua-10141	42	3	of	of	ADP
aiua-10141	42	4	serum	serum	NOUN
aiua-10141	42	5	testosterone	testosterone	NOUN
aiua-10141	42	6	before	before	ADP
aiua-10141	42	7	and	and	CCONJ
aiua-10141	42	8	after	after	ADP
aiua-10141	42	9	covid-19	covid-19	PROPN
aiua-10141	42	10	were	be	AUX
aiua-10141	42	11	compared	compare	VERB
aiua-10141	42	12	among	among	ADP
aiua-10141	42	13	the	the	DET
aiua-10141	42	14	groups	group	NOUN
aiua-10141	42	15	.	.	PUNCT
aiua-10141	43	1	the	the	DET
aiua-10141	43	2	relationship	relationship	NOUN
aiua-10141	43	3	between	between	ADP
aiua-10141	43	4	the	the	DET
aiua-10141	43	5	levels	level	NOUN
aiua-10141	43	6	of	of	ADP
aiua-10141	43	7	testosterone	testosterone	NOUN
aiua-10141	43	8	and	and	CCONJ
aiua-10141	43	9	the	the	DET
aiua-10141	43	10	hospitalization	hospitalization	NOUN
aiua-10141	43	11	in	in	ADP
aiua-10141	43	12	the	the	DET
aiua-10141	43	13	intensive	intensive	ADJ
aiua-10141	43	14	care	care	NOUN
aiua-10141	43	15	unit	unit	NOUN
aiua-10141	43	16	and	and	CCONJ
aiua-10141	43	17	ed	ed	NOUN
aiua-10141	43	18	states	state	NOUN
aiua-10141	43	19	of	of	ADP
aiua-10141	43	20	the	the	DET
aiua-10141	43	21	patients	patient	NOUN
aiua-10141	43	22	hospitalized	hospitalize	VERB
aiua-10141	43	23	in	in	ADP
aiua-10141	43	24	the	the	DET
aiua-10141	43	25	intensive	intensive	ADJ
aiua-10141	43	26	care	care	NOUN
aiua-10141	43	27	unit	unit	NOUN
aiua-10141	43	28	were	be	AUX
aiua-10141	43	29	evaluated	evaluate	VERB
aiua-10141	43	30	.	.	PUNCT
aiua-10141	44	1	data	datum	NOUN
aiua-10141	44	2	collection	collection	NOUN
aiua-10141	44	3	the	the	DET
aiua-10141	44	4	electronic	electronic	ADJ
aiua-10141	44	5	hospital	hospital	NOUN
aiua-10141	44	6	information	information	NOUN
aiua-10141	44	7	system	system	NOUN
aiua-10141	44	8	was	be	AUX
aiua-10141	44	9	used	use	VERB
aiua-10141	44	10	to	to	PART
aiua-10141	44	11	get	get	VERB
aiua-10141	44	12	epidemiological	epidemiological	ADJ
aiua-10141	44	13	data	datum	NOUN
aiua-10141	44	14	,	,	PUNCT
aiua-10141	44	15	including	include	VERB
aiua-10141	44	16	demographic	demographic	ADJ
aiua-10141	44	17	,	,	PUNCT
aiua-10141	44	18	clinical	clinical	ADJ
aiua-10141	44	19	and	and	CCONJ
aiua-10141	44	20	laboratory	laboratory	NOUN
aiua-10141	44	21	findings	finding	NOUN
aiua-10141	44	22	.	.	PUNCT
aiua-10141	45	1	considering	consider	VERB
aiua-10141	45	2	the	the	DET
aiua-10141	45	3	circadian	circadian	ADJ
aiua-10141	45	4	rhythm	rhythm	NOUN
aiua-10141	45	5	of	of	ADP
aiua-10141	45	6	testosterone	testosterone	NOUN
aiua-10141	45	7	release	release	NOUN
aiua-10141	45	8	,	,	PUNCT
aiua-10141	45	9	the	the	DET
aiua-10141	45	10	total	total	ADJ
aiua-10141	45	11	testosterone	testosterone	NOUN
aiua-10141	45	12	which	which	PRON
aiua-10141	45	13	were	be	AUX
aiua-10141	45	14	measured	measure	VERB
aiua-10141	45	15	in	in	ADP
aiua-10141	45	16	the	the	DET
aiua-10141	45	17	venous	venous	ADJ
aiua-10141	45	18	blood	blood	NOUN
aiua-10141	45	19	sample	sample	NOUN
aiua-10141	45	20	between	between	ADP
aiua-10141	45	21	7	7	NUM
aiua-10141	45	22	and	and	CCONJ
aiua-10141	45	23	11	11	NUM
aiua-10141	45	24	in	in	ADP
aiua-10141	45	25	the	the	DET
aiua-10141	45	26	morning	morning	NOUN
aiua-10141	45	27	were	be	AUX
aiua-10141	45	28	recorded	record	VERB
aiua-10141	45	29	.	.	PUNCT
aiua-10141	46	1	peripheral	peripheral	ADJ
aiua-10141	46	2	venous	venous	ADJ
aiua-10141	46	3	blood	blood	NOUN
aiua-10141	46	4	samples	sample	NOUN
aiua-10141	46	5	were	be	AUX
aiua-10141	46	6	evaluated	evaluate	VERB
aiua-10141	46	7	in	in	ADP
aiua-10141	46	8	the	the	DET
aiua-10141	46	9	central	central	ADJ
aiua-10141	46	10	laboratory	laboratory	NOUN
aiua-10141	46	11	of	of	ADP
aiua-10141	46	12	adana	adana	PROPN
aiua-10141	46	13	city	city	PROPN
aiua-10141	46	14	training	training	NOUN
aiua-10141	46	15	and	and	CCONJ
aiua-10141	46	16	research	research	NOUN
aiua-10141	46	17	hospital	hospital	NOUN
aiua-10141	46	18	by	by	ADP
aiua-10141	46	19	using	use	VERB
aiua-10141	46	20	the	the	DET
aiua-10141	46	21	standard	standard	ADJ
aiua-10141	46	22	procedures	procedure	NOUN
aiua-10141	46	23	.	.	PUNCT
aiua-10141	47	1	biochemical	biochemical	ADJ
aiua-10141	47	2	hormonal	hormonal	ADJ
aiua-10141	47	3	parameters	parameter	NOUN
aiua-10141	47	4	were	be	AUX
aiua-10141	47	5	measured	measure	VERB
aiua-10141	47	6	by	by	ADP
aiua-10141	47	7	siemens	siemens	PROPN
aiua-10141	47	8	advia	advia	PROPN
aiua-10141	47	9	1800	1800	NUM
aiua-10141	47	10	automatic	automatic	ADJ
aiua-10141	47	11	biochemistry	biochemistry	NOUN
aiua-10141	47	12	analyser	analyser	NOUN
aiua-10141	47	13	(	(	PUNCT
aiua-10141	47	14	siemens	siemens	PROPN
aiua-10141	47	15	healthcare	healthcare	PROPN
aiua-10141	47	16	diagnostics	diagnostics	PROPN
aiua-10141	47	17	inc	inc	PROPN
aiua-10141	47	18	,	,	PUNCT
aiua-10141	47	19	laboratory	laboratory	NOUN
aiua-10141	47	20	diagnostics	diagnostic	NOUN
aiua-10141	47	21	,	,	PUNCT
aiua-10141	47	22	advia	advia	PROPN
aiua-10141	47	23	centaur	centaur	PROPN
aiua-10141	47	24	xpt	xpt	PROPN
aiua-10141	47	25	,	,	PUNCT
aiua-10141	47	26	erlangen	erlangen	PROPN
aiua-10141	47	27	,	,	PUNCT
aiua-10141	47	28	germany	germany	PROPN
aiua-10141	47	29	,	,	PUNCT
aiua-10141	47	30	manufactured	manufacture	VERB
aiua-10141	47	31	in	in	ADP
aiua-10141	47	32	ireland	ireland	PROPN
aiua-10141	47	33	)	)	PUNCT
aiua-10141	47	34	.	.	PUNCT
aiua-10141	48	1	statistical	statistical	ADJ
aiua-10141	48	2	analysis	analysis	NOUN
aiua-10141	48	3	spss	spss	X
aiua-10141	48	4	23.0	23.0	NUM
aiua-10141	48	5	package	package	NOUN
aiua-10141	48	6	program	program	NOUN
aiua-10141	48	7	(	(	PUNCT
aiua-10141	48	8	ibm	ibm	PROPN
aiua-10141	48	9	,	,	PUNCT
aiua-10141	48	10	armonk	armonk	PROPN
aiua-10141	48	11	,	,	PUNCT
aiua-10141	48	12	ny	ny	PROPN
aiua-10141	48	13	)	)	PUNCT
aiua-10141	48	14	was	be	AUX
aiua-10141	48	15	used	use	VERB
aiua-10141	48	16	in	in	ADP
aiua-10141	48	17	the	the	DET
aiua-10141	48	18	statistical	statistical	ADJ
aiua-10141	48	19	analysis	analysis	NOUN
aiua-10141	48	20	of	of	ADP
aiua-10141	48	21	data	datum	NOUN
aiua-10141	48	22	.	.	PUNCT
aiua-10141	49	1	categorical	categorical	ADJ
aiua-10141	49	2	measurements	measurement	NOUN
aiua-10141	49	3	were	be	AUX
aiua-10141	49	4	summarized	summarize	VERB
aiua-10141	49	5	as	as	ADP
aiua-10141	49	6	numbers	number	NOUN
aiua-10141	49	7	and	and	CCONJ
aiua-10141	49	8	percentages	percentage	NOUN
aiua-10141	49	9	,	,	PUNCT
aiua-10141	49	10	continuous	continuous	ADJ
aiua-10141	49	11	measurements	measurement	NOUN
aiua-10141	49	12	were	be	AUX
aiua-10141	49	13	summarized	summarize	VERB
aiua-10141	49	14	as	as	ADP
aiua-10141	49	15	mean	mean	ADJ
aiua-10141	49	16	,	,	PUNCT
aiua-10141	49	17	standard	standard	ADJ
aiua-10141	49	18	deviation	deviation	NOUN
aiua-10141	49	19	and	and	CCONJ
aiua-10141	49	20	minimum	minimum	NOUN
aiua-10141	49	21	-	-	PUNCT
aiua-10141	49	22	maximum	maximum	NOUN
aiua-10141	49	23	.	.	PUNCT
aiua-10141	50	1	the	the	DET
aiua-10141	50	2	appropriateness	appropriateness	NOUN
aiua-10141	50	3	of	of	ADP
aiua-10141	50	4	the	the	DET
aiua-10141	50	5	variables	variable	NOUN
aiua-10141	50	6	to	to	ADP
aiua-10141	50	7	normal	normal	ADJ
aiua-10141	50	8	distribution	distribution	NOUN
aiua-10141	50	9	was	be	AUX
aiua-10141	50	10	investigated	investigate	VERB
aiua-10141	50	11	by	by	ADP
aiua-10141	50	12	using	use	VERB
aiua-10141	50	13	kolmogorov	kolmogorov	ADJ
aiua-10141	50	14	-	-	PUNCT
aiua-10141	50	15	smirnov	smirnov	NOUN
aiua-10141	50	16	/	/	SYM
aiua-10141	50	17	shapiro	shapiro	NOUN
aiua-10141	50	18	-	-	PUNCT
aiua-10141	50	19	wilk	wilk	NOUN
aiua-10141	50	20	tests	test	NOUN
aiua-10141	50	21	.	.	PUNCT
aiua-10141	51	1	mann	mann	PROPN
aiua-10141	51	2	-	-	PUNCT
aiua-10141	51	3	whitney	whitney	PROPN
aiua-10141	51	4	u	u	PROPN
aiua-10141	51	5	test	test	NOUN
aiua-10141	51	6	and	and	CCONJ
aiua-10141	51	7	wilcoxon	wilcoxon	PROPN
aiua-10141	51	8	test	test	NOUN
aiua-10141	51	9	were	be	AUX
aiua-10141	51	10	used	use	VERB
aiua-10141	51	11	in	in	ADP
aiua-10141	51	12	the	the	DET
aiua-10141	51	13	groups	group	NOUN
aiua-10141	51	14	which	which	PRON
aiua-10141	51	15	do	do	AUX
aiua-10141	51	16	not	not	PART
aiua-10141	51	17	agree	agree	VERB
aiua-10141	51	18	with	with	ADP
aiua-10141	51	19	normal	normal	ADJ
aiua-10141	51	20	distribution	distribution	NOUN
aiua-10141	51	21	.	.	PUNCT
aiua-10141	52	1	spearman	spearman	NOUN
aiua-10141	52	2	correlation	correlation	NOUN
aiua-10141	52	3	analysis	analysis	NOUN
aiua-10141	52	4	was	be	AUX
aiua-10141	52	5	benefited	benefit	VERB
aiua-10141	52	6	from	from	ADP
aiua-10141	52	7	in	in	ADP
aiua-10141	52	8	the	the	DET
aiua-10141	52	9	comparison	comparison	NOUN
aiua-10141	52	10	of	of	ADP
aiua-10141	52	11	the	the	DET
aiua-10141	52	12	relationship	relationship	NOUN
aiua-10141	52	13	between	between	ADP
aiua-10141	52	14	the	the	DET
aiua-10141	52	15	numerical	numerical	ADJ
aiua-10141	52	16	variables	variable	NOUN
aiua-10141	52	17	.	.	PUNCT
aiua-10141	53	1	statistical	statistical	ADJ
aiua-10141	53	2	significance	significance	NOUN
aiua-10141	53	3	level	level	NOUN
aiua-10141	53	4	was	be	AUX
aiua-10141	53	5	taken	take	VERB
aiua-10141	53	6	as	as	ADP
aiua-10141	53	7	0.05	0.05	NUM
aiua-10141	53	8	in	in	ADP
aiua-10141	53	9	all	all	DET
aiua-10141	53	10	tests	test	NOUN
aiua-10141	53	11	.	.	PUNCT
aiua-10141	54	1	results	result	VERB
aiua-10141	54	2	the	the	DET
aiua-10141	54	3	mean	mean	ADJ
aiua-10141	54	4	age	age	NOUN
aiua-10141	54	5	in	in	ADP
aiua-10141	54	6	our	our	PRON
aiua-10141	54	7	study	study	NOUN
aiua-10141	54	8	was	be	AUX
aiua-10141	54	9	52.3	52.3	NUM
aiua-10141	54	10	±	±	NUM
aiua-10141	54	11	13.5	13.5	NUM
aiua-10141	54	12	years	year	NOUN
aiua-10141	54	13	.	.	PUNCT
aiua-10141	55	1	when	when	SCONJ
aiua-10141	55	2	the	the	DET
aiua-10141	55	3	groups	group	NOUN
aiua-10141	55	4	were	be	AUX
aiua-10141	55	5	considered	consider	VERB
aiua-10141	55	6	,	,	PUNCT
aiua-10141	55	7	it	it	PRON
aiua-10141	55	8	was	be	AUX
aiua-10141	55	9	seen	see	VERB
aiua-10141	55	10	that	that	SCONJ
aiua-10141	55	11	22.9	22.9	NUM
aiua-10141	55	12	%	%	NOUN
aiua-10141	55	13	(	(	PUNCT
aiua-10141	55	14	n	n	NOUN
aiua-10141	55	15	=	=	SYM
aiua-10141	55	16	16	16	NUM
aiua-10141	55	17	)	)	PUNCT
aiua-10141	55	18	of	of	ADP
aiua-10141	55	19	the	the	DET
aiua-10141	55	20	patients	patient	NOUN
aiua-10141	55	21	were	be	AUX
aiua-10141	55	22	in	in	ADP
aiua-10141	55	23	group	group	NOUN
aiua-10141	55	24	1	1	NUM
aiua-10141	55	25	,	,	PUNCT
aiua-10141	55	26	47.1	47.1	NUM
aiua-10141	55	27	%	%	NOUN
aiua-10141	55	28	(	(	PUNCT
aiua-10141	55	29	n	n	NOUN
aiua-10141	55	30	=	=	SYM
aiua-10141	55	31	33	33	NUM
aiua-10141	55	32	)	)	PUNCT
aiua-10141	55	33	were	be	AUX
aiua-10141	55	34	in	in	ADP
aiua-10141	55	35	group	group	NOUN
aiua-10141	55	36	2	2	NUM
aiua-10141	55	37	and	and	CCONJ
aiua-10141	55	38	30	30	NUM
aiua-10141	55	39	%	%	NOUN
aiua-10141	55	40	(	(	PUNCT
aiua-10141	55	41	n	n	NOUN
aiua-10141	55	42	=	=	SYM
aiua-10141	55	43	21	21	NUM
aiua-10141	55	44	)	)	PUNCT
aiua-10141	55	45	were	be	AUX
aiua-10141	55	46	in	in	ADP
aiua-10141	55	47	group	group	NOUN
aiua-10141	55	48	3	3	NUM
aiua-10141	55	49	.	.	PUNCT
aiua-10141	56	1	the	the	DET
aiua-10141	56	2	mean	mean	ADJ
aiua-10141	56	3	iief	iief	ADJ
aiua-10141	56	4	score	score	NOUN
aiua-10141	56	5	of	of	ADP
aiua-10141	56	6	the	the	DET
aiua-10141	56	7	patients	patient	NOUN
aiua-10141	56	8	was	be	AUX
aiua-10141	56	9	23	23	NUM
aiua-10141	56	10	before	before	ADP
aiua-10141	56	11	covid-19	covid-19	PROPN
aiua-10141	56	12	and	and	CCONJ
aiua-10141	56	13	11.03	11.03	NUM
aiua-10141	56	14	after	after	ADP
aiua-10141	56	15	covid-19	covid-19	PROPN
aiua-10141	56	16	(	(	PUNCT
aiua-10141	56	17	table	table	NOUN
aiua-10141	56	18	1	1	NUM
aiua-10141	56	19	)	)	PUNCT
aiua-10141	56	20	.	.	PUNCT
aiua-10141	57	1	no	no	DET
aiua-10141	57	2	statistical	statistical	ADJ
aiua-10141	57	3	difference	difference	NOUN
aiua-10141	57	4	was	be	AUX
aiua-10141	57	5	observed	observe	VERB
aiua-10141	57	6	between	between	ADP
aiua-10141	57	7	the	the	DET
aiua-10141	57	8	patient	patient	NOUN
aiua-10141	57	9	’s	’s	PART
aiua-10141	57	10	age	age	NOUN
aiua-10141	57	11	and	and	CCONJ
aiua-10141	57	12	the	the	DET
aiua-10141	57	13	rate	rate	NOUN
aiua-10141	57	14	of	of	ADP
aiua-10141	57	15	hospitalization	hospitalization	NOUN
aiua-10141	57	16	in	in	ADP
aiua-10141	57	17	the	the	DET
aiua-10141	57	18	intensive	intensive	ADJ
aiua-10141	57	19	care	care	NOUN
aiua-10141	57	20	unit	unit	NOUN
aiua-10141	57	21	(	(	PUNCT
aiua-10141	57	22	p	p	X
aiua-10141	57	23	>	>	X
aiua-10141	57	24	0.05	0.05	NUM
aiua-10141	57	25	)	)	PUNCT
aiua-10141	57	26	.	.	PUNCT
aiua-10141	58	1	a	a	DET
aiua-10141	58	2	statistically	statistically	ADV
aiua-10141	58	3	significant	significant	ADJ
aiua-10141	58	4	difference	difference	NOUN
aiua-10141	58	5	was	be	AUX
aiua-10141	58	6	observed	observe	VERB
aiua-10141	58	7	between	between	ADP
aiua-10141	58	8	the	the	DET
aiua-10141	58	9	iief	iief	ADJ
aiua-10141	58	10	scores	score	NOUN
aiua-10141	58	11	of	of	ADP
aiua-10141	58	12	the	the	DET
aiua-10141	58	13	patients	patient	NOUN
aiua-10141	58	14	with	with	ADP
aiua-10141	58	15	and	and	CCONJ
aiua-10141	58	16	without	without	ADP
aiua-10141	58	17	intensive	intensive	ADJ
aiua-10141	58	18	care	care	NOUN
aiua-10141	58	19	need	need	NOUN
aiua-10141	58	20	in	in	ADP
aiua-10141	58	21	the	the	DET
aiua-10141	58	22	period	period	NOUN
aiua-10141	58	23	after	after	ADP
aiua-10141	58	24	covid-19	covid-19	PROPN
aiua-10141	58	25	(	(	PUNCT
aiua-10141	58	26	p	p	X
aiua-10141	58	27	<	<	X
aiua-10141	58	28	0.05	0.05	NUM
aiua-10141	58	29	)	)	PUNCT
aiua-10141	58	30	.	.	PUNCT
aiua-10141	59	1	testosterone	testosterone	NOUN
aiua-10141	59	2	levels	level	NOUN
aiua-10141	59	3	of	of	ADP
aiua-10141	59	4	patients	patient	NOUN
aiua-10141	59	5	with	with	ADP
aiua-10141	59	6	intensive	intensive	ADJ
aiua-10141	59	7	care	care	NOUN
aiua-10141	59	8	need	need	NOUN
aiua-10141	59	9	were	be	AUX
aiua-10141	59	10	significantly	significantly	ADV
aiua-10141	59	11	higher	high	ADJ
aiua-10141	59	12	than	than	ADP
aiua-10141	59	13	those	those	PRON
aiua-10141	59	14	of	of	ADP
aiua-10141	59	15	the	the	DET
aiua-10141	59	16	patients	patient	NOUN
aiua-10141	59	17	without	without	ADP
aiua-10141	59	18	intensive	intensive	ADJ
aiua-10141	59	19	care	care	NOUN
aiua-10141	59	20	need	need	NOUN
aiua-10141	59	21	(	(	PUNCT
aiua-10141	59	22	p	p	X
aiua-10141	59	23	<	<	X
aiua-10141	59	24	0.05	0.05	NUM
aiua-10141	59	25	)	)	PUNCT
aiua-10141	59	26	(	(	PUNCT
aiua-10141	59	27	table	table	NOUN
aiua-10141	59	28	2	2	NUM
aiua-10141	59	29	)	)	PUNCT
aiua-10141	59	30	.	.	PUNCT
aiua-10141	60	1	testosterone	testosterone	NOUN
aiua-10141	60	2	levels	level	NOUN
aiua-10141	60	3	after	after	SCONJ
aiua-10141	60	4	covid-19	covid-19	PROPN
aiua-10141	60	5	were	be	AUX
aiua-10141	60	6	found	find	VERB
aiua-10141	60	7	significantly	significantly	ADV
aiua-10141	60	8	lower	low	ADJ
aiua-10141	60	9	than	than	ADP
aiua-10141	60	10	the	the	DET
aiua-10141	60	11	testosterone	testosterone	NOUN
aiua-10141	60	12	levels	level	NOUN
aiua-10141	60	13	before	before	ADP
aiua-10141	60	14	covid19	covid19	NOUN
aiua-10141	60	15	(	(	PUNCT
aiua-10141	60	16	p	p	X
aiua-10141	60	17	<	<	X
aiua-10141	60	18	0.001	0.001	NUM
aiua-10141	60	19	)	)	PUNCT
aiua-10141	60	20	.	.	PUNCT
aiua-10141	61	1	in	in	ADP
aiua-10141	61	2	all	all	DET
aiua-10141	61	3	three	three	NUM
aiua-10141	61	4	groups	group	NOUN
aiua-10141	61	5	,	,	PUNCT
aiua-10141	61	6	it	it	PRON
aiua-10141	61	7	was	be	AUX
aiua-10141	61	8	seen	see	VERB
aiua-10141	61	9	that	that	SCONJ
aiua-10141	61	10	testosterone	testosterone	NOUN
aiua-10141	61	11	levels	level	NOUN
aiua-10141	61	12	and	and	CCONJ
aiua-10141	61	13	iief	iief	ADJ
aiua-10141	61	14	scores	score	NOUN
aiua-10141	61	15	after	after	SCONJ
aiua-10141	61	16	covid-19	covid-19	PROPN
aiua-10141	61	17	were	be	AUX
aiua-10141	61	18	statistically	statistically	ADV
aiua-10141	61	19	and	and	CCONJ
aiua-10141	61	20	significantly	significantly	ADV
aiua-10141	61	21	different	different	ADJ
aiua-10141	61	22	compared	compare	VERB
aiua-10141	61	23	to	to	ADP
aiua-10141	61	24	the	the	DET
aiua-10141	61	25	ones	one	NOUN
aiua-10141	61	26	before	before	ADP
aiua-10141	61	27	covid-19	covid-19	PROPN
aiua-10141	61	28	(	(	PUNCT
aiua-10141	61	29	p	p	X
aiua-10141	61	30	<	<	X
aiua-10141	61	31	0.05	0.05	NUM
aiua-10141	61	32	)	)	PUNCT
aiua-10141	61	33	.	.	PUNCT
aiua-10141	62	1	as	as	SCONJ
aiua-10141	62	2	the	the	DET
aiua-10141	62	3	age	age	NOUN
aiua-10141	62	4	of	of	ADP
aiua-10141	62	5	the	the	DET
aiua-10141	62	6	patients	patient	NOUN
aiua-10141	62	7	increased	increase	VERB
aiua-10141	62	8	,	,	PUNCT
aiua-10141	62	9	iief	iief	ADJ
aiua-10141	62	10	scores	score	NOUN
aiua-10141	62	11	after	after	ADP
aiua-10141	62	12	covid-19	covid-19	PROPN
aiua-10141	62	13	and	and	CCONJ
aiua-10141	62	14	testosterone	testosterone	NOUN
aiua-10141	62	15	levels	level	NOUN
aiua-10141	62	16	before	before	ADP
aiua-10141	62	17	and	and	CCONJ
aiua-10141	62	18	after	after	SCONJ
aiua-10141	62	19	covid-19	covid-19	PROPN
aiua-10141	62	20	were	be	AUX
aiua-10141	62	21	found	find	VERB
aiua-10141	62	22	to	to	PART
aiua-10141	62	23	be	be	AUX
aiua-10141	62	24	significantly	significantly	ADV
aiua-10141	62	25	lower	low	ADJ
aiua-10141	62	26	(	(	PUNCT
aiua-10141	62	27	p	p	X
aiua-10141	62	28	<	<	X
aiua-10141	62	29	0.05	0.05	NUM
aiua-10141	62	30	)	)	PUNCT
aiua-10141	62	31	.	.	PUNCT
aiua-10141	63	1	also	also	ADV
aiua-10141	63	2	,	,	PUNCT
aiua-10141	63	3	there	there	PRON
aiua-10141	63	4	was	be	VERB
aiua-10141	63	5	a	a	DET
aiua-10141	63	6	statistically	statistically	ADV
aiua-10141	63	7	significant	significant	ADJ
aiua-10141	63	8	relationship	relationship	NOUN
aiua-10141	63	9	between	between	ADP
aiua-10141	63	10	iief	iief	ADJ
aiua-10141	63	11	scores	score	NOUN
aiua-10141	63	12	and	and	CCONJ
aiua-10141	63	13	testosterone	testosterone	NOUN
aiua-10141	63	14	levels	level	NOUN
aiua-10141	63	15	(	(	PUNCT
aiua-10141	63	16	p	p	X
aiua-10141	63	17	<	<	X
aiua-10141	63	18	0.05	0.05	NUM
aiua-10141	63	19	)	)	PUNCT
aiua-10141	63	20	.	.	PUNCT
aiua-10141	64	1	while	while	SCONJ
aiua-10141	64	2	there	there	PRON
aiua-10141	64	3	was	be	VERB
aiua-10141	64	4	a	a	DET
aiua-10141	64	5	positive	positive	ADJ
aiua-10141	64	6	corretable	corretable	NOUN
aiua-10141	64	7	1	1	NUM
aiua-10141	64	8	.	.	PUNCT
aiua-10141	64	9	demographic	demographic	ADJ
aiua-10141	64	10	data	datum	NOUN
aiua-10141	64	11	and	and	CCONJ
aiua-10141	64	12	mean	mean	VERB
aiua-10141	64	13	iief	iief	ADJ
aiua-10141	64	14	according	accord	VERB
aiua-10141	64	15	to	to	ADP
aiua-10141	64	16	the	the	DET
aiua-10141	64	17	patient	patient	ADJ
aiua-10141	64	18	groups	group	NOUN
aiua-10141	64	19	.	.	PUNCT
aiua-10141	65	1	age	age	NOUN
aiua-10141	65	2	frequency	frequency	NOUN
aiua-10141	65	3	(	(	PUNCT
aiua-10141	65	4	n	n	CCONJ
aiua-10141	65	5	)	)	PUNCT
aiua-10141	65	6	percentage	percentage	NOUN
aiua-10141	65	7	(	(	PUNCT
aiua-10141	65	8	%	%	NOUN
aiua-10141	65	9	)	)	PUNCT
aiua-10141	65	10	20	20	NUM
aiua-10141	65	11	-	-	SYM
aiua-10141	65	12	40	40	NUM
aiua-10141	65	13	16	16	NUM
aiua-10141	65	14	22.9	22.9	NUM
aiua-10141	65	15	40	40	NUM
aiua-10141	65	16	-	-	SYM
aiua-10141	65	17	60	60	NUM
aiua-10141	65	18	33	33	NUM
aiua-10141	65	19	47.1	47.1	NUM
aiua-10141	65	20	60	60	NUM
aiua-10141	65	21	and	and	CCONJ
aiua-10141	65	22	over	over	ADP
aiua-10141	65	23	21	21	NUM
aiua-10141	65	24	30	30	NUM
aiua-10141	65	25	mean	mean	NOUN
aiua-10141	65	26	±	±	NUM
aiua-10141	65	27	sd	sd	ADP
aiua-10141	65	28	mediann	mediann	PROPN
aiua-10141	65	29	(	(	PUNCT
aiua-10141	65	30	min	min	NOUN
aiua-10141	65	31	-	-	PUNCT
aiua-10141	65	32	max	max	NOUN
aiua-10141	65	33	)	)	PUNCT
aiua-10141	65	34	age	age	NOUN
aiua-10141	65	35	52.33	52.33	NUM
aiua-10141	65	36	±	±	NUM
aiua-10141	65	37	13.51	13.51	NUM
aiua-10141	65	38	56	56	NUM
aiua-10141	65	39	(	(	PUNCT
aiua-10141	65	40	22	22	NUM
aiua-10141	65	41	-	-	SYM
aiua-10141	65	42	74	74	NUM
aiua-10141	65	43	)	)	PUNCT
aiua-10141	65	44	iief	iief	ADJ
aiua-10141	65	45	score	score	NOUN
aiua-10141	65	46	before	before	SCONJ
aiua-10141	65	47	covid	covid	VERB
aiua-10141	65	48	23.5	23.5	NUM
aiua-10141	65	49	±	±	NUM
aiua-10141	65	50	1.57	1.57	NUM
aiua-10141	65	51	23	23	NUM
aiua-10141	65	52	(	(	PUNCT
aiua-10141	65	53	22	22	NUM
aiua-10141	65	54	-	-	SYM
aiua-10141	65	55	25	25	NUM
aiua-10141	65	56	)	)	PUNCT
aiua-10141	65	57	iief	iief	ADJ
aiua-10141	65	58	score	score	NOUN
aiua-10141	65	59	after	after	ADP
aiua-10141	65	60	covid	covid	PROPN
aiua-10141	65	61	11.03	11.03	NUM
aiua-10141	65	62	±	±	NUM
aiua-10141	65	63	3.76	3.76	NUM
aiua-10141	65	64	11	11	NUM
aiua-10141	65	65	(	(	PUNCT
aiua-10141	65	66	5	5	NUM
aiua-10141	65	67	-	-	SYM
aiua-10141	65	68	18	18	NUM
aiua-10141	65	69	)	)	PUNCT
aiua-10141	65	70	archivio	archivio	NOUN
aiua-10141	65	71	italiano	italiano	NOUN
aiua-10141	65	72	di	di	X
aiua-10141	65	73	urologia	urologia	PROPN
aiua-10141	65	74	e	e	PROPN
aiua-10141	65	75	andrologia	andrologia	NOUN
aiua-10141	65	76	2021	2021	NUM
aiua-10141	65	77	;	;	PUNCT
aiua-10141	65	78	93	93	NUM
aiua-10141	65	79	,	,	PUNCT
aiua-10141	65	80	4	4	NUM
aiua-10141	65	81	k.	k.	PROPN
aiua-10141	65	82	karkin	karkin	PROPN
aiua-10141	65	83	,	,	PUNCT
aiua-10141	65	84	e.	e.	PROPN
aiua-10141	65	85	alma	alma	PROPN
aiua-10141	66	1	462	462	NUM
aiua-10141	66	2	lation	lation	NOUN
aiua-10141	66	3	between	between	ADP
aiua-10141	66	4	the	the	DET
aiua-10141	66	5	testosterone	testosterone	NOUN
aiua-10141	66	6	level	level	NOUN
aiua-10141	66	7	findings	finding	NOUN
aiua-10141	66	8	,	,	PUNCT
aiua-10141	66	9	the	the	DET
aiua-10141	66	10	iief	iief	ADJ
aiua-10141	66	11	scores	score	NOUN
aiua-10141	66	12	before	before	ADP
aiua-10141	66	13	covid-19	covid-19	PROPN
aiua-10141	66	14	(	(	PUNCT
aiua-10141	66	15	r	r	NOUN
aiua-10141	66	16	=	=	SYM
aiua-10141	66	17	0.383	0.383	NUM
aiua-10141	66	18	)	)	PUNCT
aiua-10141	66	19	and	and	CCONJ
aiua-10141	66	20	the	the	DET
aiua-10141	66	21	iief	iief	ADJ
aiua-10141	66	22	scores	score	NOUN
aiua-10141	66	23	after	after	ADP
aiua-10141	66	24	covid-19	covid-19	PROPN
aiua-10141	66	25	(	(	PUNCT
aiua-10141	66	26	r	r	NOUN
aiua-10141	66	27	=	=	SYM
aiua-10141	66	28	0.423	0.423	NUM
aiua-10141	66	29	)	)	PUNCT
aiua-10141	66	30	of	of	ADP
aiua-10141	66	31	the	the	DET
aiua-10141	66	32	patients	patient	NOUN
aiua-10141	66	33	who	who	PRON
aiua-10141	66	34	participated	participate	VERB
aiua-10141	66	35	in	in	ADP
aiua-10141	66	36	the	the	DET
aiua-10141	66	37	study	study	NOUN
aiua-10141	66	38	,	,	PUNCT
aiua-10141	66	39	there	there	PRON
aiua-10141	66	40	was	be	VERB
aiua-10141	66	41	a	a	DET
aiua-10141	66	42	negative	negative	ADJ
aiua-10141	66	43	correlation	correlation	NOUN
aiua-10141	66	44	between	between	ADP
aiua-10141	66	45	the	the	DET
aiua-10141	66	46	ages	age	NOUN
aiua-10141	66	47	of	of	ADP
aiua-10141	66	48	the	the	DET
aiua-10141	66	49	patients	patient	NOUN
aiua-10141	66	50	and	and	CCONJ
aiua-10141	66	51	the	the	DET
aiua-10141	66	52	iief	iief	ADJ
aiua-10141	66	53	scores	score	NOUN
aiua-10141	66	54	before	before	ADP
aiua-10141	66	55	covid-19	covid-19	PROPN
aiua-10141	66	56	(	(	PUNCT
aiua-10141	66	57	r	r	NOUN
aiua-10141	66	58	=	=	PUNCT
aiua-10141	66	59	-0.675	-0.675	NOUN
aiua-10141	66	60	)	)	PUNCT
aiua-10141	66	61	and	and	CCONJ
aiua-10141	66	62	the	the	DET
aiua-10141	66	63	iief	iief	ADJ
aiua-10141	66	64	scores	score	NOUN
aiua-10141	66	65	after	after	ADP
aiua-10141	66	66	covid-19	covid-19	PROPN
aiua-10141	66	67	(	(	PUNCT
aiua-10141	66	68	r	r	NOUN
aiua-10141	66	69	=	=	PUNCT
aiua-10141	66	70	-0.557	-0.557	PUNCT
aiua-10141	66	71	)	)	PUNCT
aiua-10141	66	72	(	(	PUNCT
aiua-10141	66	73	p	p	X
aiua-10141	66	74	<	<	X
aiua-10141	66	75	0.05	0.05	NUM
aiua-10141	66	76	)	)	PUNCT
aiua-10141	66	77	(	(	PUNCT
aiua-10141	66	78	table	table	NOUN
aiua-10141	66	79	3	3	NUM
aiua-10141	66	80	)	)	PUNCT
aiua-10141	66	81	.	.	PUNCT
aiua-10141	67	1	discussion	discussion	NOUN
aiua-10141	67	2	we	we	PRON
aiua-10141	67	3	showed	show	VERB
aiua-10141	67	4	with	with	ADP
aiua-10141	67	5	this	this	DET
aiua-10141	67	6	study	study	NOUN
aiua-10141	67	7	that	that	PRON
aiua-10141	67	8	covid-19	covid-19	PROPN
aiua-10141	67	9	causes	cause	VERB
aiua-10141	67	10	ed	ed	NOUN
aiua-10141	67	11	in	in	ADP
aiua-10141	67	12	all	all	DET
aiua-10141	67	13	age	age	NOUN
aiua-10141	67	14	groups	group	NOUN
aiua-10141	67	15	,	,	PUNCT
aiua-10141	67	16	reducing	reduce	VERB
aiua-10141	67	17	testosterone	testosterone	NOUN
aiua-10141	67	18	levels	level	NOUN
aiua-10141	67	19	seriously	seriously	ADV
aiua-10141	67	20	.	.	PUNCT
aiua-10141	68	1	moreover	moreover	ADV
aiua-10141	68	2	,	,	PUNCT
aiua-10141	68	3	we	we	PRON
aiua-10141	68	4	also	also	ADV
aiua-10141	68	5	oberved	oberve	VERB
aiua-10141	68	6	that	that	SCONJ
aiua-10141	68	7	the	the	PRON
aiua-10141	68	8	higher	high	ADJ
aiua-10141	68	9	the	the	DET
aiua-10141	68	10	testosterone	testosterone	NOUN
aiua-10141	68	11	levels	level	NOUN
aiua-10141	68	12	during	during	ADP
aiua-10141	68	13	covid-19	covid-19	PROPN
aiua-10141	68	14	,	,	PUNCT
aiua-10141	68	15	the	the	PRON
aiua-10141	68	16	more	more	ADV
aiua-10141	68	17	severe	severe	ADJ
aiua-10141	68	18	the	the	DET
aiua-10141	68	19	disease	disease	NOUN
aiua-10141	68	20	progresses	progress	VERB
aiua-10141	68	21	.	.	PUNCT
aiua-10141	69	1	to	to	ADP
aiua-10141	69	2	the	the	DET
aiua-10141	69	3	best	good	ADJ
aiua-10141	69	4	of	of	ADP
aiua-10141	69	5	our	our	PRON
aiua-10141	69	6	knowledge	knowledge	NOUN
aiua-10141	69	7	,	,	PUNCT
aiua-10141	69	8	a	a	DET
aiua-10141	69	9	similar	similar	ADJ
aiua-10141	69	10	study	study	NOUN
aiua-10141	69	11	suggesting	suggest	VERB
aiua-10141	69	12	that	that	SCONJ
aiua-10141	69	13	covid-19	covid-19	PROPN
aiua-10141	69	14	causes	cause	VERB
aiua-10141	69	15	ed	ed	NOUN
aiua-10141	69	16	has	have	AUX
aiua-10141	69	17	not	not	PART
aiua-10141	69	18	been	be	AUX
aiua-10141	69	19	published	publish	VERB
aiua-10141	69	20	before	before	ADV
aiua-10141	69	21	in	in	ADP
aiua-10141	69	22	the	the	DET
aiua-10141	69	23	related	related	ADJ
aiua-10141	69	24	literature	literature	NOUN
aiua-10141	69	25	.	.	PUNCT
aiua-10141	70	1	ed	ed	NOUN
aiua-10141	70	2	is	be	AUX
aiua-10141	70	3	multidimensional	multidimensional	ADJ
aiua-10141	70	4	and	and	CCONJ
aiua-10141	70	5	commonly	commonly	ADV
aiua-10141	70	6	male	male	ADJ
aiua-10141	70	7	sexual	sexual	ADJ
aiua-10141	70	8	dysfunction	dysfunction	NOUN
aiua-10141	70	9	involves	involve	VERB
aiua-10141	70	10	a	a	DET
aiua-10141	70	11	change	change	NOUN
aiua-10141	70	12	in	in	ADP
aiua-10141	70	13	any	any	DET
aiua-10141	70	14	component	component	NOUN
aiua-10141	70	15	of	of	ADP
aiua-10141	70	16	the	the	DET
aiua-10141	70	17	erectile	erectile	NOUN
aiua-10141	70	18	response	response	NOUN
aiua-10141	70	19	,	,	PUNCT
aiua-10141	70	20	including	include	VERB
aiua-10141	70	21	organic	organic	ADJ
aiua-10141	70	22	,	,	PUNCT
aiua-10141	70	23	relational	relational	ADJ
aiua-10141	70	24	,	,	PUNCT
aiua-10141	70	25	and	and	CCONJ
aiua-10141	70	26	psychological	psychological	ADJ
aiua-10141	70	27	.	.	PUNCT
aiua-10141	71	1	non	non	ADJ
aiua-10141	71	2	-	-	ADJ
aiua-10141	71	3	endocrine	endocrine	ADJ
aiua-10141	71	4	(	(	PUNCT
aiua-10141	71	5	neurogenic	neurogenic	ADJ
aiua-10141	71	6	,	,	PUNCT
aiua-10141	71	7	vasculogenic	vasculogenic	ADJ
aiua-10141	71	8	,	,	PUNCT
aiua-10141	71	9	and	and	CCONJ
aiua-10141	71	10	iatrogenic	iatrogenic	ADJ
aiua-10141	71	11	)	)	PUNCT
aiua-10141	71	12	and	and	CCONJ
aiua-10141	71	13	endocrine	endocrine	NOUN
aiua-10141	71	14	pathways	pathway	NOUN
aiua-10141	71	15	may	may	AUX
aiua-10141	71	16	cause	cause	VERB
aiua-10141	71	17	ed	ed	NOUN
aiua-10141	71	18	(	(	PUNCT
aiua-10141	71	19	12	12	NUM
aiua-10141	71	20	,	,	PUNCT
aiua-10141	71	21	13	13	NUM
aiua-10141	71	22	)	)	PUNCT
aiua-10141	71	23	.	.	PUNCT
aiua-10141	72	1	endothelial	endothelial	ADJ
aiua-10141	72	2	dysfunction	dysfunction	NOUN
aiua-10141	72	3	equals	equal	VERB
aiua-10141	72	4	erectile	erectile	ADJ
aiua-10141	72	5	dysfunction	dysfunction	NOUN
aiua-10141	72	6	or	or	CCONJ
aiua-10141	72	7	vice	vice	NOUN
aiua-10141	72	8	versa	versa	ADV
aiua-10141	72	9	(	(	PUNCT
aiua-10141	72	10	ed	ed	NOUN
aiua-10141	72	11	-	-	PUNCT
aiua-10141	72	12	ed	ed	NOUN
aiua-10141	72	13	)	)	PUNCT
aiua-10141	72	14	.	.	PUNCT
aiua-10141	73	1	it	it	PRON
aiua-10141	73	2	is	be	AUX
aiua-10141	73	3	presented	present	VERB
aiua-10141	73	4	in	in	ADP
aiua-10141	73	5	the	the	DET
aiua-10141	73	6	literature	literature	NOUN
aiua-10141	73	7	that	that	PRON
aiua-10141	73	8	the	the	DET
aiua-10141	73	9	prevalence	prevalence	NOUN
aiua-10141	73	10	of	of	ADP
aiua-10141	73	11	ed	ed	NOUN
aiua-10141	73	12	can	can	AUX
aiua-10141	73	13	be	be	AUX
aiua-10141	73	14	up	up	ADV
aiua-10141	73	15	to	to	PART
aiua-10141	73	16	30	30	NUM
aiua-10141	73	17	%	%	NOUN
aiua-10141	73	18	in	in	ADP
aiua-10141	73	19	young	young	ADJ
aiua-10141	73	20	men	man	NOUN
aiua-10141	73	21	and	and	CCONJ
aiua-10141	73	22	that	that	SCONJ
aiua-10141	73	23	the	the	DET
aiua-10141	73	24	rare	rare	NOUN
aiua-10141	73	25	of	of	ADP
aiua-10141	73	26	ed	ed	NOUN
aiua-10141	73	27	is	be	AUX
aiua-10141	73	28	further	far	ADV
aiua-10141	73	29	increased	increase	VERB
aiua-10141	73	30	in	in	ADP
aiua-10141	73	31	elderly	elderly	ADJ
aiua-10141	73	32	due	due	ADP
aiua-10141	73	33	to	to	ADP
aiua-10141	73	34	diseases	disease	NOUN
aiua-10141	73	35	of	of	ADP
aiua-10141	73	36	coronary	coronary	ADJ
aiua-10141	73	37	and	and	CCONJ
aiua-10141	73	38	penile	penile	ADJ
aiua-10141	73	39	arteries	artery	NOUN
aiua-10141	73	40	(	(	PUNCT
aiua-10141	73	41	14	14	NUM
aiua-10141	73	42	-	-	SYM
aiua-10141	73	43	16	16	NUM
aiua-10141	73	44	)	)	PUNCT
aiua-10141	73	45	.	.	PUNCT
aiua-10141	74	1	in	in	ADP
aiua-10141	74	2	covid-19	covid-19	PROPN
aiua-10141	74	3	infection	infection	NOUN
aiua-10141	74	4	,	,	PUNCT
aiua-10141	74	5	the	the	DET
aiua-10141	74	6	ace	ace	NOUN
aiua-10141	74	7	enzyme	enzyme	NOUN
aiua-10141	74	8	,	,	PUNCT
aiua-10141	74	9	which	which	PRON
aiua-10141	74	10	provides	provide	VERB
aiua-10141	74	11	access	access	NOUN
aiua-10141	74	12	to	to	ADP
aiua-10141	74	13	host	host	NOUN
aiua-10141	74	14	cells	cell	NOUN
aiua-10141	74	15	,	,	PUNCT
aiua-10141	74	16	is	be	AUX
aiua-10141	74	17	expressed	express	VERB
aiua-10141	74	18	by	by	ADP
aiua-10141	74	19	endothelial	endothelial	ADJ
aiua-10141	74	20	cells	cell	NOUN
aiua-10141	74	21	and	and	CCONJ
aiua-10141	74	22	the	the	DET
aiua-10141	74	23	fragile	fragile	ADJ
aiua-10141	74	24	vascular	vascular	ADJ
aiua-10141	74	25	bed	bed	NOUN
aiua-10141	74	26	is	be	AUX
aiua-10141	74	27	affected	affect	VERB
aiua-10141	74	28	preparing	prepare	VERB
aiua-10141	74	29	the	the	DET
aiua-10141	74	30	ground	ground	NOUN
aiua-10141	74	31	for	for	ADP
aiua-10141	74	32	the	the	DET
aiua-10141	74	33	development	development	NOUN
aiua-10141	74	34	of	of	ADP
aiua-10141	74	35	ed	ed	PROPN
aiua-10141	74	36	(	(	PUNCT
aiua-10141	74	37	17	17	NUM
aiua-10141	74	38	-	-	SYM
aiua-10141	74	39	22	22	NUM
aiua-10141	74	40	)	)	PUNCT
aiua-10141	74	41	.	.	PUNCT
aiua-10141	75	1	testosterone	testosterone	NOUN
aiua-10141	75	2	deficiency	deficiency	NOUN
aiua-10141	75	3	is	be	AUX
aiua-10141	75	4	one	one	NUM
aiua-10141	75	5	of	of	ADP
aiua-10141	75	6	the	the	DET
aiua-10141	75	7	most	most	ADV
aiua-10141	75	8	important	important	ADJ
aiua-10141	75	9	hormonal	hormonal	ADJ
aiua-10141	75	10	causes	cause	NOUN
aiua-10141	75	11	of	of	ADP
aiua-10141	75	12	ed	ed	PROPN
aiua-10141	75	13	development	development	NOUN
aiua-10141	75	14	.	.	PUNCT
aiua-10141	76	1	testosterone	testosterone	NOUN
aiua-10141	76	2	modulates	modulate	NOUN
aiua-10141	76	3	almost	almost	ADV
aiua-10141	76	4	all	all	PRON
aiua-10141	76	5	components	component	NOUN
aiua-10141	76	6	of	of	ADP
aiua-10141	76	7	the	the	DET
aiua-10141	76	8	erectile	erectile	NOUN
aiua-10141	76	9	mechanism	mechanism	NOUN
aiua-10141	76	10	,	,	PUNCT
aiua-10141	76	11	down	down	ADP
aiua-10141	76	12	to	to	ADP
aiua-10141	76	13	the	the	DET
aiua-10141	76	14	endothelial	endothelial	ADJ
aiua-10141	76	15	cells	cell	NOUN
aiua-10141	76	16	in	in	ADP
aiua-10141	76	17	the	the	DET
aiua-10141	76	18	corpus	corpus	NOUN
aiua-10141	76	19	cavernosum	cavernosum	NOUN
aiua-10141	76	20	.	.	PUNCT
aiua-10141	77	1	current	current	ADJ
aiua-10141	77	2	eau	eau	PROPN
aiua-10141	77	3	guidelines	guideline	NOUN
aiua-10141	77	4	recommend	recommend	VERB
aiua-10141	77	5	to	to	PART
aiua-10141	77	6	measure	measure	VERB
aiua-10141	77	7	baseline	baseline	NOUN
aiua-10141	77	8	testosterone	testosterone	NOUN
aiua-10141	77	9	levels	level	NOUN
aiua-10141	77	10	in	in	ADP
aiua-10141	77	11	all	all	DET
aiua-10141	77	12	men	man	NOUN
aiua-10141	77	13	who	who	PRON
aiua-10141	77	14	admit	admit	VERB
aiua-10141	77	15	with	with	ADP
aiua-10141	77	16	a	a	DET
aiua-10141	77	17	complaint	complaint	NOUN
aiua-10141	77	18	of	of	ADP
aiua-10141	77	19	ed	ed	NOUN
aiua-10141	77	20	(	(	PUNCT
aiua-10141	77	21	7	7	NUM
aiua-10141	77	22	)	)	PUNCT
aiua-10141	77	23	.	.	PUNCT
aiua-10141	78	1	araujo	araujo	NOUN
aiua-10141	78	2	et	et	PROPN
aiua-10141	79	1	al	al	PROPN
aiua-10141	79	2	.	.	PROPN
aiua-10141	79	3	showed	show	VERB
aiua-10141	79	4	in	in	ADP
aiua-10141	79	5	their	their	PRON
aiua-10141	79	6	studies	study	NOUN
aiua-10141	79	7	that	that	SCONJ
aiua-10141	79	8	the	the	DET
aiua-10141	79	9	testosterone	testosterone	NOUN
aiua-10141	79	10	levels	level	NOUN
aiua-10141	79	11	of	of	ADP
aiua-10141	79	12	24	24	NUM
aiua-10141	79	13	%	%	NOUN
aiua-10141	79	14	of	of	ADP
aiua-10141	79	15	men	man	NOUN
aiua-10141	79	16	aged	age	VERB
aiua-10141	79	17	between	between	ADP
aiua-10141	79	18	30	30	NUM
aiua-10141	79	19	-	-	SYM
aiua-10141	79	20	79	79	NUM
aiua-10141	79	21	were	be	AUX
aiua-10141	79	22	below	below	ADP
aiua-10141	79	23	300	300	NUM
aiua-10141	79	24	and	and	CCONJ
aiua-10141	79	25	5.6	5.6	NUM
aiua-10141	79	26	%	%	NOUN
aiua-10141	79	27	of	of	ADP
aiua-10141	79	28	them	they	PRON
aiua-10141	79	29	had	have	VERB
aiua-10141	79	30	symptomatic	symptomatic	ADJ
aiua-10141	79	31	androgen	androgen	NOUN
aiua-10141	79	32	deficiency	deficiency	NOUN
aiua-10141	79	33	(	(	PUNCT
aiua-10141	79	34	23	23	NUM
aiua-10141	79	35	)	)	PUNCT
aiua-10141	79	36	.	.	PUNCT
aiua-10141	80	1	yassin	yassin	PROPN
aiua-10141	80	2	et	et	PROPN
aiua-10141	80	3	al	al	PROPN
aiua-10141	80	4	.	.	PROPN
aiua-10141	80	5	reported	report	VERB
aiua-10141	80	6	that	that	SCONJ
aiua-10141	80	7	testosterone	testosterone	NOUN
aiua-10141	80	8	replacement	replacement	NOUN
aiua-10141	80	9	therapy	therapy	NOUN
aiua-10141	80	10	(	(	PUNCT
aiua-10141	80	11	trt	trt	PROPN
aiua-10141	80	12	)	)	PUNCT
aiua-10141	80	13	improved	improve	VERB
aiua-10141	80	14	erectile	erectile	NOUN
aiua-10141	80	15	function	function	NOUN
aiua-10141	80	16	in	in	ADP
aiua-10141	80	17	hypogonadal	hypogonadal	ADJ
aiua-10141	80	18	men	man	NOUN
aiua-10141	80	19	who	who	PRON
aiua-10141	80	20	previously	previously	ADV
aiua-10141	80	21	received	receive	VERB
aiua-10141	80	22	phosphodisterase-5	phosphodisterase-5	NUM
aiua-10141	80	23	inhibitor	inhibitor	NOUN
aiua-10141	80	24	(	(	PUNCT
aiua-10141	80	25	pde5i	pde5i	PROPN
aiua-10141	80	26	)	)	PUNCT
aiua-10141	80	27	before	before	ADP
aiua-10141	80	28	(	(	PUNCT
aiua-10141	80	29	24	24	NUM
aiua-10141	80	30	)	)	PUNCT
aiua-10141	80	31	.	.	PUNCT
aiua-10141	81	1	rizk	rizk	PROPN
aiua-10141	81	2	et	et	PROPN
aiua-10141	81	3	al	al	PROPN
aiua-10141	81	4	.	.	PROPN
aiua-10141	81	5	suggested	suggest	VERB
aiua-10141	81	6	that	that	SCONJ
aiua-10141	81	7	the	the	DET
aiua-10141	81	8	use	use	NOUN
aiua-10141	81	9	of	of	ADP
aiua-10141	81	10	trt	trt	NOUN
aiua-10141	81	11	as	as	ADP
aiua-10141	81	12	monotherapy	monotherapy	NOUN
aiua-10141	81	13	in	in	ADP
aiua-10141	81	14	patients	patient	NOUN
aiua-10141	81	15	with	with	ADP
aiua-10141	81	16	mild	mild	ADJ
aiua-10141	81	17	ed	ed	NOUN
aiua-10141	81	18	was	be	AUX
aiua-10141	81	19	effective	effective	ADJ
aiua-10141	81	20	(	(	PUNCT
aiua-10141	81	21	25	25	NUM
aiua-10141	81	22	)	)	PUNCT
aiua-10141	81	23	.	.	PUNCT
aiua-10141	82	1	our	our	PRON
aiua-10141	82	2	present	present	ADJ
aiua-10141	82	3	study	study	NOUN
aiua-10141	82	4	shows	show	VERB
aiua-10141	82	5	that	that	SCONJ
aiua-10141	82	6	patients	patient	NOUN
aiua-10141	82	7	of	of	ADP
aiua-10141	82	8	all	all	DET
aiua-10141	82	9	age	age	NOUN
aiua-10141	82	10	groups	group	NOUN
aiua-10141	82	11	are	be	AUX
aiua-10141	82	12	affected	affect	VERB
aiua-10141	82	13	,	,	PUNCT
aiua-10141	82	14	although	although	SCONJ
aiua-10141	82	15	ed	ed	NOUN
aiua-10141	82	16	which	which	PRON
aiua-10141	82	17	develops	develop	VERB
aiua-10141	82	18	after	after	ADP
aiua-10141	82	19	covid-19	covid-19	PROPN
aiua-10141	82	20	seems	seem	VERB
aiua-10141	82	21	to	to	PART
aiua-10141	82	22	affect	affect	VERB
aiua-10141	82	23	more	more	ADV
aiua-10141	82	24	elderly	elderly	ADJ
aiua-10141	82	25	patients	patient	NOUN
aiua-10141	82	26	.	.	PUNCT
aiua-10141	83	1	it	it	PRON
aiua-10141	83	2	was	be	AUX
aiua-10141	83	3	also	also	ADV
aiua-10141	83	4	revealed	reveal	VERB
aiua-10141	83	5	that	that	SCONJ
aiua-10141	83	6	testosterone	testosterone	NOUN
aiua-10141	83	7	levels	level	NOUN
aiua-10141	83	8	of	of	ADP
aiua-10141	83	9	the	the	DET
aiua-10141	83	10	patients	patient	NOUN
aiua-10141	83	11	were	be	AUX
aiua-10141	83	12	significantly	significantly	ADV
aiua-10141	83	13	lower	low	ADJ
aiua-10141	83	14	in	in	ADP
aiua-10141	83	15	all	all	DET
aiua-10141	83	16	age	age	NOUN
aiua-10141	83	17	groups	group	NOUN
aiua-10141	83	18	,	,	PUNCT
aiua-10141	83	19	especially	especially	ADV
aiua-10141	83	20	in	in	ADP
aiua-10141	83	21	elderly	elderly	ADJ
aiua-10141	83	22	patients	patient	NOUN
aiua-10141	83	23	.	.	PUNCT
aiua-10141	84	1	in	in	ADP
aiua-10141	84	2	covid-19	covid-19	PROPN
aiua-10141	84	3	infection	infection	NOUN
aiua-10141	84	4	,	,	PUNCT
aiua-10141	84	5	leydig	leydig	NOUN
aiua-10141	84	6	cells	cell	NOUN
aiua-10141	84	7	in	in	ADP
aiua-10141	84	8	the	the	DET
aiua-10141	84	9	testicles	testicle	NOUN
aiua-10141	84	10	are	be	AUX
aiua-10141	84	11	damaged	damage	VERB
aiua-10141	84	12	and	and	CCONJ
aiua-10141	84	13	this	this	DET
aiua-10141	84	14	testicular	testicular	ADJ
aiua-10141	84	15	damage	damage	NOUN
aiua-10141	84	16	causes	cause	VERB
aiua-10141	84	17	a	a	DET
aiua-10141	84	18	decrease	decrease	NOUN
aiua-10141	84	19	in	in	ADP
aiua-10141	84	20	serum	serum	NOUN
aiua-10141	84	21	testosterone	testosterone	NOUN
aiua-10141	84	22	levels	level	NOUN
aiua-10141	84	23	(	(	PUNCT
aiua-10141	84	24	26	26	NUM
aiua-10141	84	25	)	)	PUNCT
aiua-10141	84	26	.	.	PUNCT
aiua-10141	85	1	ling	ling	PROPN
aiua-10141	85	2	ma	ma	PROPN
aiua-10141	85	3	et	et	PROPN
aiua-10141	85	4	al	al	PROPN
aiua-10141	85	5	.	.	PROPN
aiua-10141	85	6	reported	report	VERB
aiua-10141	85	7	that	that	SCONJ
aiua-10141	85	8	testosterone	testosterone	NOUN
aiua-10141	85	9	/	/	SYM
aiua-10141	85	10	luteinizing	luteinize	VERB
aiua-10141	85	11	hormone	hormone	NOUN
aiua-10141	85	12	(	(	PUNCT
aiua-10141	85	13	lh	lh	NOUN
aiua-10141	85	14	)	)	PUNCT
aiua-10141	85	15	ratios	ratio	NOUN
aiua-10141	85	16	were	be	AUX
aiua-10141	85	17	significantly	significantly	ADV
aiua-10141	85	18	lower	low	ADJ
aiua-10141	85	19	in	in	ADP
aiua-10141	85	20	patients	patient	NOUN
aiua-10141	85	21	with	with	ADP
aiua-10141	85	22	covid-19	covid-19	PROPN
aiua-10141	85	23	infection	infection	NOUN
aiua-10141	85	24	(	(	PUNCT
aiua-10141	85	25	27	27	NUM
aiua-10141	85	26	)	)	PUNCT
aiua-10141	85	27	.	.	PUNCT
aiua-10141	86	1	vanhorebeek	vanhorebeek	NOUN
aiua-10141	86	2	et	et	PROPN
aiua-10141	86	3	al	al	PROPN
aiua-10141	86	4	.	.	PROPN
aiua-10141	86	5	observed	observe	VERB
aiua-10141	86	6	that	that	SCONJ
aiua-10141	86	7	there	there	PRON
aiua-10141	86	8	was	be	VERB
aiua-10141	86	9	a	a	DET
aiua-10141	86	10	decrease	decrease	NOUN
aiua-10141	86	11	in	in	ADP
aiua-10141	86	12	testosterone	testosterone	NOUN
aiua-10141	86	13	level	level	NOUN
aiua-10141	86	14	in	in	ADP
aiua-10141	86	15	the	the	DET
aiua-10141	86	16	acute	acute	ADJ
aiua-10141	86	17	phase	phase	NOUN
aiua-10141	86	18	of	of	ADP
aiua-10141	86	19	covid-19	covid-19	PROPN
aiua-10141	86	20	(	(	PUNCT
aiua-10141	86	21	28	28	NUM
aiua-10141	86	22	)	)	PUNCT
aiua-10141	86	23	.	.	PUNCT
aiua-10141	87	1	also	also	ADV
aiua-10141	87	2	okçelik	okçelik	PROPN
aiua-10141	87	3	reported	report	VERB
aiua-10141	87	4	that	that	SCONJ
aiua-10141	87	5	testosterone	testosterone	NOUN
aiua-10141	87	6	levels	level	NOUN
aiua-10141	87	7	decreased	decrease	VERB
aiua-10141	87	8	during	during	ADP
aiua-10141	87	9	acute	acute	ADJ
aiua-10141	87	10	covid-19	covid-19	PROPN
aiua-10141	87	11	infection	infection	NOUN
aiua-10141	87	12	and	and	CCONJ
aiua-10141	87	13	especially	especially	ADV
aiua-10141	87	14	in	in	ADP
aiua-10141	87	15	patients	patient	NOUN
aiua-10141	87	16	with	with	ADP
aiua-10141	87	17	pulmonary	pulmonary	ADJ
aiua-10141	87	18	involvement	involvement	NOUN
aiua-10141	87	19	(	(	PUNCT
aiua-10141	87	20	29	29	NUM
aiua-10141	87	21	)	)	PUNCT
aiua-10141	87	22	.	.	PUNCT
aiua-10141	88	1	it	it	PRON
aiua-10141	88	2	was	be	AUX
aiua-10141	88	3	also	also	ADV
aiua-10141	88	4	concluded	conclude	VERB
aiua-10141	88	5	in	in	ADP
aiua-10141	88	6	our	our	PRON
aiua-10141	88	7	study	study	NOUN
aiua-10141	88	8	that	that	SCONJ
aiua-10141	88	9	the	the	DET
aiua-10141	88	10	significant	significant	ADJ
aiua-10141	88	11	decrease	decrease	NOUN
aiua-10141	88	12	in	in	ADP
aiua-10141	88	13	the	the	DET
aiua-10141	88	14	testosterone	testosterone	NOUN
aiua-10141	88	15	levels	level	NOUN
aiua-10141	88	16	of	of	ADP
aiua-10141	88	17	patients	patient	NOUN
aiua-10141	88	18	after	after	ADP
aiua-10141	88	19	covid-19	covid-19	PROPN
aiua-10141	88	20	is	be	AUX
aiua-10141	88	21	an	an	DET
aiua-10141	88	22	indicator	indicator	NOUN
aiua-10141	88	23	of	of	ADP
aiua-10141	88	24	a	a	DET
aiua-10141	88	25	possible	possible	ADJ
aiua-10141	88	26	testicular	testicular	ADJ
aiua-10141	88	27	damage	damage	NOUN
aiua-10141	88	28	and	and	CCONJ
aiua-10141	88	29	this	this	DET
aiua-10141	88	30	finding	finding	NOUN
aiua-10141	88	31	supports	support	VERB
aiua-10141	88	32	the	the	DET
aiua-10141	88	33	studies	study	NOUN
aiua-10141	88	34	in	in	ADP
aiua-10141	88	35	the	the	DET
aiua-10141	88	36	literature	literature	NOUN
aiua-10141	88	37	.	.	PUNCT
aiua-10141	89	1	testosterone	testosterone	NOUN
aiua-10141	89	2	is	be	AUX
aiua-10141	89	3	a	a	DET
aiua-10141	89	4	hormone	hormone	NOUN
aiua-10141	89	5	which	which	PRON
aiua-10141	89	6	has	have	VERB
aiua-10141	89	7	an	an	DET
aiua-10141	89	8	effect	effect	NOUN
aiua-10141	89	9	not	not	PART
aiua-10141	89	10	only	only	ADV
aiua-10141	89	11	on	on	ADP
aiua-10141	89	12	the	the	DET
aiua-10141	89	13	erection	erection	NOUN
aiua-10141	89	14	mechanism	mechanism	NOUN
aiua-10141	89	15	but	but	CCONJ
aiua-10141	89	16	also	also	ADV
aiua-10141	89	17	on	on	ADP
aiua-10141	89	18	many	many	ADJ
aiua-10141	89	19	functions	function	NOUN
aiua-10141	89	20	in	in	ADP
aiua-10141	89	21	the	the	DET
aiua-10141	89	22	body	body	NOUN
aiua-10141	89	23	.	.	PUNCT
aiua-10141	90	1	inflammation	inflammation	NOUN
aiua-10141	90	2	is	be	AUX
aiua-10141	90	3	known	know	VERB
aiua-10141	90	4	to	to	PART
aiua-10141	90	5	be	be	AUX
aiua-10141	90	6	suppressed	suppress	VERB
aiua-10141	90	7	as	as	ADP
aiua-10141	90	8	a	a	DET
aiua-10141	90	9	result	result	NOUN
aiua-10141	90	10	of	of	ADP
aiua-10141	90	11	the	the	DET
aiua-10141	90	12	decrease	decrease	NOUN
aiua-10141	90	13	in	in	ADP
aiua-10141	90	14	pro	pro	ADJ
aiua-10141	90	15	-	-	ADJ
aiua-10141	90	16	inflammatory	inflammatory	ADJ
aiua-10141	90	17	cytokines	cytokine	NOUN
aiua-10141	90	18	and	and	CCONJ
aiua-10141	90	19	the	the	DET
aiua-10141	90	20	increase	increase	NOUN
aiua-10141	90	21	of	of	ADP
aiua-10141	90	22	anti	anti	ADJ
aiua-10141	90	23	-	-	ADJ
aiua-10141	90	24	inflammatory	inflammatory	ADJ
aiua-10141	90	25	cytokines	cytokine	NOUN
aiua-10141	90	26	while	while	SCONJ
aiua-10141	90	27	responding	respond	VERB
aiua-10141	90	28	to	to	ADP
aiua-10141	90	29	infections	infection	NOUN
aiua-10141	90	30	.	.	PUNCT
aiua-10141	91	1	it	it	PRON
aiua-10141	91	2	was	be	AUX
aiua-10141	91	3	shown	show	VERB
aiua-10141	91	4	in	in	ADP
aiua-10141	91	5	the	the	DET
aiua-10141	91	6	study	study	NOUN
aiua-10141	91	7	of	of	ADP
aiua-10141	91	8	mohamad	mohamad	PROPN
aiua-10141	91	9	et	et	PROPN
aiua-10141	91	10	al	al	PROPN
aiua-10141	91	11	.	.	PUNCT
aiua-10141	92	1	that	that	DET
aiua-10141	92	2	testosterone	testosterone	NOUN
aiua-10141	92	3	suppresses	suppress	VERB
aiua-10141	92	4	inflammation	inflammation	NOUN
aiua-10141	92	5	by	by	ADP
aiua-10141	92	6	increasing	increase	VERB
aiua-10141	92	7	anti	anti	ADJ
aiua-10141	92	8	-	-	ADJ
aiua-10141	92	9	inflammatory	inflammatory	ADJ
aiua-10141	92	10	cytokines	cytokine	NOUN
aiua-10141	92	11	and	and	CCONJ
aiua-10141	92	12	decreasing	decrease	VERB
aiua-10141	92	13	pro	pro	ADJ
aiua-10141	92	14	-	-	ADJ
aiua-10141	92	15	inflammatory	inflammatory	ADJ
aiua-10141	92	16	cytokines	cytokine	NOUN
aiua-10141	92	17	(	(	PUNCT
aiua-10141	92	18	30	30	NUM
aiua-10141	92	19	)	)	PUNCT
aiua-10141	92	20	.	.	PUNCT
aiua-10141	93	1	malkin	malkin	PROPN
aiua-10141	93	2	et	et	PROPN
aiua-10141	93	3	al	al	PROPN
aiua-10141	93	4	.	.	PROPN
aiua-10141	93	5	conducted	conduct	VERB
aiua-10141	93	6	a	a	DET
aiua-10141	93	7	crossover	crossover	NOUN
aiua-10141	93	8	study	study	NOUN
aiua-10141	93	9	with	with	ADP
aiua-10141	93	10	27	27	NUM
aiua-10141	93	11	men	man	NOUN
aiua-10141	93	12	with	with	ADP
aiua-10141	93	13	symptomatic	symptomatic	ADJ
aiua-10141	93	14	androgen	androgen	NOUN
aiua-10141	93	15	deficiency	deficiency	NOUN
aiua-10141	93	16	.	.	PUNCT
aiua-10141	94	1	they	they	PRON
aiua-10141	94	2	concluded	conclude	VERB
aiua-10141	94	3	that	that	SCONJ
aiua-10141	94	4	testosterone	testosterone	NOUN
aiua-10141	94	5	treatment	treatment	NOUN
aiua-10141	94	6	decreased	decrease	VERB
aiua-10141	94	7	pro	pro	ADJ
aiua-10141	94	8	-	-	ADJ
aiua-10141	94	9	inflammatory	inflammatory	ADJ
aiua-10141	94	10	cytokine	cytokine	NOUN
aiua-10141	94	11	levels	level	NOUN
aiua-10141	94	12	and	and	CCONJ
aiua-10141	94	13	increased	increase	VERB
aiua-10141	94	14	the	the	DET
aiua-10141	94	15	concentration	concentration	NOUN
aiua-10141	94	16	of	of	ADP
aiua-10141	94	17	interleukins	interleukin	NOUN
aiua-10141	94	18	,	,	PUNCT
aiua-10141	94	19	which	which	PRON
aiua-10141	94	20	are	be	AUX
aiua-10141	94	21	some	some	PRON
aiua-10141	94	22	of	of	ADP
aiua-10141	94	23	the	the	DET
aiua-10141	94	24	anti	anti	ADJ
aiua-10141	94	25	-	-	ADJ
aiua-10141	94	26	inflammatory	inflammatory	ADJ
aiua-10141	94	27	cytokines	cytokine	NOUN
aiua-10141	94	28	(	(	PUNCT
aiua-10141	94	29	31	31	NUM
aiua-10141	94	30	)	)	PUNCT
aiua-10141	94	31	.	.	PUNCT
aiua-10141	95	1	although	although	SCONJ
aiua-10141	95	2	table	table	NOUN
aiua-10141	95	3	2	2	NUM
aiua-10141	95	4	.	.	PUNCT
aiua-10141	95	5	rates	rate	NOUN
aiua-10141	95	6	of	of	ADP
aiua-10141	95	7	hospitalization	hospitalization	NOUN
aiua-10141	95	8	in	in	ADP
aiua-10141	95	9	the	the	DET
aiua-10141	95	10	intensive	intensive	ADJ
aiua-10141	95	11	care	care	NOUN
aiua-10141	95	12	according	accord	VERB
aiua-10141	95	13	to	to	ADP
aiua-10141	95	14	groups	group	NOUN
aiua-10141	95	15	,	,	PUNCT
aiua-10141	95	16	evaluation	evaluation	NOUN
aiua-10141	95	17	of	of	ADP
aiua-10141	95	18	hospitalization	hospitalization	NOUN
aiua-10141	95	19	in	in	ADP
aiua-10141	95	20	the	the	DET
aiua-10141	95	21	intensive	intensive	ADJ
aiua-10141	95	22	care	care	NOUN
aiua-10141	95	23	and	and	CCONJ
aiua-10141	95	24	iief	iief	ADJ
aiua-10141	95	25	score	score	NOUN
aiua-10141	95	26	before	before	ADV
aiua-10141	95	27	and	and	CCONJ
aiua-10141	95	28	after	after	ADP
aiua-10141	95	29	covid-19	covid-19	PROPN
aiua-10141	95	30	and	and	CCONJ
aiua-10141	95	31	correlation	correlation	NOUN
aiua-10141	95	32	between	between	ADP
aiua-10141	95	33	the	the	DET
aiua-10141	95	34	hospitalization	hospitalization	NOUN
aiua-10141	95	35	in	in	ADP
aiua-10141	95	36	the	the	DET
aiua-10141	95	37	intensive	intensive	ADJ
aiua-10141	95	38	care	care	NOUN
aiua-10141	95	39	and	and	CCONJ
aiua-10141	95	40	testosterone	testosterone	NOUN
aiua-10141	95	41	level	level	NOUN
aiua-10141	95	42	.	.	PUNCT
aiua-10141	95	43	20	20	NUM
aiua-10141	95	44	-	-	SYM
aiua-10141	95	45	40	40	NUM
aiua-10141	95	46	40	40	NUM
aiua-10141	95	47	-	-	SYM
aiua-10141	95	48	60	60	NUM
aiua-10141	95	49	60	60	NUM
aiua-10141	95	50	and	and	CCONJ
aiua-10141	95	51	over	over	ADP
aiua-10141	95	52	p	p	X
aiua-10141	95	53	(	(	PUNCT
aiua-10141	95	54	n	n	NOUN
aiua-10141	95	55	=	=	SYM
aiua-10141	95	56	16	16	NUM
aiua-10141	95	57	)	)	PUNCT
aiua-10141	95	58	(	(	PUNCT
aiua-10141	95	59	n	n	NOUN
aiua-10141	95	60	=	=	SYM
aiua-10141	95	61	33	33	NUM
aiua-10141	95	62	)	)	PUNCT
aiua-10141	95	63	(	(	PUNCT
aiua-10141	95	64	n	n	NOUN
aiua-10141	95	65	=	=	SYM
aiua-10141	95	66	21	21	NUM
aiua-10141	95	67	)	)	PUNCT
aiua-10141	95	68	n	n	PROPN
aiua-10141	95	69	(	(	PUNCT
aiua-10141	95	70	%	%	NOUN
aiua-10141	95	71	)	)	PUNCT
aiua-10141	95	72	n	n	CCONJ
aiua-10141	95	73	(	(	PUNCT
aiua-10141	95	74	%	%	NOUN
aiua-10141	95	75	)	)	PUNCT
aiua-10141	95	76	n	n	CCONJ
aiua-10141	95	77	(	(	PUNCT
aiua-10141	95	78	%	%	INTJ
aiua-10141	95	79	)	)	PUNCT
aiua-10141	95	80	hospitalization	hospitalization	NOUN
aiua-10141	95	81	in	in	ADP
aiua-10141	95	82	the	the	DET
aiua-10141	95	83	intensive	intensive	ADJ
aiua-10141	95	84	care	care	NOUN
aiua-10141	95	85	yes	yes	INTJ
aiua-10141	95	86	5	5	NUM
aiua-10141	95	87	(	(	PUNCT
aiua-10141	95	88	31.2	31.2	NUM
aiua-10141	95	89	)	)	PUNCT
aiua-10141	95	90	11	11	NUM
aiua-10141	95	91	(	(	PUNCT
aiua-10141	95	92	33.3	33.3	NUM
aiua-10141	95	93	)	)	PUNCT
aiua-10141	95	94	6	6	NUM
aiua-10141	95	95	(	(	PUNCT
aiua-10141	95	96	28.6	28.6	NUM
aiua-10141	95	97	)	)	PUNCT
aiua-10141	95	98	.93	.93	NUM
aiua-10141	96	1	no	no	DET
aiua-10141	96	2	11	11	NUM
aiua-10141	96	3	(	(	PUNCT
aiua-10141	96	4	68.8	68.8	NUM
aiua-10141	96	5	)	)	PUNCT
aiua-10141	96	6	22	22	NUM
aiua-10141	96	7	(	(	PUNCT
aiua-10141	96	8	66.7	66.7	NUM
aiua-10141	96	9	)	)	PUNCT
aiua-10141	96	10	15	15	NUM
aiua-10141	96	11	(	(	PUNCT
aiua-10141	96	12	71.4	71.4	NUM
aiua-10141	96	13	)	)	PUNCT
aiua-10141	96	14	iief	iief	ADJ
aiua-10141	96	15	score	score	NOUN
aiua-10141	96	16	before	before	ADP
aiua-10141	96	17	covid	covid	PROPN
aiua-10141	96	18	iief	iief	PROPN
aiua-10141	96	19	score	score	PROPN
aiua-10141	96	20	after	after	ADP
aiua-10141	96	21	covid	covid	PROPN
aiua-10141	96	22	p	p	PROPN
aiua-10141	96	23	median	median	PROPN
aiua-10141	96	24	(	(	PUNCT
aiua-10141	96	25	min	min	NOUN
aiua-10141	96	26	-	-	PUNCT
aiua-10141	96	27	max	max	ADJ
aiua-10141	96	28	)	)	PUNCT
aiua-10141	96	29	median	median	NOUN
aiua-10141	96	30	(	(	PUNCT
aiua-10141	96	31	min	min	NOUN
aiua-10141	96	32	-	-	PUNCT
aiua-10141	96	33	max	max	NOUN
aiua-10141	96	34	)	)	PUNCT
aiua-10141	96	35	hospitalization	hospitalization	NOUN
aiua-10141	96	36	in	in	ADP
aiua-10141	96	37	the	the	DET
aiua-10141	96	38	intensive	intensive	ADJ
aiua-10141	96	39	care	care	NOUN
aiua-10141	96	40	no	no	DET
aiua-10141	96	41	24	24	NUM
aiua-10141	96	42	(	(	PUNCT
aiua-10141	96	43	22	22	NUM
aiua-10141	96	44	-	-	SYM
aiua-10141	96	45	25	25	NUM
aiua-10141	96	46	)	)	PUNCT
aiua-10141	96	47	13	13	NUM
aiua-10141	96	48	(	(	PUNCT
aiua-10141	96	49	5	5	NUM
aiua-10141	96	50	-	-	SYM
aiua-10141	96	51	18	18	NUM
aiua-10141	96	52	)	)	PUNCT
aiua-10141	96	53	<	<	X
aiua-10141	96	54	.001	.001	NUM
aiua-10141	97	1	yes	yes	NOUN
aiua-10141	97	2	23	23	NUM
aiua-10141	97	3	(	(	PUNCT
aiua-10141	97	4	22	22	NUM
aiua-10141	97	5	-	-	SYM
aiua-10141	97	6	24	24	NUM
aiua-10141	97	7	)	)	PUNCT
aiua-10141	97	8	8	8	NUM
aiua-10141	97	9	(	(	PUNCT
aiua-10141	97	10	5	5	NUM
aiua-10141	97	11	-	-	SYM
aiua-10141	97	12	13	13	NUM
aiua-10141	97	13	)	)	PUNCT
aiua-10141	97	14	<	<	X
aiua-10141	97	15	.001	.001	NUM
aiua-10141	97	16	p	p	NOUN
aiua-10141	97	17	.95	.95	NUM
aiua-10141	97	18	<	<	X
aiua-10141	97	19	.001	.001	NUM
aiua-10141	97	20	testosterone	testosterone	NOUN
aiua-10141	97	21	level	level	NOUN
aiua-10141	97	22	p	p	NOUN
aiua-10141	97	23	median	median	NOUN
aiua-10141	97	24	(	(	PUNCT
aiua-10141	97	25	min	min	NOUN
aiua-10141	97	26	-	-	PUNCT
aiua-10141	97	27	max	max	NOUN
aiua-10141	97	28	)	)	PUNCT
aiua-10141	97	29	hospitalization	hospitalization	NOUN
aiua-10141	97	30	in	in	ADP
aiua-10141	97	31	the	the	DET
aiua-10141	97	32	intensive	intensive	ADJ
aiua-10141	97	33	care	care	NOUN
aiua-10141	97	34	no	no	DET
aiua-10141	97	35	291	291	NUM
aiua-10141	97	36	(	(	PUNCT
aiua-10141	97	37	112	112	NUM
aiua-10141	97	38	-	-	SYM
aiua-10141	97	39	531	531	NUM
aiua-10141	97	40	)	)	PUNCT
aiua-10141	97	41	<	<	X
aiua-10141	98	1	.001	.001	NUM
aiua-10141	99	1	yes	yes	INTJ
aiua-10141	99	2	390	390	NUM
aiua-10141	99	3	(	(	PUNCT
aiua-10141	99	4	180	180	NUM
aiua-10141	99	5	-	-	PUNCT
aiua-10141	99	6	680	680	NUM
aiua-10141	99	7	)	)	PUNCT
aiua-10141	99	8	table	table	NOUN
aiua-10141	100	1	3	3	NUM
aiua-10141	100	2	.	.	PUNCT
aiua-10141	100	3	comparison	comparison	NOUN
aiua-10141	100	4	of	of	ADP
aiua-10141	100	5	the	the	DET
aiua-10141	100	6	iief	iief	ADJ
aiua-10141	100	7	scores	score	NOUN
aiua-10141	100	8	and	and	CCONJ
aiua-10141	100	9	testosterone	testosterone	NOUN
aiua-10141	100	10	levels	level	NOUN
aiua-10141	100	11	before	before	ADP
aiua-10141	100	12	and	and	CCONJ
aiua-10141	100	13	after	after	ADP
aiua-10141	100	14	covid-19	covid-19	PROPN
aiua-10141	100	15	,	,	PUNCT
aiua-10141	100	16	evaluation	evaluation	NOUN
aiua-10141	100	17	of	of	ADP
aiua-10141	100	18	the	the	DET
aiua-10141	100	19	iief	iief	ADJ
aiua-10141	100	20	scores	score	NOUN
aiua-10141	100	21	and	and	CCONJ
aiua-10141	100	22	testosterone	testosterone	NOUN
aiua-10141	100	23	levels	level	NOUN
aiua-10141	100	24	before	before	ADP
aiua-10141	100	25	and	and	CCONJ
aiua-10141	100	26	after	after	ADP
aiua-10141	100	27	covid-19	covid-19	PROPN
aiua-10141	100	28	according	accord	VERB
aiua-10141	100	29	to	to	ADP
aiua-10141	100	30	groups	group	NOUN
aiua-10141	100	31	and	and	CCONJ
aiua-10141	100	32	correlation	correlation	NOUN
aiua-10141	100	33	between	between	ADP
aiua-10141	100	34	testosterone	testosterone	NOUN
aiua-10141	100	35	level	level	NOUN
aiua-10141	100	36	,	,	PUNCT
aiua-10141	100	37	age	age	NOUN
aiua-10141	100	38	and	and	CCONJ
aiua-10141	100	39	iief	iief	PROPN
aiua-10141	100	40	score	score	NOUN
aiua-10141	100	41	.	.	PUNCT
aiua-10141	101	1	mean	mean	VERB
aiua-10141	101	2	±	±	NUM
aiua-10141	101	3	sd	sd	ADP
aiua-10141	101	4	p	p	PROPN
aiua-10141	101	5	iief	iief	ADJ
aiua-10141	101	6	score	score	NOUN
aiua-10141	101	7	before	before	SCONJ
aiua-10141	101	8	covid	covid	VERB
aiua-10141	101	9	23.5	23.5	NUM
aiua-10141	101	10	±	±	NUM
aiua-10141	101	11	1.57	1.57	NUM
aiua-10141	101	12	<	<	X
aiua-10141	101	13	.001	.001	NUM
aiua-10141	101	14	iief	iief	ADJ
aiua-10141	101	15	score	score	NOUN
aiua-10141	101	16	after	after	ADP
aiua-10141	101	17	covid	covid	PROPN
aiua-10141	101	18	11.03	11.03	NUM
aiua-10141	101	19	±	±	NUM
aiua-10141	101	20	3.76	3.76	NUM
aiua-10141	101	21	testosterone	testosterone	NOUN
aiua-10141	101	22	level	level	NOUN
aiua-10141	101	23	before	before	ADP
aiua-10141	101	24	covid	covid	PROPN
aiua-10141	101	25	345.67	345.67	NUM
aiua-10141	101	26	±	±	NOUN
aiua-10141	101	27	109.48	109.48	NUM
aiua-10141	101	28	<	<	X
aiua-10141	101	29	.001	.001	NUM
aiua-10141	101	30	testosterone	testosterone	NOUN
aiua-10141	101	31	level	level	NOUN
aiua-10141	101	32	after	after	ADP
aiua-10141	101	33	covid	covid	PROPN
aiua-10141	101	34	297.31	297.31	NUM
aiua-10141	101	35	±	±	NUM
aiua-10141	101	36	96.04	96.04	NUM
aiua-10141	101	37	according	accord	VERB
aiua-10141	101	38	to	to	ADP
aiua-10141	101	39	groups	group	NOUN
aiua-10141	101	40	20	20	NUM
aiua-10141	101	41	-	-	SYM
aiua-10141	101	42	40	40	NUM
aiua-10141	101	43	40	40	NUM
aiua-10141	101	44	-	-	SYM
aiua-10141	101	45	60	60	NUM
aiua-10141	101	46	60	60	NUM
aiua-10141	101	47	and	and	CCONJ
aiua-10141	101	48	over	over	ADP
aiua-10141	101	49	p	p	X
aiua-10141	101	50	(	(	PUNCT
aiua-10141	101	51	n	n	NOUN
aiua-10141	101	52	=	=	SYM
aiua-10141	101	53	16	16	NUM
aiua-10141	101	54	)	)	PUNCT
aiua-10141	101	55	(	(	PUNCT
aiua-10141	101	56	n	n	NOUN
aiua-10141	101	57	=	=	SYM
aiua-10141	101	58	33	33	NUM
aiua-10141	101	59	)	)	PUNCT
aiua-10141	101	60	(	(	PUNCT
aiua-10141	101	61	n	n	NOUN
aiua-10141	101	62	=	=	SYM
aiua-10141	101	63	21	21	NUM
aiua-10141	101	64	)	)	PUNCT
aiua-10141	101	65	median	median	NOUN
aiua-10141	101	66	(	(	PUNCT
aiua-10141	101	67	min	min	NOUN
aiua-10141	101	68	-	-	PUNCT
aiua-10141	101	69	max	max	ADJ
aiua-10141	101	70	)	)	PUNCT
aiua-10141	101	71	median	median	NOUN
aiua-10141	101	72	(	(	PUNCT
aiua-10141	101	73	min	min	NOUN
aiua-10141	101	74	-	-	PUNCT
aiua-10141	101	75	max	max	ADJ
aiua-10141	101	76	)	)	PUNCT
aiua-10141	101	77	median	median	NOUN
aiua-10141	101	78	(	(	PUNCT
aiua-10141	101	79	min	min	NOUN
aiua-10141	101	80	-	-	PUNCT
aiua-10141	101	81	max	max	NOUN
aiua-10141	101	82	)	)	PUNCT
aiua-10141	101	83	iief	iief	ADJ
aiua-10141	101	84	score	score	NOUN
aiua-10141	101	85	before	before	ADP
aiua-10141	101	86	covid	covid	VERB
aiua-10141	101	87	24(23	24(23	PROPN
aiua-10141	101	88	-	-	SYM
aiua-10141	101	89	25	25	NUM
aiua-10141	101	90	)	)	PUNCT
aiua-10141	101	91	23	23	NUM
aiua-10141	101	92	(	(	PUNCT
aiua-10141	101	93	22	22	NUM
aiua-10141	101	94	-	-	SYM
aiua-10141	101	95	25	25	NUM
aiua-10141	101	96	)	)	PUNCT
aiua-10141	101	97	22	22	NUM
aiua-10141	101	98	(	(	PUNCT
aiua-10141	101	99	22	22	NUM
aiua-10141	101	100	-	-	SYM
aiua-10141	101	101	23	23	NUM
aiua-10141	101	102	)	)	PUNCT
aiua-10141	101	103	.9	.9	NUM
aiua-10141	102	1	iief	iief	ADJ
aiua-10141	102	2	score	score	NOUN
aiua-10141	102	3	after	after	ADP
aiua-10141	102	4	covid	covid	PROPN
aiua-10141	102	5	14(6	14(6	PROPN
aiua-10141	102	6	-	-	PUNCT
aiua-10141	102	7	18	18	NUM
aiua-10141	102	8	)	)	PUNCT
aiua-10141	102	9	11	11	NUM
aiua-10141	102	10	(	(	PUNCT
aiua-10141	102	11	5	5	NUM
aiua-10141	102	12	-	-	SYM
aiua-10141	102	13	18	18	NUM
aiua-10141	102	14	)	)	PUNCT
aiua-10141	102	15	8	8	NUM
aiua-10141	102	16	(	(	PUNCT
aiua-10141	102	17	5	5	NUM
aiua-10141	102	18	-	-	SYM
aiua-10141	102	19	17	17	NUM
aiua-10141	102	20	)	)	PUNCT
aiua-10141	102	21	<	<	X
aiua-10141	102	22	.001	.001	NUM
aiua-10141	102	23	testosterone	testosterone	NOUN
aiua-10141	102	24	before	before	ADP
aiua-10141	102	25	covid	covid	PROPN
aiua-10141	102	26	400	400	NUM
aiua-10141	102	27	(	(	PUNCT
aiua-10141	102	28	213	213	NUM
aiua-10141	102	29	-	-	SYM
aiua-10141	102	30	531	531	NUM
aiua-10141	102	31	)	)	PUNCT
aiua-10141	102	32	390	390	NUM
aiua-10141	102	33	(	(	PUNCT
aiua-10141	102	34	122	122	NUM
aiua-10141	102	35	-	-	SYM
aiua-10141	102	36	680	680	NUM
aiua-10141	102	37	)	)	PUNCT
aiua-10141	102	38	225	225	NUM
aiua-10141	102	39	(	(	PUNCT
aiua-10141	102	40	112	112	NUM
aiua-10141	102	41	-	-	SYM
aiua-10141	102	42	423	423	NUM
aiua-10141	102	43	)	)	PUNCT
aiua-10141	102	44	<	<	X
aiua-10141	102	45	.001	.001	NUM
aiua-10141	102	46	testosterone	testosterone	NOUN
aiua-10141	102	47	after	after	ADP
aiua-10141	102	48	covid	covid	PROPN
aiua-10141	102	49	300	300	NUM
aiua-10141	102	50	(	(	PUNCT
aiua-10141	102	51	230	230	NUM
aiua-10141	102	52	-	-	SYM
aiua-10141	102	53	449	449	NUM
aiua-10141	102	54	)	)	PUNCT
aiua-10141	102	55	300	300	NUM
aiua-10141	102	56	(	(	PUNCT
aiua-10141	102	57	100	100	NUM
aiua-10141	102	58	-	-	SYM
aiua-10141	102	59	600	600	NUM
aiua-10141	102	60	)	)	PUNCT
aiua-10141	102	61	200	200	NUM
aiua-10141	102	62	(	(	PUNCT
aiua-10141	102	63	100	100	NUM
aiua-10141	102	64	-	-	SYM
aiua-10141	102	65	400	400	NUM
aiua-10141	102	66	)	)	PUNCT
aiua-10141	102	67	<	<	X
aiua-10141	102	68	.001	.001	NUM
aiua-10141	102	69	testosterone	testosterone	NOUN
aiua-10141	102	70	level	level	NOUN
aiua-10141	102	71	age	age	NOUN
aiua-10141	102	72	r	r	NOUN
aiua-10141	102	73	p	p	NOUN
aiua-10141	102	74	r	r	NOUN
aiua-10141	102	75	p	p	NOUN
aiua-10141	102	76	iief	iief	ADJ
aiua-10141	102	77	score	score	NOUN
aiua-10141	102	78	before	before	ADP
aiua-10141	102	79	covid	covid	PROPN
aiua-10141	102	80	0.383	0.383	NUM
aiua-10141	102	81	.001	.001	NUM
aiua-10141	102	82	-0.675	-0.675	NOUN
aiua-10141	102	83	<	<	X
aiua-10141	102	84	.001	.001	NUM
aiua-10141	102	85	iief	iief	ADJ
aiua-10141	102	86	score	score	NOUN
aiua-10141	102	87	after	after	ADP
aiua-10141	102	88	covid	covid	PROPN
aiua-10141	102	89	0.423	0.423	NUM
aiua-10141	102	90	<	<	X
aiua-10141	102	91	.001	.001	NUM
aiua-10141	102	92	-0.557	-0.557	PUNCT
aiua-10141	102	93	<	<	X
aiua-10141	102	94	.001	.001	NUM
aiua-10141	102	95	463archivio	463archivio	PROPN
aiua-10141	102	96	italiano	italiano	NOUN
aiua-10141	102	97	di	di	X
aiua-10141	102	98	urologia	urologia	PROPN
aiua-10141	102	99	e	e	PROPN
aiua-10141	102	100	andrologia	andrologia	NOUN
aiua-10141	102	101	2021	2021	NUM
aiua-10141	102	102	;	;	PUNCT
aiua-10141	102	103	93	93	NUM
aiua-10141	102	104	,	,	PUNCT
aiua-10141	102	105	4	4	NUM
aiua-10141	102	106	erectile	erectile	NOUN
aiua-10141	102	107	dysfunction	dysfunction	NOUN
aiua-10141	102	108	and	and	CCONJ
aiua-10141	102	109	testosterone	testosterone	NOUN
aiua-10141	102	110	in	in	ADP
aiua-10141	102	111	covid-19	covid-19	PROPN
aiua-10141	102	112	our	our	PRON
aiua-10141	102	113	study	study	NOUN
aiua-10141	102	114	did	do	AUX
aiua-10141	102	115	not	not	PART
aiua-10141	102	116	focus	focus	VERB
aiua-10141	102	117	on	on	ADP
aiua-10141	102	118	any	any	DET
aiua-10141	102	119	evaluation	evaluation	NOUN
aiua-10141	102	120	in	in	ADP
aiua-10141	102	121	this	this	DET
aiua-10141	102	122	direction	direction	NOUN
aiua-10141	102	123	,	,	PUNCT
aiua-10141	102	124	we	we	PRON
aiua-10141	102	125	assume	assume	VERB
aiua-10141	102	126	that	that	SCONJ
aiua-10141	102	127	the	the	DET
aiua-10141	102	128	low	low	ADJ
aiua-10141	102	129	testosterone	testosterone	NOUN
aiua-10141	102	130	level	level	NOUN
aiua-10141	102	131	in	in	ADP
aiua-10141	102	132	patients	patient	NOUN
aiua-10141	102	133	after	after	SCONJ
aiua-10141	102	134	covid-19	covid-19	PROPN
aiua-10141	102	135	may	may	AUX
aiua-10141	102	136	have	have	AUX
aiua-10141	102	137	contributed	contribute	VERB
aiua-10141	102	138	to	to	ADP
aiua-10141	102	139	inflammation	inflammation	NOUN
aiua-10141	102	140	.	.	PUNCT
aiua-10141	103	1	we	we	PRON
aiua-10141	103	2	also	also	ADV
aiua-10141	103	3	believe	believe	VERB
aiua-10141	103	4	that	that	SCONJ
aiua-10141	103	5	the	the	DET
aiua-10141	103	6	investigation	investigation	NOUN
aiua-10141	103	7	of	of	ADP
aiua-10141	103	8	the	the	DET
aiua-10141	103	9	effect	effect	NOUN
aiua-10141	103	10	of	of	ADP
aiua-10141	103	11	trt	trt	NOUN
aiua-10141	103	12	on	on	ADP
aiua-10141	103	13	the	the	DET
aiua-10141	103	14	clinical	clinical	ADJ
aiua-10141	103	15	findings	finding	NOUN
aiua-10141	103	16	of	of	ADP
aiua-10141	103	17	the	the	DET
aiua-10141	103	18	patients	patient	NOUN
aiua-10141	103	19	should	should	AUX
aiua-10141	103	20	be	be	AUX
aiua-10141	103	21	supported	support	VERB
aiua-10141	103	22	by	by	ADP
aiua-10141	103	23	prospective	prospective	ADJ
aiua-10141	103	24	studies	study	NOUN
aiua-10141	103	25	.	.	PUNCT
aiua-10141	104	1	during	during	ADP
aiua-10141	104	2	the	the	DET
aiua-10141	104	3	cytokine	cytokine	NOUN
aiua-10141	104	4	storm	storm	NOUN
aiua-10141	104	5	caused	cause	VERB
aiua-10141	104	6	by	by	ADP
aiua-10141	104	7	covid-19	covid-19	PROPN
aiua-10141	104	8	,	,	PUNCT
aiua-10141	104	9	low	low	ADJ
aiua-10141	104	10	testosterone	testosterone	NOUN
aiua-10141	104	11	can	can	AUX
aiua-10141	104	12	also	also	ADV
aiua-10141	104	13	affect	affect	VERB
aiua-10141	104	14	the	the	DET
aiua-10141	104	15	prognosis	prognosis	NOUN
aiua-10141	104	16	of	of	ADP
aiua-10141	104	17	the	the	DET
aiua-10141	104	18	disease	disease	NOUN
aiua-10141	104	19	.	.	PUNCT
aiua-10141	105	1	jiawei	jiawei	NOUN
aiua-10141	105	2	et	et	PROPN
aiua-10141	105	3	al	al	PROPN
aiua-10141	105	4	.	.	PROPN
aiua-10141	105	5	have	have	AUX
aiua-10141	105	6	suggested	suggest	VERB
aiua-10141	105	7	in	in	ADP
aiua-10141	105	8	their	their	PRON
aiua-10141	105	9	study	study	NOUN
aiua-10141	105	10	that	that	PRON
aiua-10141	105	11	testosterone	testosterone	NOUN
aiua-10141	105	12	may	may	AUX
aiua-10141	105	13	play	play	VERB
aiua-10141	105	14	a	a	DET
aiua-10141	105	15	role	role	NOUN
aiua-10141	105	16	in	in	ADP
aiua-10141	105	17	the	the	DET
aiua-10141	105	18	chain	chain	NOUN
aiua-10141	105	19	of	of	ADP
aiua-10141	105	20	events	event	NOUN
aiua-10141	105	21	leading	lead	VERB
aiua-10141	105	22	to	to	ADP
aiua-10141	105	23	the	the	DET
aiua-10141	105	24	progression	progression	NOUN
aiua-10141	105	25	of	of	ADP
aiua-10141	105	26	covid-19	covid-19	PROPN
aiua-10141	105	27	infection	infection	NOUN
aiua-10141	105	28	due	due	ADP
aiua-10141	105	29	to	to	ADP
aiua-10141	105	30	the	the	DET
aiua-10141	105	31	cytokine	cytokine	NOUN
aiua-10141	105	32	storm	storm	NOUN
aiua-10141	105	33	.	.	PUNCT
aiua-10141	106	1	it	it	PRON
aiua-10141	106	2	was	be	AUX
aiua-10141	106	3	concluded	conclude	VERB
aiua-10141	106	4	with	with	ADP
aiua-10141	106	5	this	this	DET
aiua-10141	106	6	study	study	NOUN
aiua-10141	106	7	that	that	SCONJ
aiua-10141	106	8	there	there	PRON
aiua-10141	106	9	may	may	AUX
aiua-10141	106	10	be	be	AUX
aiua-10141	106	11	a	a	DET
aiua-10141	106	12	negative	negative	ADJ
aiua-10141	106	13	correlation	correlation	NOUN
aiua-10141	106	14	between	between	ADP
aiua-10141	106	15	ace2	ace2	NOUN
aiua-10141	106	16	expression	expression	NOUN
aiua-10141	106	17	and	and	CCONJ
aiua-10141	106	18	covid-19	covid-19	PROPN
aiua-10141	106	19	mortality	mortality	NOUN
aiua-10141	106	20	as	as	ADP
aiua-10141	106	21	a	a	DET
aiua-10141	106	22	result	result	NOUN
aiua-10141	106	23	of	of	ADP
aiua-10141	106	24	suppression	suppression	NOUN
aiua-10141	106	25	of	of	ADP
aiua-10141	106	26	ace2	ace2	NOUN
aiua-10141	106	27	expression	expression	NOUN
aiua-10141	106	28	by	by	ADP
aiua-10141	106	29	inflammatory	inflammatory	ADJ
aiua-10141	106	30	cytokines	cytokine	NOUN
aiua-10141	106	31	accompanying	accompany	VERB
aiua-10141	106	32	the	the	DET
aiua-10141	106	33	decrease	decrease	NOUN
aiua-10141	106	34	in	in	ADP
aiua-10141	106	35	androgens	androgen	NOUN
aiua-10141	106	36	and	and	CCONJ
aiua-10141	106	37	oestrogens	oestrogen	NOUN
aiua-10141	106	38	in	in	ADP
aiua-10141	106	39	the	the	DET
aiua-10141	106	40	elderly	elderly	ADJ
aiua-10141	106	41	(	(	PUNCT
aiua-10141	106	42	32	32	NUM
aiua-10141	106	43	)	)	PUNCT
aiua-10141	106	44	.	.	PUNCT
aiua-10141	107	1	giagulli	giagulli	PROPN
aiua-10141	107	2	et	et	PROPN
aiua-10141	107	3	al	al	PROPN
aiua-10141	107	4	.	.	PROPN
aiua-10141	107	5	has	have	AUX
aiua-10141	107	6	shown	show	VERB
aiua-10141	107	7	that	that	SCONJ
aiua-10141	107	8	testosterone	testosterone	NOUN
aiua-10141	107	9	can	can	AUX
aiua-10141	107	10	make	make	VERB
aiua-10141	107	11	men	man	NOUN
aiua-10141	107	12	susceptible	susceptible	ADJ
aiua-10141	107	13	to	to	ADP
aiua-10141	107	14	a	a	DET
aiua-10141	107	15	common	common	ADJ
aiua-10141	107	16	covid-19	covid-19	PROPN
aiua-10141	107	17	infection	infection	NOUN
aiua-10141	107	18	compared	compare	VERB
aiua-10141	107	19	to	to	ADP
aiua-10141	107	20	oestrogen	oestrogen	NOUN
aiua-10141	107	21	,	,	PUNCT
aiua-10141	107	22	and	and	CCONJ
aiua-10141	107	23	low	low	ADJ
aiua-10141	107	24	serum	serum	NOUN
aiua-10141	107	25	testosterone	testosterone	NOUN
aiua-10141	107	26	levels	level	NOUN
aiua-10141	107	27	in	in	ADP
aiua-10141	107	28	severe	severe	ADJ
aiua-10141	107	29	patients	patient	NOUN
aiua-10141	107	30	make	make	VERB
aiua-10141	107	31	men	man	NOUN
aiua-10141	107	32	,	,	PUNCT
aiua-10141	107	33	especially	especially	ADV
aiua-10141	107	34	older	old	ADJ
aiua-10141	107	35	,	,	PUNCT
aiua-10141	107	36	susceptible	susceptible	ADJ
aiua-10141	107	37	to	to	ADP
aiua-10141	107	38	poor	poor	ADJ
aiua-10141	107	39	prognosis	prognosis	NOUN
aiua-10141	107	40	or	or	CCONJ
aiua-10141	107	41	death	death	NOUN
aiua-10141	107	42	(	(	PUNCT
aiua-10141	107	43	33	33	NUM
aiua-10141	107	44	)	)	PUNCT
aiua-10141	107	45	.	.	PUNCT
aiua-10141	108	1	papadopoulos	papadopoulos	PROPN
aiua-10141	108	2	et	et	PROPN
aiua-10141	108	3	al	al	PROPN
aiua-10141	108	4	.	.	PROPN
aiua-10141	108	5	reported	report	VERB
aiua-10141	108	6	that	that	SCONJ
aiua-10141	108	7	low	low	ADJ
aiua-10141	108	8	testosterone	testosterone	NOUN
aiua-10141	108	9	levels	level	NOUN
aiua-10141	108	10	are	be	AUX
aiua-10141	108	11	associated	associate	VERB
aiua-10141	108	12	with	with	ADP
aiua-10141	108	13	ards	ard	NOUN
aiua-10141	108	14	increasing	increase	VERB
aiua-10141	108	15	the	the	DET
aiua-10141	108	16	severity	severity	NOUN
aiua-10141	108	17	of	of	ADP
aiua-10141	108	18	covid-19	covid-19	PROPN
aiua-10141	108	19	infection	infection	NOUN
aiua-10141	108	20	in	in	ADP
aiua-10141	108	21	elderly	elderly	ADJ
aiua-10141	108	22	men	man	NOUN
aiua-10141	108	23	and	and	CCONJ
aiua-10141	108	24	they	they	PRON
aiua-10141	108	25	added	add	VERB
aiua-10141	108	26	that	that	SCONJ
aiua-10141	108	27	normal	normal	ADJ
aiua-10141	108	28	testosterone	testosterone	NOUN
aiua-10141	108	29	levels	level	NOUN
aiua-10141	108	30	may	may	AUX
aiua-10141	108	31	also	also	ADV
aiua-10141	108	32	provide	provide	VERB
aiua-10141	108	33	some	some	DET
aiua-10141	108	34	slight	slight	ADJ
aiua-10141	108	35	protection	protection	NOUN
aiua-10141	108	36	against	against	ADP
aiua-10141	108	37	covid-19	covid-19	PROPN
aiua-10141	108	38	(	(	PUNCT
aiua-10141	108	39	13	13	NUM
aiua-10141	108	40	)	)	PUNCT
aiua-10141	108	41	.	.	PUNCT
aiua-10141	109	1	similar	similar	ADJ
aiua-10141	109	2	studies	study	NOUN
aiua-10141	109	3	in	in	ADP
aiua-10141	109	4	the	the	DET
aiua-10141	109	5	literature	literature	NOUN
aiua-10141	109	6	support	support	VERB
aiua-10141	109	7	a	a	DET
aiua-10141	109	8	relationship	relationship	NOUN
aiua-10141	109	9	between	between	ADP
aiua-10141	109	10	the	the	DET
aiua-10141	109	11	need	need	NOUN
aiua-10141	109	12	for	for	ADP
aiua-10141	109	13	intensive	intensive	ADJ
aiua-10141	109	14	care	care	NOUN
aiua-10141	109	15	and	and	CCONJ
aiua-10141	109	16	low	low	ADJ
aiua-10141	109	17	testosterone	testosterone	NOUN
aiua-10141	109	18	levels	level	NOUN
aiua-10141	109	19	in	in	ADP
aiua-10141	109	20	covid-19	covid-19	PROPN
aiua-10141	109	21	infection	infection	NOUN
aiua-10141	109	22	(	(	PUNCT
aiua-10141	109	23	34	34	NUM
aiua-10141	109	24	,	,	PUNCT
aiua-10141	109	25	35	35	NUM
aiua-10141	109	26	)	)	PUNCT
aiua-10141	109	27	.	.	PUNCT
aiua-10141	110	1	studies	study	NOUN
aiua-10141	110	2	have	have	AUX
aiua-10141	110	3	also	also	ADV
aiua-10141	110	4	been	be	AUX
aiua-10141	110	5	reported	report	VERB
aiua-10141	110	6	that	that	SCONJ
aiua-10141	110	7	testosterone	testosterone	NOUN
aiua-10141	110	8	affects	affect	VERB
aiua-10141	110	9	by	by	ADP
aiua-10141	110	10	using	use	VERB
aiua-10141	110	11	a	a	DET
aiua-10141	110	12	different	different	ADJ
aiua-10141	110	13	mechanism	mechanism	NOUN
aiua-10141	110	14	apart	apart	ADV
aiua-10141	110	15	from	from	ADP
aiua-10141	110	16	the	the	DET
aiua-10141	110	17	cytokine	cytokine	ADJ
aiua-10141	110	18	mechanism	mechanism	NOUN
aiua-10141	110	19	during	during	ADP
aiua-10141	110	20	covid-19	covid-19	PROPN
aiua-10141	110	21	infection	infection	NOUN
aiua-10141	110	22	.	.	PUNCT
aiua-10141	111	1	it	it	PRON
aiua-10141	111	2	has	have	AUX
aiua-10141	111	3	been	be	AUX
aiua-10141	111	4	reported	report	VERB
aiua-10141	111	5	in	in	ADP
aiua-10141	111	6	the	the	DET
aiua-10141	111	7	study	study	NOUN
aiua-10141	111	8	of	of	ADP
aiua-10141	111	9	lii	lii	PROPN
aiua-10141	111	10	et	et	PROPN
aiua-10141	111	11	al	al	PROPN
aiua-10141	111	12	.	.	PUNCT
aiua-10141	112	1	that	that	SCONJ
aiua-10141	112	2	the	the	DET
aiua-10141	112	3	first	first	ADJ
aiua-10141	112	4	biological	biological	ADJ
aiua-10141	112	5	step	step	NOUN
aiua-10141	112	6	which	which	PRON
aiua-10141	112	7	is	be	AUX
aiua-10141	112	8	necessary	necessary	ADJ
aiua-10141	112	9	for	for	SCONJ
aiua-10141	112	10	the	the	DET
aiua-10141	112	11	potential	potential	ADJ
aiua-10141	112	12	infectivity	infectivity	NOUN
aiua-10141	112	13	of	of	ADP
aiua-10141	112	14	covid-19	covid-19	PROPN
aiua-10141	112	15	is	be	AUX
aiua-10141	112	16	to	to	PART
aiua-10141	112	17	activate	activate	VERB
aiua-10141	112	18	ace2	ace2	NOUN
aiua-10141	112	19	as	as	ADP
aiua-10141	112	20	the	the	DET
aiua-10141	112	21	entry	entry	NOUN
aiua-10141	112	22	receptor	receptor	NOUN
aiua-10141	112	23	and	and	CCONJ
aiua-10141	112	24	to	to	PART
aiua-10141	112	25	use	use	VERB
aiua-10141	112	26	cellular	cellular	ADJ
aiua-10141	112	27	transmembrane	transmembrane	ADJ
aiua-10141	112	28	protease	protease	NOUN
aiua-10141	112	29	serine	serine	NOUN
aiua-10141	112	30	2	2	NUM
aiua-10141	112	31	(	(	PUNCT
aiua-10141	112	32	tmprss2	tmprss2	ADV
aiua-10141	112	33	)	)	PUNCT
aiua-10141	112	34	to	to	PART
aiua-10141	112	35	prepare	prepare	VERB
aiua-10141	112	36	spike	spike	ADJ
aiua-10141	112	37	protein	protein	NOUN
aiua-10141	112	38	(	(	PUNCT
aiua-10141	112	39	36	36	NUM
aiua-10141	112	40	)	)	PUNCT
aiua-10141	112	41	.	.	PUNCT
aiua-10141	113	1	hoffmann	hoffmann	PROPN
aiua-10141	113	2	et	et	PROPN
aiua-10141	113	3	al	al	PROPN
aiua-10141	113	4	.	.	PROPN
aiua-10141	113	5	showed	show	VERB
aiua-10141	113	6	in	in	ADP
aiua-10141	113	7	their	their	PRON
aiua-10141	113	8	study	study	NOUN
aiua-10141	113	9	that	that	DET
aiua-10141	113	10	viral	viral	ADJ
aiua-10141	113	11	spread	spread	NOUN
aiua-10141	113	12	and	and	CCONJ
aiua-10141	113	13	pathogenesis	pathogenesis	NOUN
aiua-10141	113	14	are	be	AUX
aiua-10141	113	15	provided	provide	VERB
aiua-10141	113	16	in	in	ADP
aiua-10141	113	17	infected	infected	ADJ
aiua-10141	113	18	hosts	host	NOUN
aiua-10141	113	19	by	by	ADP
aiua-10141	113	20	spike	spike	ADJ
aiua-10141	113	21	proteins	protein	NOUN
aiua-10141	113	22	becoming	become	VERB
aiua-10141	113	23	ready	ready	ADJ
aiua-10141	113	24	by	by	ADP
aiua-10141	113	25	tmprss2	tmprss2	ADP
aiua-10141	113	26	(	(	PUNCT
aiua-10141	113	27	37	37	NUM
aiua-10141	113	28	)	)	PUNCT
aiua-10141	113	29	.	.	PUNCT
aiua-10141	114	1	heurich	heurich	INTJ
aiua-10141	114	2	et	et	PROPN
aiua-10141	114	3	al	al	PROPN
aiua-10141	114	4	.	.	PROPN
aiua-10141	114	5	presented	present	VERB
aiua-10141	114	6	in	in	ADP
aiua-10141	114	7	their	their	PRON
aiua-10141	114	8	study	study	NOUN
aiua-10141	114	9	that	that	SCONJ
aiua-10141	114	10	tmprss2	tmprss2	PRON
aiua-10141	114	11	can	can	AUX
aiua-10141	114	12	also	also	ADV
aiua-10141	114	13	break	break	VERB
aiua-10141	114	14	down	down	ADP
aiua-10141	114	15	ace2	ace2	NOUN
aiua-10141	114	16	for	for	ADP
aiua-10141	114	17	viral	viral	ADJ
aiua-10141	114	18	entry	entry	NOUN
aiua-10141	114	19	and	and	CCONJ
aiua-10141	114	20	that	that	SCONJ
aiua-10141	114	21	androgen	androgen	NOUN
aiua-10141	114	22	receptor	receptor	NOUN
aiua-10141	114	23	activity	activity	NOUN
aiua-10141	114	24	is	be	AUX
aiua-10141	114	25	a	a	DET
aiua-10141	114	26	requirement	requirement	NOUN
aiua-10141	114	27	for	for	ADP
aiua-10141	114	28	the	the	DET
aiua-10141	114	29	transcription	transcription	NOUN
aiua-10141	114	30	of	of	ADP
aiua-10141	114	31	the	the	DET
aiua-10141	114	32	tmprss2	tmprss2	ADJ
aiua-10141	114	33	gene	gene	NOUN
aiua-10141	114	34	(	(	PUNCT
aiua-10141	114	35	38	38	NUM
aiua-10141	114	36	)	)	PUNCT
aiua-10141	114	37	.	.	PUNCT
aiua-10141	115	1	there	there	PRON
aiua-10141	115	2	are	be	VERB
aiua-10141	115	3	studies	study	NOUN
aiua-10141	115	4	reporting	report	VERB
aiua-10141	115	5	that	that	SCONJ
aiua-10141	115	6	high	high	ADJ
aiua-10141	115	7	testosterone	testosterone	NOUN
aiua-10141	115	8	levels	level	NOUN
aiua-10141	115	9	are	be	AUX
aiua-10141	115	10	associated	associate	VERB
aiua-10141	115	11	with	with	ADP
aiua-10141	115	12	poor	poor	ADJ
aiua-10141	115	13	prognosis	prognosis	NOUN
aiua-10141	115	14	in	in	ADP
aiua-10141	115	15	covid-19	covid-19	PROPN
aiua-10141	115	16	through	through	ADP
aiua-10141	115	17	this	this	DET
aiua-10141	115	18	mechanism	mechanism	NOUN
aiua-10141	115	19	.	.	PUNCT
aiua-10141	116	1	wambier	wambi	ADJ
aiua-10141	116	2	et	et	PROPN
aiua-10141	116	3	al	al	PROPN
aiua-10141	116	4	.	.	PROPN
aiua-10141	116	5	reported	report	VERB
aiua-10141	116	6	that	that	SCONJ
aiua-10141	116	7	the	the	DET
aiua-10141	116	8	hyperandrogenic	hyperandrogenic	ADJ
aiua-10141	116	9	phenotype	phenotype	NOUN
aiua-10141	116	10	may	may	AUX
aiua-10141	116	11	be	be	AUX
aiua-10141	116	12	associated	associate	VERB
aiua-10141	116	13	with	with	ADP
aiua-10141	116	14	increased	increase	VERB
aiua-10141	116	15	viral	viral	ADJ
aiua-10141	116	16	load	load	NOUN
aiua-10141	116	17	,	,	PUNCT
aiua-10141	116	18	increased	increase	VERB
aiua-10141	116	19	viral	viral	ADJ
aiua-10141	116	20	spread	spread	NOUN
aiua-10141	116	21	,	,	PUNCT
aiua-10141	116	22	and	and	CCONJ
aiua-10141	116	23	severity	severity	NOUN
aiua-10141	116	24	of	of	ADP
aiua-10141	116	25	lung	lung	NOUN
aiua-10141	116	26	involvement	involvement	NOUN
aiua-10141	116	27	for	for	ADP
aiua-10141	116	28	covid-19	covid-19	PROPN
aiua-10141	116	29	(	(	PUNCT
aiua-10141	116	30	39	39	NUM
aiua-10141	116	31	)	)	PUNCT
aiua-10141	116	32	.	.	PUNCT
aiua-10141	117	1	it	it	PRON
aiua-10141	117	2	was	be	AUX
aiua-10141	117	3	reported	report	VERB
aiua-10141	117	4	by	by	ADP
aiua-10141	117	5	rozhivanov	rozhivanov	PROPN
aiua-10141	117	6	et	et	PROPN
aiua-10141	117	7	al	al	PROPN
aiua-10141	117	8	.	.	PUNCT
aiua-10141	118	1	that	that	SCONJ
aiua-10141	118	2	both	both	PRON
aiua-10141	118	3	tmprss2	tmprss2	SCONJ
aiua-10141	118	4	expression	expression	NOUN
aiua-10141	118	5	and	and	CCONJ
aiua-10141	118	6	a	a	DET
aiua-10141	118	7	more	more	ADV
aiua-10141	118	8	severe	severe	ADJ
aiua-10141	118	9	course	course	NOUN
aiua-10141	118	10	of	of	ADP
aiua-10141	118	11	coronavirus	coronavirus	NOUN
aiua-10141	118	12	infection	infection	NOUN
aiua-10141	118	13	were	be	AUX
aiua-10141	118	14	observed	observe	VERB
aiua-10141	118	15	in	in	ADP
aiua-10141	118	16	men	man	NOUN
aiua-10141	118	17	with	with	ADP
aiua-10141	118	18	hyperandrogenism	hyperandrogenism	NOUN
aiua-10141	118	19	.	.	PUNCT
aiua-10141	119	1	in	in	ADP
aiua-10141	119	2	this	this	DET
aiua-10141	119	3	context	context	NOUN
aiua-10141	119	4	,	,	PUNCT
aiua-10141	119	5	some	some	DET
aiua-10141	119	6	researchers	researcher	NOUN
aiua-10141	119	7	suggested	suggest	VERB
aiua-10141	119	8	the	the	DET
aiua-10141	119	9	creation	creation	NOUN
aiua-10141	119	10	of	of	ADP
aiua-10141	119	11	androgen	androgen	NOUN
aiua-10141	119	12	deprivation	deprivation	NOUN
aiua-10141	119	13	with	with	ADP
aiua-10141	119	14	drug	drug	NOUN
aiua-10141	119	15	treatments	treatment	NOUN
aiua-10141	119	16	for	for	ADP
aiua-10141	119	17	men	man	NOUN
aiua-10141	119	18	at	at	ADP
aiua-10141	119	19	high	high	ADJ
aiua-10141	119	20	risk	risk	NOUN
aiua-10141	119	21	of	of	ADP
aiua-10141	119	22	developing	develop	VERB
aiua-10141	119	23	covid-19	covid-19	PROPN
aiua-10141	119	24	(	(	PUNCT
aiua-10141	119	25	40	40	NUM
aiua-10141	119	26	)	)	PUNCT
aiua-10141	119	27	.	.	PUNCT
aiua-10141	120	1	there	there	PRON
aiua-10141	120	2	are	be	VERB
aiua-10141	120	3	some	some	DET
aiua-10141	120	4	contrasting	contrast	VERB
aiua-10141	120	5	views	view	NOUN
aiua-10141	120	6	in	in	ADP
aiua-10141	120	7	the	the	DET
aiua-10141	120	8	literature	literature	NOUN
aiua-10141	120	9	on	on	ADP
aiua-10141	120	10	the	the	DET
aiua-10141	120	11	effect	effect	NOUN
aiua-10141	120	12	of	of	ADP
aiua-10141	120	13	testosterone	testosterone	NOUN
aiua-10141	120	14	level	level	NOUN
aiua-10141	120	15	on	on	ADP
aiua-10141	120	16	covid-19	covid-19	PROPN
aiua-10141	120	17	prognosis	prognosis	NOUN
aiua-10141	120	18	and	and	CCONJ
aiua-10141	120	19	further	further	ADJ
aiua-10141	120	20	studies	study	NOUN
aiua-10141	120	21	are	be	AUX
aiua-10141	120	22	required	require	VERB
aiua-10141	120	23	to	to	PART
aiua-10141	120	24	support	support	VERB
aiua-10141	120	25	them	they	PRON
aiua-10141	120	26	.	.	PUNCT
aiua-10141	121	1	the	the	DET
aiua-10141	121	2	results	result	NOUN
aiua-10141	121	3	of	of	ADP
aiua-10141	121	4	our	our	PRON
aiua-10141	121	5	study	study	NOUN
aiua-10141	121	6	showed	show	VERB
aiua-10141	121	7	that	that	SCONJ
aiua-10141	121	8	patients	patient	NOUN
aiua-10141	121	9	with	with	ADP
aiua-10141	121	10	high	high	ADJ
aiua-10141	121	11	testosterone	testosterone	NOUN
aiua-10141	121	12	levels	level	NOUN
aiua-10141	121	13	need	need	VERB
aiua-10141	121	14	intensive	intensive	ADJ
aiua-10141	121	15	care	care	NOUN
aiua-10141	121	16	more	more	ADV
aiua-10141	121	17	and	and	CCONJ
aiua-10141	121	18	this	this	PRON
aiua-10141	121	19	supports	support	VERB
aiua-10141	121	20	the	the	DET
aiua-10141	121	21	studies	study	NOUN
aiua-10141	121	22	in	in	ADP
aiua-10141	121	23	the	the	DET
aiua-10141	121	24	literature	literature	NOUN
aiua-10141	121	25	claiming	claim	VERB
aiua-10141	121	26	that	that	DET
aiua-10141	121	27	high	high	ADJ
aiua-10141	121	28	testosterone	testosterone	NOUN
aiua-10141	121	29	level	level	NOUN
aiua-10141	121	30	is	be	AUX
aiua-10141	121	31	a	a	DET
aiua-10141	121	32	poor	poor	ADJ
aiua-10141	121	33	prognostic	prognostic	ADJ
aiua-10141	121	34	factor	factor	NOUN
aiua-10141	121	35	for	for	ADP
aiua-10141	121	36	covid-19	covid-19	PROPN
aiua-10141	121	37	.	.	PUNCT
aiua-10141	122	1	there	there	PRON
aiua-10141	122	2	are	be	VERB
aiua-10141	122	3	some	some	DET
aiua-10141	122	4	limitations	limitation	NOUN
aiua-10141	122	5	of	of	ADP
aiua-10141	122	6	our	our	PRON
aiua-10141	122	7	study	study	NOUN
aiua-10141	122	8	.	.	PUNCT
aiua-10141	123	1	our	our	PRON
aiua-10141	123	2	study	study	NOUN
aiua-10141	123	3	reflects	reflect	VERB
aiua-10141	123	4	the	the	DET
aiua-10141	123	5	results	result	NOUN
aiua-10141	123	6	of	of	ADP
aiua-10141	123	7	one	one	NUM
aiua-10141	123	8	centre	centre	NOUN
aiua-10141	123	9	and	and	CCONJ
aiua-10141	123	10	includes	include	VERB
aiua-10141	123	11	a	a	DET
aiua-10141	123	12	limited	limited	ADJ
aiua-10141	123	13	number	number	NOUN
aiua-10141	123	14	of	of	ADP
aiua-10141	123	15	patients	patient	NOUN
aiua-10141	123	16	.	.	PUNCT
aiua-10141	124	1	besides	besides	SCONJ
aiua-10141	124	2	,	,	PUNCT
aiua-10141	124	3	although	although	SCONJ
aiua-10141	124	4	we	we	PRON
aiua-10141	124	5	have	have	AUX
aiua-10141	124	6	excluded	exclude	VERB
aiua-10141	124	7	many	many	ADJ
aiua-10141	124	8	factors	factor	NOUN
aiua-10141	124	9	that	that	PRON
aiua-10141	124	10	cause	cause	VERB
aiua-10141	124	11	ed	ed	NOUN
aiua-10141	124	12	(	(	PUNCT
aiua-10141	124	13	such	such	ADJ
aiua-10141	124	14	as	as	ADP
aiua-10141	124	15	obesity	obesity	NOUN
aiua-10141	124	16	,	,	PUNCT
aiua-10141	124	17	hypertension	hypertension	NOUN
aiua-10141	124	18	,	,	PUNCT
aiua-10141	124	19	diabetes	diabetes	NOUN
aiua-10141	124	20	or	or	CCONJ
aiua-10141	124	21	heart	heart	NOUN
aiua-10141	124	22	disease	disease	NOUN
aiua-10141	124	23	)	)	PUNCT
aiua-10141	124	24	,	,	PUNCT
aiua-10141	124	25	the	the	DET
aiua-10141	124	26	ed	ed	NOUN
aiua-10141	124	27	mechanism	mechanism	NOUN
aiua-10141	124	28	is	be	AUX
aiua-10141	124	29	dependent	dependent	ADJ
aiua-10141	124	30	on	on	ADP
aiua-10141	124	31	a	a	DET
aiua-10141	124	32	lot	lot	NOUN
aiua-10141	124	33	of	of	ADP
aiua-10141	124	34	factors	factor	NOUN
aiua-10141	124	35	that	that	PRON
aiua-10141	124	36	our	our	PRON
aiua-10141	124	37	study	study	NOUN
aiua-10141	124	38	may	may	AUX
aiua-10141	124	39	not	not	PART
aiua-10141	124	40	have	have	AUX
aiua-10141	124	41	been	be	AUX
aiua-10141	124	42	able	able	ADJ
aiua-10141	124	43	to	to	PART
aiua-10141	124	44	evaluate	evaluate	VERB
aiua-10141	124	45	adequately	adequately	ADV
aiua-10141	124	46	since	since	SCONJ
aiua-10141	124	47	a	a	DET
aiua-10141	124	48	non	non	ADJ
aiua-10141	124	49	-	-	ADJ
aiua-10141	124	50	ed	ed	ADJ
aiua-10141	124	51	vital	vital	ADJ
aiua-10141	124	52	disease	disease	NOUN
aiua-10141	124	53	is	be	AUX
aiua-10141	124	54	discussed	discuss	VERB
aiua-10141	124	55	.	.	PUNCT
aiua-10141	125	1	other	other	ADJ
aiua-10141	125	2	limitations	limitation	NOUN
aiua-10141	125	3	are	be	AUX
aiua-10141	125	4	that	that	SCONJ
aiua-10141	125	5	the	the	DET
aiua-10141	125	6	psychological	psychological	ADJ
aiua-10141	125	7	state	state	NOUN
aiua-10141	125	8	of	of	ADP
aiua-10141	125	9	the	the	DET
aiua-10141	125	10	patients	patient	NOUN
aiua-10141	125	11	may	may	AUX
aiua-10141	125	12	have	have	AUX
aiua-10141	125	13	affected	affect	VERB
aiua-10141	125	14	the	the	DET
aiua-10141	125	15	iief-5	iief-5	NUM
aiua-10141	125	16	score	score	NOUN
aiua-10141	125	17	,	,	PUNCT
aiua-10141	125	18	and	and	CCONJ
aiua-10141	125	19	conditions	condition	NOUN
aiua-10141	125	20	such	such	ADJ
aiua-10141	125	21	as	as	ADP
aiua-10141	125	22	varicocele	varicocele	NOUN
aiua-10141	125	23	and	and	CCONJ
aiua-10141	125	24	infertility	infertility	NOUN
aiua-10141	125	25	may	may	AUX
aiua-10141	125	26	cause	cause	VERB
aiua-10141	125	27	low	low	ADJ
aiua-10141	125	28	testosterone	testosterone	NOUN
aiua-10141	125	29	levels	level	NOUN
aiua-10141	125	30	,	,	PUNCT
aiua-10141	125	31	which	which	PRON
aiua-10141	125	32	may	may	AUX
aiua-10141	125	33	affect	affect	VERB
aiua-10141	125	34	our	our	PRON
aiua-10141	125	35	results	result	NOUN
aiua-10141	125	36	.	.	PUNCT
aiua-10141	126	1	however	however	ADV
aiua-10141	126	2	,	,	PUNCT
aiua-10141	126	3	to	to	ADP
aiua-10141	126	4	the	the	DET
aiua-10141	126	5	best	good	ADJ
aiua-10141	126	6	of	of	ADP
aiua-10141	126	7	our	our	PRON
aiua-10141	126	8	knowledge	knowledge	NOUN
aiua-10141	126	9	,	,	PUNCT
aiua-10141	126	10	our	our	PRON
aiua-10141	126	11	study	study	NOUN
aiua-10141	126	12	is	be	AUX
aiua-10141	126	13	one	one	NUM
aiua-10141	126	14	of	of	ADP
aiua-10141	126	15	the	the	DET
aiua-10141	126	16	first	first	ADJ
aiua-10141	126	17	studies	study	NOUN
aiua-10141	126	18	showing	show	VERB
aiua-10141	126	19	that	that	SCONJ
aiua-10141	126	20	covid-19	covid-19	PROPN
aiua-10141	126	21	causes	cause	VERB
aiua-10141	126	22	erectile	erectile	ADJ
aiua-10141	126	23	dysfunction	dysfunction	NOUN
aiua-10141	126	24	and	and	CCONJ
aiua-10141	126	25	there	there	PRON
aiua-10141	126	26	are	be	VERB
aiua-10141	126	27	only	only	ADV
aiua-10141	126	28	a	a	DET
aiua-10141	126	29	limited	limited	ADJ
aiua-10141	126	30	number	number	NOUN
aiua-10141	126	31	of	of	ADP
aiua-10141	126	32	studies	study	NOUN
aiua-10141	126	33	in	in	ADP
aiua-10141	126	34	the	the	DET
aiua-10141	126	35	literature	literature	NOUN
aiua-10141	126	36	on	on	ADP
aiua-10141	126	37	this	this	DET
aiua-10141	126	38	subject	subject	NOUN
aiua-10141	126	39	.	.	PUNCT
aiua-10141	127	1	we	we	PRON
aiua-10141	127	2	hope	hope	VERB
aiua-10141	127	3	that	that	SCONJ
aiua-10141	127	4	our	our	PRON
aiua-10141	127	5	study	study	NOUN
aiua-10141	127	6	will	will	AUX
aiua-10141	127	7	make	make	VERB
aiua-10141	127	8	a	a	DET
aiua-10141	127	9	considerable	considerable	ADJ
aiua-10141	127	10	contribution	contribution	NOUN
aiua-10141	127	11	to	to	ADP
aiua-10141	127	12	the	the	DET
aiua-10141	127	13	literature	literature	NOUN
aiua-10141	127	14	with	with	ADP
aiua-10141	127	15	this	this	DET
aiua-10141	127	16	aspect	aspect	NOUN
aiua-10141	127	17	.	.	PUNCT
aiua-10141	128	1	conclusions	conclusion	NOUN
aiua-10141	128	2	covid-19	covid-19	PROPN
aiua-10141	128	3	can	can	AUX
aiua-10141	128	4	cause	cause	VERB
aiua-10141	128	5	erectile	erectile	ADJ
aiua-10141	128	6	dysfunction	dysfunction	NOUN
aiua-10141	128	7	in	in	ADP
aiua-10141	128	8	men	man	NOUN
aiua-10141	128	9	of	of	ADP
aiua-10141	128	10	all	all	DET
aiua-10141	128	11	age	age	NOUN
aiua-10141	128	12	groups	group	NOUN
aiua-10141	128	13	,	,	PUNCT
aiua-10141	128	14	and	and	CCONJ
aiua-10141	128	15	high	high	ADJ
aiua-10141	128	16	testosterone	testosterone	NOUN
aiua-10141	128	17	increases	increase	VERB
aiua-10141	128	18	the	the	DET
aiua-10141	128	19	rate	rate	NOUN
aiua-10141	128	20	of	of	ADP
aiua-10141	128	21	hospitalization	hospitalization	NOUN
aiua-10141	128	22	in	in	ADP
aiua-10141	128	23	the	the	DET
aiua-10141	128	24	intensive	intensive	ADJ
aiua-10141	128	25	care	care	NOUN
aiua-10141	128	26	unit	unit	NOUN
aiua-10141	128	27	by	by	ADP
aiua-10141	128	28	intensifying	intensify	VERB
aiua-10141	128	29	the	the	DET
aiua-10141	128	30	disease	disease	NOUN
aiua-10141	128	31	.	.	PUNCT
aiua-10141	129	1	acknowledgment	acknowledgment	NOUN
aiua-10141	129	2	we	we	PRON
aiua-10141	129	3	would	would	AUX
aiua-10141	129	4	like	like	VERB
aiua-10141	129	5	to	to	PART
aiua-10141	129	6	thank	thank	VERB
aiua-10141	129	7	the	the	DET
aiua-10141	129	8	adana	adana	PROPN
aiua-10141	129	9	city	city	PROPN
aiua-10141	129	10	hospital	hospital	PROPN
aiua-10141	129	11	urology	urology	NOUN
aiua-10141	129	12	clinic	clinic	NOUN
aiua-10141	129	13	for	for	ADP
aiua-10141	129	14	their	their	PRON
aiua-10141	129	15	contribution	contribution	NOUN
aiua-10141	129	16	.	.	PUNCT
aiua-10141	130	1	references	reference	NOUN
aiua-10141	130	2	1	1	NUM
aiua-10141	130	3	.	.	PUNCT
aiua-10141	131	1	jose	jose	PROPN
aiua-10141	131	2	rj	rj	PROPN
aiua-10141	131	3	,	,	PUNCT
aiua-10141	131	4	manuel	manuel	PROPN
aiua-10141	131	5	a.	a.	PROPN
aiua-10141	131	6	covid-19	covid-19	PROPN
aiua-10141	131	7	cytokine	cytokine	NOUN
aiua-10141	131	8	storm	storm	NOUN
aiua-10141	131	9	:	:	PUNCT
aiua-10141	131	10	the	the	DET
aiua-10141	131	11	interplay	interplay	NOUN
aiua-10141	131	12	between	between	ADP
aiua-10141	131	13	inflammation	inflammation	NOUN
aiua-10141	131	14	and	and	CCONJ
aiua-10141	131	15	coagulation	coagulation	NOUN
aiua-10141	131	16	.	.	PUNCT
aiua-10141	132	1	lancet	lancet	PROPN
aiua-10141	132	2	respir	respir	VERB
aiua-10141	132	3	med	med	ADJ
aiua-10141	132	4	2020	2020	NUM
aiua-10141	132	5	;	;	PUNCT
aiua-10141	132	6	8	8	NUM
aiua-10141	132	7	:	:	PUNCT
aiua-10141	132	8	e46	e46	PROPN
aiua-10141	132	9	-	-	NOUN
aiua-10141	132	10	e47	e47	NOUN
aiua-10141	132	11	.	.	PROPN
aiua-10141	133	1	2	2	NUM
aiua-10141	133	2	.	.	X
aiua-10141	133	3	menter	menter	PROPN
aiua-10141	133	4	t	t	PROPN
aiua-10141	133	5	,	,	PUNCT
aiua-10141	133	6	haslbauer	haslbauer	PROPN
aiua-10141	133	7	jd	jd	PROPN
aiua-10141	133	8	,	,	PUNCT
aiua-10141	133	9	nienhold	nienhold	PROPN
aiua-10141	133	10	r	r	NOUN
aiua-10141	133	11	,	,	PUNCT
aiua-10141	133	12	et	et	PROPN
aiua-10141	134	1	al	al	PROPN
aiua-10141	134	2	.	.	PROPN
aiua-10141	134	3	postmortem	postmortem	PROPN
aiua-10141	134	4	examination	examination	NOUN
aiua-10141	134	5	of	of	ADP
aiua-10141	134	6	covid-19	covid-19	PROPN
aiua-10141	134	7	patients	patient	NOUN
aiua-10141	134	8	reveals	reveal	VERB
aiua-10141	134	9	diffuse	diffuse	VERB
aiua-10141	134	10	alveolar	alveolar	ADJ
aiua-10141	134	11	damage	damage	NOUN
aiua-10141	134	12	with	with	ADP
aiua-10141	134	13	severe	severe	ADJ
aiua-10141	134	14	capillary	capillary	ADJ
aiua-10141	134	15	congestion	congestion	NOUN
aiua-10141	134	16	and	and	CCONJ
aiua-10141	134	17	variegated	variegate	VERB
aiua-10141	134	18	findings	finding	NOUN
aiua-10141	134	19	in	in	ADP
aiua-10141	134	20	lungs	lung	NOUN
aiua-10141	134	21	and	and	CCONJ
aiua-10141	134	22	other	other	ADJ
aiua-10141	134	23	organs	organ	NOUN
aiua-10141	134	24	suggesting	suggest	VERB
aiua-10141	134	25	vascular	vascular	ADJ
aiua-10141	134	26	dysfunction	dysfunction	NOUN
aiua-10141	134	27	.	.	PUNCT
aiua-10141	135	1	histopathology	histopathology	NOUN
aiua-10141	135	2	.	.	PUNCT
aiua-10141	136	1	2020	2020	NUM
aiua-10141	136	2	;	;	PUNCT
aiua-10141	136	3	77:198	77:198	PROPN
aiua-10141	136	4	-	-	SYM
aiua-10141	136	5	209	209	NUM
aiua-10141	136	6	.	.	PUNCT
aiua-10141	137	1	3	3	X
aiua-10141	137	2	.	.	X
aiua-10141	137	3	jannini	jannini	PROPN
aiua-10141	137	4	ea	ea	PROPN
aiua-10141	137	5	.	.	PUNCT
aiua-10141	138	1	sm	sm	PROPN
aiua-10141	138	2	=	=	SYM
aiua-10141	138	3	sm	sm	PROPN
aiua-10141	138	4	:	:	PUNCT
aiua-10141	138	5	the	the	DET
aiua-10141	138	6	interface	interface	NOUN
aiua-10141	138	7	of	of	ADP
aiua-10141	138	8	systems	system	NOUN
aiua-10141	138	9	medicine	medicine	NOUN
aiua-10141	138	10	and	and	CCONJ
aiua-10141	138	11	sexual	sexual	ADJ
aiua-10141	138	12	medicine	medicine	NOUN
aiua-10141	138	13	for	for	ADP
aiua-10141	138	14	facing	face	VERB
aiua-10141	138	15	non	non	ADJ
aiua-10141	138	16	-	-	ADJ
aiua-10141	138	17	communicable	communicable	ADJ
aiua-10141	138	18	diseases	disease	NOUN
aiua-10141	138	19	in	in	ADP
aiua-10141	138	20	a	a	DET
aiua-10141	138	21	genderdependent	genderdependent	NOUN
aiua-10141	138	22	manner	manner	NOUN
aiua-10141	138	23	.	.	PUNCT
aiua-10141	139	1	sex	sex	PROPN
aiua-10141	139	2	med	med	PROPN
aiua-10141	139	3	rev	rev	PROPN
aiua-10141	139	4	.	.	PROPN
aiua-10141	139	5	2017	2017	NUM
aiua-10141	139	6	;	;	PUNCT
aiua-10141	139	7	5:349	5:349	NUM
aiua-10141	139	8	-	-	SYM
aiua-10141	139	9	364	364	NUM
aiua-10141	139	10	.	.	NOUN
aiua-10141	140	1	4	4	NUM
aiua-10141	140	2	.	.	X
aiua-10141	140	3	isidori	isidori	NOUN
aiua-10141	140	4	am	be	AUX
aiua-10141	140	5	,	,	PUNCT
aiua-10141	140	6	buvat	buvat	PROPN
aiua-10141	140	7	j	j	PROPN
aiua-10141	140	8	,	,	PUNCT
aiua-10141	140	9	corona	corona	NOUN
aiua-10141	140	10	g	g	NOUN
aiua-10141	140	11	,	,	PUNCT
aiua-10141	140	12	et	et	PROPN
aiua-10141	140	13	al	al	PROPN
aiua-10141	140	14	.	.	PUNCT
aiua-10141	141	1	a	a	DET
aiua-10141	141	2	critical	critical	ADJ
aiua-10141	141	3	analysis	analysis	NOUN
aiua-10141	141	4	of	of	ADP
aiua-10141	141	5	the	the	DET
aiua-10141	141	6	role	role	NOUN
aiua-10141	141	7	of	of	ADP
aiua-10141	141	8	testosterone	testosterone	NOUN
aiua-10141	141	9	in	in	ADP
aiua-10141	141	10	erectile	erectile	ADJ
aiua-10141	141	11	function	function	NOUN
aiua-10141	141	12	:	:	PUNCT
aiua-10141	141	13	from	from	ADP
aiua-10141	141	14	pathophysiology	pathophysiology	NOUN
aiua-10141	141	15	to	to	ADP
aiua-10141	141	16	treatment	treatment	NOUN
aiua-10141	141	17	-	-	PUNCT
aiua-10141	141	18	a	a	DET
aiua-10141	141	19	systematic	systematic	ADJ
aiua-10141	141	20	review	review	NOUN
aiua-10141	141	21	.	.	PUNCT
aiua-10141	142	1	eur	eur	PROPN
aiua-10141	142	2	urol	urol	PROPN
aiua-10141	142	3	.	.	PUNCT
aiua-10141	142	4	2014	2014	NUM
aiua-10141	142	5	;	;	PUNCT
aiua-10141	142	6	65:99	65:99	NUM
aiua-10141	142	7	-	-	SYM
aiua-10141	142	8	112	112	NUM
aiua-10141	142	9	.	.	PUNCT
aiua-10141	143	1	5	5	X
aiua-10141	143	2	.	.	X
aiua-10141	143	3	schubert	schubert	PROPN
aiua-10141	143	4	m	m	PROPN
aiua-10141	143	5	,	,	PUNCT
aiua-10141	143	6	jockenhovel	jockenhovel	PROPN
aiua-10141	143	7	f.	f.	PROPN
aiua-10141	143	8	late	late	ADJ
aiua-10141	143	9	-	-	PUNCT
aiua-10141	143	10	onset	onset	NOUN
aiua-10141	143	11	hypogonadism	hypogonadism	NOUN
aiua-10141	143	12	in	in	ADP
aiua-10141	143	13	the	the	DET
aiua-10141	143	14	aging	age	VERB
aiua-10141	143	15	male	male	NOUN
aiua-10141	143	16	(	(	PUNCT
aiua-10141	143	17	loh	loh	PROPN
aiua-10141	143	18	):	):	PUNCT
aiua-10141	143	19	definition	definition	NOUN
aiua-10141	143	20	,	,	PUNCT
aiua-10141	143	21	diagnostic	diagnostic	ADJ
aiua-10141	143	22	and	and	CCONJ
aiua-10141	143	23	clinical	clinical	ADJ
aiua-10141	143	24	aspects	aspect	NOUN
aiua-10141	143	25	.	.	PUNCT
aiua-10141	144	1	j	j	PROPN
aiua-10141	144	2	endocrinol	endocrinol	NOUN
aiua-10141	144	3	invest	inv	ADJ
aiua-10141	144	4	.	.	PUNCT
aiua-10141	145	1	2005	2005	NUM
aiua-10141	145	2	;	;	PUNCT
aiua-10141	145	3	28:23	28:23	NUM
aiua-10141	145	4	-	-	SYM
aiua-10141	145	5	27	27	NUM
aiua-10141	145	6	.	.	NOUN
aiua-10141	146	1	6	6	NUM
aiua-10141	146	2	.	.	X
aiua-10141	146	3	blute	blute	PROPN
aiua-10141	146	4	m	m	PROPN
aiua-10141	146	5	,	,	PUNCT
aiua-10141	146	6	hakimian	hakimian	PROPN
aiua-10141	146	7	p	p	X
aiua-10141	146	8	,	,	PUNCT
aiua-10141	146	9	kashanian	kashanian	PROPN
aiua-10141	146	10	j	j	PROPN
aiua-10141	146	11	,	,	PUNCT
aiua-10141	146	12	et	et	PROPN
aiua-10141	146	13	al	al	PROPN
aiua-10141	146	14	.	.	PROPN
aiua-10141	146	15	erectile	erectile	ADJ
aiua-10141	146	16	dysfunction	dysfunction	NOUN
aiua-10141	146	17	and	and	CCONJ
aiua-10141	146	18	testosterone	testosterone	NOUN
aiua-10141	146	19	deficiency	deficiency	NOUN
aiua-10141	146	20	.	.	PUNCT
aiua-10141	147	1	front	front	ADJ
aiua-10141	147	2	horm	horm	NOUN
aiua-10141	147	3	res	re	NOUN
aiua-10141	147	4	.	.	PUNCT
aiua-10141	147	5	2009	2009	NUM
aiua-10141	147	6	;	;	PUNCT
aiua-10141	147	7	37:108	37:108	NUM
aiua-10141	147	8	-	-	SYM
aiua-10141	147	9	122	122	NUM
aiua-10141	147	10	.	.	PUNCT
aiua-10141	148	1	7	7	NUM
aiua-10141	148	2	.	.	NUM
aiua-10141	148	3	mohamed	mohamed	PROPN
aiua-10141	148	4	ms	ms	PROPN
aiua-10141	148	5	,	,	PUNCT
aiua-10141	148	6	moulin	moulin	PROPN
aiua-10141	148	7	tc	tc	PROPN
aiua-10141	148	8	,	,	PUNCT
aiua-10141	148	9	schiöth	schiöth	PROPN
aiua-10141	148	10	hb	hb	PROPN
aiua-10141	148	11	.	.	PUNCT
aiua-10141	149	1	sex	sex	NOUN
aiua-10141	149	2	differences	difference	NOUN
aiua-10141	149	3	in	in	ADP
aiua-10141	149	4	covid19	covid19	NOUN
aiua-10141	149	5	:	:	PUNCT
aiua-10141	149	6	the	the	DET
aiua-10141	149	7	role	role	NOUN
aiua-10141	149	8	of	of	ADP
aiua-10141	149	9	androgens	androgen	NOUN
aiua-10141	149	10	in	in	ADP
aiua-10141	149	11	disease	disease	NOUN
aiua-10141	149	12	severity	severity	NOUN
aiua-10141	149	13	and	and	CCONJ
aiua-10141	149	14	progression	progression	NOUN
aiua-10141	149	15	.	.	PUNCT
aiua-10141	150	1	endocrine	endocrine	NOUN
aiua-10141	150	2	.	.	PUNCT
aiua-10141	150	3	2021	2021	NUM
aiua-10141	150	4	;	;	PUNCT
aiua-10141	150	5	71:3	71:3	NUM
aiua-10141	150	6	-	-	SYM
aiua-10141	150	7	8	8	NUM
aiua-10141	150	8	.	.	NOUN
aiua-10141	150	9	8	8	NUM
aiua-10141	150	10	.	.	PUNCT
aiua-10141	151	1	rodriguez	rodriguez	PROPN
aiua-10141	151	2	bustos	bustos	PROPN
aiua-10141	151	3	h	h	PROPN
aiua-10141	151	4	,	,	PUNCT
aiua-10141	151	5	bravo	bravo	PROPN
aiua-10141	151	6	maturana	maturana	PROPN
aiua-10141	151	7	g	g	PROPN
aiua-10141	151	8	,	,	PUNCT
aiua-10141	151	9	cortés	cortés	NOUN
aiua-10141	151	10	-	-	PUNCT
aiua-10141	151	11	chau	chau	NOUN
aiua-10141	151	12	f	f	PROPN
aiua-10141	151	13	,	,	PUNCT
aiua-10141	151	14	et	et	PROPN
aiua-10141	151	15	al	al	PROPN
aiua-10141	151	16	.	.	PUNCT
aiua-10141	151	17	effects	effect	NOUN
aiua-10141	151	18	of	of	ADP
aiua-10141	151	19	covid-19	covid-19	PROPN
aiua-10141	151	20	on	on	ADP
aiua-10141	151	21	male	male	ADJ
aiua-10141	151	22	sex	sex	NOUN
aiua-10141	151	23	function	function	NOUN
aiua-10141	151	24	and	and	CCONJ
aiua-10141	151	25	its	its	PRON
aiua-10141	151	26	potential	potential	ADJ
aiua-10141	151	27	sexual	sexual	ADJ
aiua-10141	151	28	transmission	transmission	NOUN
aiua-10141	151	29	.	.	PUNCT
aiua-10141	152	1	arch	arch	ADJ
aiua-10141	152	2	ital	ital	PROPN
aiua-10141	152	3	urol	urol	PROPN
aiua-10141	152	4	androl	androl	PROPN
aiua-10141	152	5	.	.	PROPN
aiua-10141	152	6	2021	2021	NUM
aiua-10141	152	7	;	;	PUNCT
aiua-10141	152	8	93:48	93:48	NUM
aiua-10141	152	9	-	-	SYM
aiua-10141	152	10	52	52	NUM
aiua-10141	152	11	.	.	NOUN
aiua-10141	153	1	9	9	NUM
aiua-10141	153	2	.	.	X
aiua-10141	153	3	papadopoulos	papadopoulos	PROPN
aiua-10141	153	4	v	v	PROPN
aiua-10141	153	5	,	,	PUNCT
aiua-10141	153	6	li	li	PROPN
aiua-10141	153	7	l	l	PROPN
aiua-10141	153	8	,	,	PUNCT
aiua-10141	153	9	samplaski	samplaski	NOUN
aiua-10141	153	10	m.	m.	NOUN
aiua-10141	153	11	why	why	SCONJ
aiua-10141	153	12	does	do	AUX
aiua-10141	153	13	covid-19	covid-19	PROPN
aiua-10141	153	14	kill	kill	VERB
aiua-10141	153	15	more	more	ADV
aiua-10141	153	16	elderly	elderly	ADJ
aiua-10141	153	17	men	man	NOUN
aiua-10141	153	18	than	than	ADP
aiua-10141	153	19	women	woman	NOUN
aiua-10141	153	20	?	?	PUNCT
aiua-10141	154	1	is	be	AUX
aiua-10141	154	2	there	there	PRON
aiua-10141	154	3	a	a	DET
aiua-10141	154	4	role	role	NOUN
aiua-10141	154	5	for	for	ADP
aiua-10141	154	6	testosterone	testosterone	NOUN
aiua-10141	154	7	?	?	PUNCT
aiua-10141	155	1	andrology	andrology	PROPN
aiua-10141	155	2	.	.	PUNCT
aiua-10141	156	1	2021	2021	NUM
aiua-10141	156	2	;	;	PUNCT
aiua-10141	156	3	9:65	9:65	NUM
aiua-10141	156	4	-	-	SYM
aiua-10141	156	5	72	72	NUM
aiua-10141	156	6	.	.	PUNCT
aiua-10141	157	1	archivio	archivio	NOUN
aiua-10141	157	2	italiano	italiano	X
aiua-10141	157	3	di	di	X
aiua-10141	157	4	urologia	urologia	PROPN
aiua-10141	157	5	e	e	PROPN
aiua-10141	157	6	andrologia	andrologia	NOUN
aiua-10141	157	7	2021	2021	NUM
aiua-10141	157	8	;	;	PUNCT
aiua-10141	157	9	93	93	NUM
aiua-10141	157	10	,	,	PUNCT
aiua-10141	157	11	4	4	NUM
aiua-10141	157	12	k.	k.	PROPN
aiua-10141	157	13	karkin	karkin	PROPN
aiua-10141	157	14	,	,	PUNCT
aiua-10141	157	15	e.	e.	PROPN
aiua-10141	157	16	alma	alma	PROPN
aiua-10141	157	17	464	464	NUM
aiua-10141	157	18	10	10	NUM
aiua-10141	157	19	.	.	PUNCT
aiua-10141	158	1	maretti	maretti	PROPN
aiua-10141	158	2	c	c	PROPN
aiua-10141	158	3	,	,	PUNCT
aiua-10141	158	4	privitera	privitera	NOUN
aiua-10141	158	5	s	s	PROPN
aiua-10141	158	6	,	,	PUNCT
aiua-10141	158	7	arcaniolo	arcaniolo	ADJ
aiua-10141	158	8	d	d	NOUN
aiua-10141	158	9	,	,	PUNCT
aiua-10141	158	10	et	et	PROPN
aiua-10141	158	11	al	al	PROPN
aiua-10141	158	12	.	.	PUNCT
aiua-10141	159	1	covid-19	covid-19	PROPN
aiua-10141	159	2	pandemic	pandemic	ADJ
aiua-10141	159	3	and	and	CCONJ
aiua-10141	159	4	its	its	PRON
aiua-10141	159	5	implications	implication	NOUN
aiua-10141	159	6	on	on	ADP
aiua-10141	159	7	sexual	sexual	ADJ
aiua-10141	159	8	life	life	NOUN
aiua-10141	159	9	:	:	PUNCT
aiua-10141	159	10	recommendations	recommendation	NOUN
aiua-10141	159	11	from	from	ADP
aiua-10141	159	12	the	the	DET
aiua-10141	159	13	italian	italian	ADJ
aiua-10141	159	14	society	society	NOUN
aiua-10141	159	15	of	of	ADP
aiua-10141	159	16	andrology	andrology	PROPN
aiua-10141	159	17	.	.	PUNCT
aiua-10141	160	1	arch	arch	PROPN
aiua-10141	160	2	ital	ital	PROPN
aiua-10141	160	3	urol	urol	PROPN
aiua-10141	160	4	androl	androl	PROPN
aiua-10141	160	5	.	.	PROPN
aiua-10141	160	6	2020	2020	NUM
aiua-10141	160	7	;	;	PUNCT
aiua-10141	160	8	92:73	92:73	NUM
aiua-10141	160	9	-	-	SYM
aiua-10141	160	10	77	77	NUM
aiua-10141	160	11	11	11	NUM
aiua-10141	160	12	.	.	PUNCT
aiua-10141	161	1	delle	delle	NOUN
aiua-10141	161	2	fave	fave	PROPN
aiua-10141	161	3	rf	rf	NOUN
aiua-10141	161	4	,	,	PUNCT
aiua-10141	161	5	polisini	polisini	VERB
aiua-10141	161	6	g	g	NOUN
aiua-10141	161	7	,	,	PUNCT
aiua-10141	161	8	giglioni	giglioni	VERB
aiua-10141	161	9	g	g	NOUN
aiua-10141	161	10	,	,	PUNCT
aiua-10141	161	11	et	et	PROPN
aiua-10141	161	12	al	al	PROPN
aiua-10141	161	13	.	.	PUNCT
aiua-10141	162	1	covid-19	covid-19	PROPN
aiua-10141	162	2	and	and	CCONJ
aiua-10141	162	3	male	male	ADJ
aiua-10141	162	4	fertility	fertility	NOUN
aiua-10141	162	5	:	:	PUNCT
aiua-10141	162	6	taking	take	VERB
aiua-10141	162	7	stock	stock	NOUN
aiua-10141	162	8	of	of	ADP
aiua-10141	162	9	one	one	NUM
aiua-10141	162	10	year	year	NOUN
aiua-10141	162	11	after	after	SCONJ
aiua-10141	162	12	the	the	DET
aiua-10141	162	13	outbreak	outbreak	NOUN
aiua-10141	162	14	began	begin	VERB
aiua-10141	162	15	.	.	PUNCT
aiua-10141	163	1	arch	arch	ADJ
aiua-10141	163	2	ital	ital	PROPN
aiua-10141	163	3	urol	urol	PROPN
aiua-10141	163	4	androl	androl	PROPN
aiua-10141	163	5	.	.	PROPN
aiua-10141	163	6	2021	2021	NUM
aiua-10141	163	7	;	;	PUNCT
aiua-10141	163	8	93:115	93:115	NUM
aiua-10141	163	9	-	-	SYM
aiua-10141	163	10	119	119	NUM
aiua-10141	163	11	.	.	NOUN
aiua-10141	163	12	12	12	NUM
aiua-10141	163	13	.	.	PUNCT
aiua-10141	164	1	yafi	yafi	PROPN
aiua-10141	164	2	fa	fa	PROPN
aiua-10141	164	3	,	,	PUNCT
aiua-10141	164	4	jenkins	jenkins	PROPN
aiua-10141	164	5	l	l	PROPN
aiua-10141	164	6	,	,	PUNCT
aiua-10141	164	7	albersen	albersen	PROPN
aiua-10141	164	8	m	m	PROPN
aiua-10141	164	9	,	,	PUNCT
aiua-10141	164	10	et	et	PROPN
aiua-10141	164	11	al	al	PROPN
aiua-10141	164	12	.	.	PROPN
aiua-10141	164	13	erectile	erectile	ADJ
aiua-10141	164	14	dysfunction	dysfunction	NOUN
aiua-10141	164	15	.	.	PUNCT
aiua-10141	165	1	nat	nat	PROPN
aiua-10141	165	2	rev	rev	VERB
aiua-10141	165	3	dis	dis	PROPN
aiua-10141	165	4	primers	primer	NOUN
aiua-10141	165	5	.	.	PUNCT
aiua-10141	166	1	2016	2016	NUM
aiua-10141	166	2	;	;	PUNCT
aiua-10141	166	3	2:16003	2:16003	NUM
aiua-10141	166	4	.	.	NOUN
aiua-10141	166	5	13	13	NUM
aiua-10141	166	6	.	.	PUNCT
aiua-10141	167	1	irwin	irwin	PROPN
aiua-10141	167	2	gm	gm	PROPN
aiua-10141	167	3	.	.	PUNCT
aiua-10141	168	1	erectile	erectile	ADJ
aiua-10141	168	2	dysfunction	dysfunction	NOUN
aiua-10141	168	3	.	.	PUNCT
aiua-10141	169	1	prim	prim	ADJ
aiua-10141	169	2	care	care	NOUN
aiua-10141	169	3	.	.	PUNCT
aiua-10141	170	1	2019	2019	NUM
aiua-10141	170	2	;	;	PUNCT
aiua-10141	170	3	46:249	46:249	NUM
aiua-10141	170	4	-	-	SYM
aiua-10141	170	5	255	255	NUM
aiua-10141	170	6	.	.	PUNCT
aiua-10141	171	1	14	14	NUM
aiua-10141	171	2	.	.	PUNCT
aiua-10141	171	3	guay	guay	PROPN
aiua-10141	171	4	at	at	ADP
aiua-10141	171	5	.	.	PUNCT
aiua-10141	172	1	ed2	ed2	NOUN
aiua-10141	172	2	:	:	PUNCT
aiua-10141	172	3	erectile	erectile	ADJ
aiua-10141	172	4	dysfunction	dysfunction	NOUN
aiua-10141	172	5	=	=	PUNCT
aiua-10141	172	6	endothelial	endothelial	ADJ
aiua-10141	172	7	dysfunction	dysfunction	NOUN
aiua-10141	172	8	.	.	PUNCT
aiua-10141	173	1	endocrinol	endocrinol	NOUN
aiua-10141	173	2	metab	metab	PROPN
aiua-10141	173	3	clin	clin	PROPN
aiua-10141	173	4	north	north	PROPN
aiua-10141	173	5	am	am	PROPN
aiua-10141	173	6	.	.	PUNCT
aiua-10141	174	1	2007	2007	NUM
aiua-10141	174	2	;	;	PUNCT
aiua-10141	174	3	36:453	36:453	NUM
aiua-10141	174	4	-	-	SYM
aiua-10141	174	5	463	463	NUM
aiua-10141	174	6	.	.	PUNCT
aiua-10141	175	1	15	15	NUM
aiua-10141	175	2	.	.	PUNCT
aiua-10141	176	1	mola	mola	PROPN
aiua-10141	176	2	jr	jr	PROPN
aiua-10141	176	3	.	.	PROPN
aiua-10141	176	4	erectile	erectile	ADJ
aiua-10141	176	5	dysfunction	dysfunction	NOUN
aiua-10141	176	6	in	in	ADP
aiua-10141	176	7	the	the	DET
aiua-10141	176	8	older	old	ADJ
aiua-10141	176	9	adult	adult	NOUN
aiua-10141	176	10	male	male	NOUN
aiua-10141	176	11	.	.	PUNCT
aiua-10141	177	1	urol	urol	PROPN
aiua-10141	177	2	nurs	nurs	PROPN
aiua-10141	177	3	.	.	PROPN
aiua-10141	178	1	2015	2015	NUM
aiua-10141	178	2	;	;	PUNCT
aiua-10141	178	3	35:87	35:87	NUM
aiua-10141	178	4	-	-	SYM
aiua-10141	178	5	93	93	NUM
aiua-10141	178	6	16	16	NUM
aiua-10141	178	7	.	.	PUNCT
aiua-10141	179	1	nguyen	nguyen	PROPN
aiua-10141	179	2	hmt	hmt	PROPN
aiua-10141	179	3	,	,	PUNCT
aiua-10141	179	4	gabrielson	gabrielson	NOUN
aiua-10141	179	5	at	at	ADP
aiua-10141	179	6	,	,	PUNCT
aiua-10141	179	7	hellstrom	hellstrom	NOUN
aiua-10141	179	8	wjg	wjg	VERB
aiua-10141	179	9	.	.	PUNCT
aiua-10141	180	1	erectile	erectile	ADJ
aiua-10141	180	2	dysfunction	dysfunction	NOUN
aiua-10141	180	3	in	in	ADP
aiua-10141	180	4	young	young	ADJ
aiua-10141	180	5	men	man	NOUN
aiua-10141	180	6	-	-	PUNCT
aiua-10141	180	7	a	a	DET
aiua-10141	180	8	review	review	NOUN
aiua-10141	180	9	of	of	ADP
aiua-10141	180	10	the	the	DET
aiua-10141	180	11	prevalence	prevalence	NOUN
aiua-10141	180	12	and	and	CCONJ
aiua-10141	180	13	risk	risk	NOUN
aiua-10141	180	14	factors	factor	NOUN
aiua-10141	180	15	.	.	PUNCT
aiua-10141	181	1	sex	sex	NOUN
aiua-10141	181	2	med	med	PROPN
aiua-10141	181	3	rev	rev	PROPN
aiua-10141	181	4	.	.	PROPN
aiua-10141	181	5	2017	2017	NUM
aiua-10141	181	6	;	;	PUNCT
aiua-10141	181	7	5:508	5:508	NUM
aiua-10141	181	8	-	-	SYM
aiua-10141	181	9	520	520	NUM
aiua-10141	181	10	.	.	PUNCT
aiua-10141	182	1	17	17	NUM
aiua-10141	182	2	.	.	PUNCT
aiua-10141	183	1	varga	varga	PROPN
aiua-10141	183	2	z	z	PROPN
aiua-10141	183	3	,	,	PUNCT
aiua-10141	183	4	flammer	flammer	PROPN
aiua-10141	183	5	aj	aj	PROPN
aiua-10141	183	6	,	,	PUNCT
aiua-10141	183	7	steiger	steiger	PROPN
aiua-10141	183	8	p	p	PROPN
aiua-10141	183	9	,	,	PUNCT
aiua-10141	183	10	et	et	PROPN
aiua-10141	183	11	al	al	PROPN
aiua-10141	183	12	.	.	PUNCT
aiua-10141	183	13	endothelial	endothelial	ADJ
aiua-10141	183	14	cell	cell	NOUN
aiua-10141	183	15	infection	infection	NOUN
aiua-10141	183	16	and	and	CCONJ
aiua-10141	183	17	endotheliitis	endotheliitis	PRON
aiua-10141	183	18	in	in	ADP
aiua-10141	183	19	covid-19	covid-19	PROPN
aiua-10141	183	20	.	.	PUNCT
aiua-10141	184	1	lancet	lancet	PROPN
aiua-10141	184	2	2020	2020	NUM
aiua-10141	184	3	;	;	PUNCT
aiua-10141	184	4	395:1417	395:1417	NUM
aiua-10141	184	5	-	-	SYM
aiua-10141	184	6	1418	1418	NUM
aiua-10141	184	7	.	.	PUNCT
aiua-10141	185	1	18	18	NUM
aiua-10141	185	2	.	.	PUNCT
aiua-10141	185	3	maiorino	maiorino	PROPN
aiua-10141	185	4	mi	mi	PROPN
aiua-10141	185	5	,	,	PUNCT
aiua-10141	185	6	bellastella	bellastella	NOUN
aiua-10141	185	7	g	g	PROPN
aiua-10141	185	8	,	,	PUNCT
aiua-10141	185	9	giugliano	giugliano	ADJ
aiua-10141	185	10	d	d	PROPN
aiua-10141	185	11	,	,	PUNCT
aiua-10141	185	12	et	et	PROPN
aiua-10141	185	13	al	al	PROPN
aiua-10141	185	14	.	.	PROPN
aiua-10141	186	1	from	from	ADP
aiua-10141	186	2	inflammation	inflammation	NOUN
aiua-10141	186	3	to	to	ADP
aiua-10141	186	4	sexual	sexual	ADJ
aiua-10141	186	5	dysfunctions	dysfunction	NOUN
aiua-10141	186	6	:	:	PUNCT
aiua-10141	186	7	a	a	DET
aiua-10141	186	8	journey	journey	NOUN
aiua-10141	186	9	through	through	ADP
aiua-10141	186	10	diabetes	diabetes	NOUN
aiua-10141	186	11	,	,	PUNCT
aiua-10141	186	12	obesity	obesity	NOUN
aiua-10141	186	13	,	,	PUNCT
aiua-10141	186	14	and	and	CCONJ
aiua-10141	186	15	metabolic	metabolic	NOUN
aiua-10141	186	16	syndrome	syndrome	NOUN
aiua-10141	186	17	.	.	PUNCT
aiua-10141	187	1	j	j	PROPN
aiua-10141	187	2	endocrinol	endocrinol	NOUN
aiua-10141	187	3	invest	inv	ADJ
aiua-10141	187	4	.	.	PUNCT
aiua-10141	188	1	2018	2018	NUM
aiua-10141	188	2	;	;	PUNCT
aiua-10141	188	3	41:1249	41:1249	X
aiua-10141	188	4	-	-	SYM
aiua-10141	188	5	1258	1258	NUM
aiua-10141	188	6	.	.	PUNCT
aiua-10141	189	1	19	19	NUM
aiua-10141	189	2	.	.	X
aiua-10141	190	1	zhang	zhang	PROPN
aiua-10141	190	2	h	h	PROPN
aiua-10141	190	3	,	,	PUNCT
aiua-10141	190	4	penninger	penninger	PROPN
aiua-10141	190	5	jm	jm	PROPN
aiua-10141	190	6	,	,	PUNCT
aiua-10141	190	7	li	li	PROPN
aiua-10141	190	8	y	y	PROPN
aiua-10141	190	9	,	,	PUNCT
aiua-10141	190	10	et	et	PROPN
aiua-10141	190	11	al	al	PROPN
aiua-10141	190	12	.	.	PUNCT
aiua-10141	190	13	angiotensin	angiotensin	NOUN
aiua-10141	190	14	-	-	PUNCT
aiua-10141	190	15	converting	convert	VERB
aiua-10141	190	16	enzyme	enzyme	NOUN
aiua-10141	190	17	2	2	NUM
aiua-10141	190	18	(	(	PUNCT
aiua-10141	190	19	ace2	ace2	PROPN
aiua-10141	190	20	)	)	PUNCT
aiua-10141	190	21	as	as	ADP
aiua-10141	190	22	a	a	DET
aiua-10141	190	23	sars	sar	NOUN
aiua-10141	190	24	-	-	PUNCT
aiua-10141	190	25	cov-2	cov-2	NOUN
aiua-10141	190	26	receptor	receptor	NOUN
aiua-10141	190	27	:	:	PUNCT
aiua-10141	190	28	molecular	molecular	ADJ
aiua-10141	190	29	mechanisms	mechanism	NOUN
aiua-10141	190	30	and	and	CCONJ
aiua-10141	190	31	potential	potential	ADJ
aiua-10141	190	32	therapeutic	therapeutic	ADJ
aiua-10141	190	33	target	target	NOUN
aiua-10141	190	34	.	.	PUNCT
aiua-10141	191	1	intensive	intensive	ADJ
aiua-10141	191	2	care	care	NOUN
aiua-10141	191	3	med	me	VERB
aiua-10141	191	4	.	.	PUNCT
aiua-10141	192	1	2020	2020	NUM
aiua-10141	192	2	;	;	PUNCT
aiua-10141	192	3	46:586590	46:586590	X
aiua-10141	192	4	.	.	PROPN
aiua-10141	192	5	20	20	NUM
aiua-10141	192	6	.	.	PUNCT
aiua-10141	193	1	zhou	zhou	PROPN
aiua-10141	193	2	p	p	PROPN
aiua-10141	193	3	,	,	PUNCT
aiua-10141	193	4	yang	yang	PROPN
aiua-10141	193	5	xl	xl	PROPN
aiua-10141	193	6	,	,	PUNCT
aiua-10141	193	7	wang	wang	PROPN
aiua-10141	193	8	xg	xg	PROPN
aiua-10141	193	9	,	,	PUNCT
aiua-10141	193	10	et	et	PROPN
aiua-10141	193	11	al	al	PROPN
aiua-10141	193	12	.	.	PUNCT
aiua-10141	194	1	a	a	DET
aiua-10141	194	2	pneumonia	pneumonia	NOUN
aiua-10141	194	3	outbreak	outbreak	NOUN
aiua-10141	194	4	associated	associate	VERB
aiua-10141	194	5	with	with	ADP
aiua-10141	194	6	a	a	DET
aiua-10141	194	7	new	new	ADJ
aiua-10141	194	8	coronavirus	coronavirus	NOUN
aiua-10141	194	9	of	of	ADP
aiua-10141	194	10	probable	probable	ADJ
aiua-10141	194	11	bat	bat	NOUN
aiua-10141	194	12	origin	origin	NOUN
aiua-10141	194	13	.	.	PUNCT
aiua-10141	195	1	nature	nature	NOUN
aiua-10141	195	2	.	.	PUNCT
aiua-10141	196	1	2020	2020	NUM
aiua-10141	196	2	;	;	PUNCT
aiua-10141	197	1	579:270	579:270	X
aiua-10141	197	2	-	-	SYM
aiua-10141	197	3	273	273	NUM
aiua-10141	197	4	.	.	PUNCT
aiua-10141	197	5	21	21	NUM
aiua-10141	197	6	.	.	PUNCT
aiua-10141	198	1	hamming	ham	VERB
aiua-10141	198	2	i	i	PRON
aiua-10141	198	3	,	,	PUNCT
aiua-10141	198	4	timens	timens	PROPN
aiua-10141	198	5	w	w	PROPN
aiua-10141	198	6	,	,	PUNCT
aiua-10141	198	7	bulthuis	bulthuis	NOUN
aiua-10141	198	8	ml	ml	PROPN
aiua-10141	198	9	,	,	PUNCT
aiua-10141	198	10	et	et	PROPN
aiua-10141	198	11	al	al	PROPN
aiua-10141	198	12	.	.	PUNCT
aiua-10141	198	13	tissue	tissue	NOUN
aiua-10141	198	14	distribution	distribution	NOUN
aiua-10141	198	15	of	of	ADP
aiua-10141	198	16	ace2	ace2	NOUN
aiua-10141	198	17	protein	protein	NOUN
aiua-10141	198	18	,	,	PUNCT
aiua-10141	198	19	the	the	DET
aiua-10141	198	20	functional	functional	ADJ
aiua-10141	198	21	receptor	receptor	NOUN
aiua-10141	198	22	for	for	ADP
aiua-10141	198	23	sars	sars	PROPN
aiua-10141	198	24	coronavirus	coronavirus	PROPN
aiua-10141	198	25	.	.	PUNCT
aiua-10141	199	1	a	a	DET
aiua-10141	199	2	first	first	ADJ
aiua-10141	199	3	step	step	NOUN
aiua-10141	199	4	in	in	ADP
aiua-10141	199	5	understanding	understand	VERB
aiua-10141	199	6	sars	sar	NOUN
aiua-10141	199	7	pathogenesis	pathogenesis	PROPN
aiua-10141	199	8	.	.	PUNCT
aiua-10141	200	1	j.	j.	PROPN
aiua-10141	200	2	pathol	pathol	PROPN
aiua-10141	200	3	.	.	PUNCT
aiua-10141	201	1	2004	2004	NUM
aiua-10141	201	2	;	;	PUNCT
aiua-10141	201	3	203:631	203:631	PROPN
aiua-10141	201	4	-	-	PUNCT
aiua-10141	201	5	637	637	NUM
aiua-10141	201	6	.	.	PUNCT
aiua-10141	202	1	22	22	NUM
aiua-10141	202	2	.	.	PUNCT
aiua-10141	203	1	lovren	lovren	PROPN
aiua-10141	203	2	f	f	PROPN
aiua-10141	203	3	,	,	PUNCT
aiua-10141	203	4	pan	pan	PROPN
aiua-10141	203	5	y	y	PROPN
aiua-10141	203	6	,	,	PUNCT
aiua-10141	203	7	quan	quan	PROPN
aiua-10141	203	8	a	a	PROPN
aiua-10141	203	9	,	,	PUNCT
aiua-10141	203	10	et	et	PROPN
aiua-10141	203	11	al	al	PROPN
aiua-10141	203	12	.	.	PROPN
aiua-10141	203	13	angiotensin	angiotensin	NOUN
aiua-10141	203	14	converting	convert	VERB
aiua-10141	203	15	enzyme2	enzyme2	ADJ
aiua-10141	203	16	confers	confer	NOUN
aiua-10141	203	17	endothelial	endothelial	ADJ
aiua-10141	203	18	protection	protection	NOUN
aiua-10141	203	19	and	and	CCONJ
aiua-10141	203	20	attenuates	attenuate	NOUN
aiua-10141	203	21	atherosclerosis	atherosclerosis	NOUN
aiua-10141	203	22	.	.	PUNCT
aiua-10141	204	1	am	be	AUX
aiua-10141	204	2	.	.	PUNCT
aiua-10141	205	1	j.	j.	PROPN
aiua-10141	205	2	physiol	physiol	PROPN
aiua-10141	205	3	.	.	PUNCT
aiua-10141	206	1	circ	circ	PROPN
aiua-10141	206	2	.	.	PUNCT
aiua-10141	207	1	physiol	physiol	PROPN
aiua-10141	207	2	.	.	PUNCT
aiua-10141	208	1	2008	2008	NUM
aiua-10141	208	2	;	;	PUNCT
aiua-10141	208	3	295	295	NUM
aiua-10141	208	4	:	:	PUNCT
aiua-10141	208	5	h1377	h1377	NOUN
aiua-10141	208	6	-	-	PUNCT
aiua-10141	208	7	h1384	h1384	NOUN
aiua-10141	208	8	.	.	NOUN
aiua-10141	209	1	23	23	NUM
aiua-10141	209	2	.	.	PUNCT
aiua-10141	210	1	araujo	araujo	PROPN
aiua-10141	210	2	ab	ab	PROPN
aiua-10141	210	3	,	,	PUNCT
aiua-10141	210	4	esche	esche	PROPN
aiua-10141	210	5	gr	gr	PROPN
aiua-10141	210	6	,	,	PUNCT
aiua-10141	210	7	kupelian	kupelian	PROPN
aiua-10141	210	8	v	v	PROPN
aiua-10141	210	9	,	,	PUNCT
aiua-10141	210	10	et	et	PROPN
aiua-10141	210	11	al	al	PROPN
aiua-10141	210	12	.	.	PUNCT
aiua-10141	211	1	prevalence	prevalence	NOUN
aiua-10141	211	2	of	of	ADP
aiua-10141	211	3	symptomatic	symptomatic	ADJ
aiua-10141	211	4	androgen	androgen	NOUN
aiua-10141	211	5	deficiency	deficiency	NOUN
aiua-10141	211	6	in	in	ADP
aiua-10141	211	7	men	man	NOUN
aiua-10141	211	8	.	.	PUNCT
aiua-10141	212	1	j	j	PROPN
aiua-10141	212	2	clin	clin	PROPN
aiua-10141	212	3	endocrinol	endocrinol	PROPN
aiua-10141	212	4	metab	metab	NOUN
aiua-10141	212	5	.	.	PUNCT
aiua-10141	213	1	2007	2007	NUM
aiua-10141	213	2	;	;	PUNCT
aiua-10141	213	3	92:4241	92:4241	NUM
aiua-10141	213	4	-	-	SYM
aiua-10141	213	5	7	7	NUM
aiua-10141	213	6	.	.	NUM
aiua-10141	213	7	24	24	NUM
aiua-10141	213	8	.	.	PUNCT
aiua-10141	214	1	aksam	aksam	PROPN
aiua-10141	214	2	a	a	DET
aiua-10141	214	3	yassin	yassin	PROPN
aiua-10141	214	4	,	,	PUNCT
aiua-10141	214	5	farid	farid	PROPN
aiua-10141	214	6	saad	saad	PROPN
aiua-10141	214	7	.	.	PUNCT
aiua-10141	215	1	testosterone	testosterone	NOUN
aiua-10141	215	2	and	and	CCONJ
aiua-10141	215	3	erectile	erectile	NOUN
aiua-10141	215	4	dysfunction	dysfunction	NOUN
aiua-10141	215	5	.	.	PUNCT
aiua-10141	216	1	j	j	PROPN
aiua-10141	216	2	androl	androl	PROPN
aiua-10141	216	3	.	.	PROPN
aiua-10141	216	4	2008	2008	NUM
aiua-10141	216	5	;	;	PUNCT
aiua-10141	216	6	29:593	29:593	NUM
aiua-10141	216	7	-	-	SYM
aiua-10141	216	8	604	604	NUM
aiua-10141	216	9	.	.	PUNCT
aiua-10141	217	1	25	25	NUM
aiua-10141	217	2	.	.	PUNCT
aiua-10141	218	1	rizk	rizk	PROPN
aiua-10141	218	2	pj	pj	PROPN
aiua-10141	218	3	,	,	PUNCT
aiua-10141	218	4	kohn	kohn	PROPN
aiua-10141	218	5	tp	tp	PROPN
aiua-10141	218	6	,	,	PUNCT
aiua-10141	218	7	pastuszak	pastuszak	PROPN
aiua-10141	218	8	aw	aw	INTJ
aiua-10141	218	9	,	,	PUNCT
aiua-10141	218	10	khera	khera	PROPN
aiua-10141	218	11	m.	m.	NOUN
aiua-10141	218	12	testosterone	testosterone	NOUN
aiua-10141	218	13	therapy	therapy	NOUN
aiua-10141	218	14	improves	improve	VERB
aiua-10141	218	15	erectile	erectile	ADJ
aiua-10141	218	16	function	function	NOUN
aiua-10141	218	17	and	and	CCONJ
aiua-10141	218	18	libido	libido	VERB
aiua-10141	218	19	in	in	ADP
aiua-10141	218	20	hypogonadal	hypogonadal	ADJ
aiua-10141	218	21	men	man	NOUN
aiua-10141	218	22	.	.	PUNCT
aiua-10141	219	1	curr	curr	PROPN
aiua-10141	219	2	opin	opin	PROPN
aiua-10141	219	3	urol	urol	PROPN
aiua-10141	219	4	.	.	PROPN
aiua-10141	219	5	2017	2017	NUM
aiua-10141	219	6	;	;	PUNCT
aiua-10141	219	7	27:511	27:511	NUM
aiua-10141	219	8	-	-	PUNCT
aiua-10141	219	9	515	515	NUM
aiua-10141	219	10	.	.	NOUN
aiua-10141	219	11	26	26	NUM
aiua-10141	219	12	.	.	PUNCT
aiua-10141	220	1	douglas	douglas	PROPN
aiua-10141	220	2	gc	gc	PROPN
aiua-10141	220	3	,	,	PUNCT
aiua-10141	220	4	o’bryan	o’bryan	X
aiua-10141	220	5	mk	mk	PROPN
aiua-10141	220	6	,	,	PUNCT
aiua-10141	220	7	hedger	hedger	PROPN
aiua-10141	220	8	mp	mp	PROPN
aiua-10141	220	9	,	,	PUNCT
aiua-10141	220	10	et	et	PROPN
aiua-10141	220	11	al	al	PROPN
aiua-10141	220	12	.	.	PUNCT
aiua-10141	221	1	the	the	DET
aiua-10141	221	2	novel	novel	ADJ
aiua-10141	221	3	angiotensin	angiotensin	NOUN
aiua-10141	221	4	-	-	PUNCT
aiua-10141	221	5	converting	convert	VERB
aiua-10141	221	6	enzyme	enzyme	NOUN
aiua-10141	221	7	(	(	PUNCT
aiua-10141	221	8	ace	ace	NOUN
aiua-10141	221	9	)	)	PUNCT
aiua-10141	221	10	homolog	homolog	NOUN
aiua-10141	221	11	,	,	PUNCT
aiua-10141	221	12	ace2	ace2	PROPN
aiua-10141	221	13	,	,	PUNCT
aiua-10141	221	14	is	be	AUX
aiua-10141	221	15	selectively	selectively	ADV
aiua-10141	221	16	expressed	express	VERB
aiua-10141	221	17	by	by	ADP
aiua-10141	221	18	adult	adult	NOUN
aiua-10141	221	19	leydig	leydig	NOUN
aiua-10141	221	20	cells	cell	NOUN
aiua-10141	221	21	of	of	ADP
aiua-10141	221	22	the	the	DET
aiua-10141	221	23	testis	testis	NOUN
aiua-10141	221	24	.	.	PUNCT
aiua-10141	222	1	endocrinology	endocrinology	NOUN
aiua-10141	222	2	.	.	PUNCT
aiua-10141	223	1	2004	2004	NUM
aiua-10141	223	2	;	;	PUNCT
aiua-10141	223	3	145:4703	145:4703	NUM
aiua-10141	223	4	-	-	SYM
aiua-10141	223	5	4711	4711	NUM
aiua-10141	223	6	.	.	PUNCT
aiua-10141	224	1	27	27	NUM
aiua-10141	224	2	.	.	PUNCT
aiua-10141	224	3	ma	ma	PROPN
aiua-10141	224	4	l	l	PROPN
aiua-10141	224	5	,	,	PUNCT
aiua-10141	224	6	xie	xie	PROPN
aiua-10141	224	7	w	w	PROPN
aiua-10141	224	8	,	,	PUNCT
aiua-10141	224	9	li	li	PROPN
aiua-10141	224	10	d	d	PROPN
aiua-10141	224	11	,	,	PUNCT
aiua-10141	224	12	et	et	PROPN
aiua-10141	224	13	al	al	PROPN
aiua-10141	224	14	.	.	PROPN
aiua-10141	224	15	effect	effect	NOUN
aiua-10141	224	16	of	of	ADP
aiua-10141	224	17	sars	sar	NOUN
aiua-10141	224	18	-	-	PUNCT
aiua-10141	224	19	cov-2	cov-2	NOUN
aiua-10141	224	20	infection	infection	NOUN
aiua-10141	224	21	upon	upon	SCONJ
aiua-10141	224	22	male	male	ADJ
aiua-10141	224	23	gonadal	gonadal	ADJ
aiua-10141	224	24	function	function	NOUN
aiua-10141	224	25	:	:	PUNCT
aiua-10141	224	26	a	a	DET
aiua-10141	224	27	single	single	ADJ
aiua-10141	224	28	center	center	NOUN
aiua-10141	224	29	-	-	PUNCT
aiua-10141	224	30	based	base	VERB
aiua-10141	224	31	study	study	NOUN
aiua-10141	224	32	.	.	PUNCT
aiua-10141	225	1	medrxiv	medrxiv	PROPN
aiua-10141	225	2	;	;	PUNCT
aiua-10141	225	3	2020	2020	NUM
aiua-10141	225	4	.	.	PUNCT
aiua-10141	226	1	28	28	NUM
aiua-10141	226	2	.	.	X
aiua-10141	227	1	vanhorebeek	vanhorebeek	PROPN
aiua-10141	228	1	i	i	PROPN
aiua-10141	228	2	,	,	PUNCT
aiua-10141	228	3	langouche	langouche	PROPN
aiua-10141	228	4	l	l	PROPN
aiua-10141	228	5	,	,	PUNCT
aiua-10141	228	6	van	van	PROPN
aiua-10141	228	7	den	den	PROPN
aiua-10141	228	8	berghe	berghe	NOUN
aiua-10141	228	9	g.	g.	PROPN
aiua-10141	228	10	endocrine	endocrine	PROPN
aiua-10141	228	11	aspects	aspect	NOUN
aiua-10141	228	12	of	of	ADP
aiua-10141	228	13	acute	acute	ADJ
aiua-10141	228	14	and	and	CCONJ
aiua-10141	228	15	prolonged	prolong	VERB
aiua-10141	228	16	critical	critical	ADJ
aiua-10141	228	17	illness	illness	NOUN
aiua-10141	228	18	.	.	PUNCT
aiua-10141	229	1	nat	nat	PROPN
aiua-10141	229	2	clin	clin	PROPN
aiua-10141	229	3	pract	pract	PROPN
aiua-10141	229	4	endocrinol	endocrinol	PROPN
aiua-10141	229	5	metab	metab	NOUN
aiua-10141	229	6	.	.	PUNCT
aiua-10141	230	1	2006	2006	NUM
aiua-10141	230	2	;	;	PUNCT
aiua-10141	230	3	2:20	2:20	NUM
aiua-10141	230	4	-	-	SYM
aiua-10141	230	5	31	31	NUM
aiua-10141	230	6	.	.	PUNCT
aiua-10141	230	7	29	29	NUM
aiua-10141	230	8	.	.	PUNCT
aiua-10141	231	1	okçelik	okçelik	PROPN
aiua-10141	231	2	s.	s.	PROPN
aiua-10141	231	3	covid-19	covid-19	PROPN
aiua-10141	231	4	pneumonia	pneumonia	NOUN
aiua-10141	231	5	causes	cause	VERB
aiua-10141	231	6	lower	low	ADJ
aiua-10141	231	7	testosterone	testosterone	NOUN
aiua-10141	231	8	levels	level	NOUN
aiua-10141	231	9	.	.	PUNCT
aiua-10141	232	1	andrologia	andrologia	NOUN
aiua-10141	232	2	.	.	PUNCT
aiua-10141	233	1	2021	2021	NUM
aiua-10141	233	2	;	;	PUNCT
aiua-10141	234	1	53	53	NUM
aiua-10141	234	2	:	:	SYM
aiua-10141	234	3	e13909	e13909	ADJ
aiua-10141	234	4	.	.	PUNCT
aiua-10141	234	5	30	30	NUM
aiua-10141	234	6	.	.	PUNCT
aiua-10141	235	1	mohamad	mohamad	PROPN
aiua-10141	235	2	nv	nv	PROPN
aiua-10141	235	3	,	,	PUNCT
aiua-10141	235	4	wong	wong	PROPN
aiua-10141	235	5	sk	sk	PROPN
aiua-10141	235	6	,	,	PUNCT
aiua-10141	235	7	wan	wan	PROPN
aiua-10141	235	8	hasan	hasan	PROPN
aiua-10141	235	9	wn	wn	PROPN
aiua-10141	235	10	.	.	PUNCT
aiua-10141	236	1	the	the	DET
aiua-10141	236	2	relationship	relationship	NOUN
aiua-10141	236	3	between	between	ADP
aiua-10141	236	4	circulating	circulate	VERB
aiua-10141	236	5	testosterone	testosterone	NOUN
aiua-10141	236	6	and	and	CCONJ
aiua-10141	236	7	inflammatory	inflammatory	ADJ
aiua-10141	236	8	cytokines	cytokine	NOUN
aiua-10141	236	9	in	in	ADP
aiua-10141	236	10	men	man	NOUN
aiua-10141	236	11	.	.	PUNCT
aiua-10141	237	1	aging	age	VERB
aiua-10141	237	2	male	male	NOUN
aiua-10141	237	3	.	.	PUNCT
aiua-10141	238	1	2019	2019	NUM
aiua-10141	238	2	;	;	PUNCT
aiua-10141	238	3	22:129	22:129	NUM
aiua-10141	238	4	-	-	SYM
aiua-10141	238	5	140	140	NUM
aiua-10141	238	6	.	.	PUNCT
aiua-10141	239	1	31	31	NUM
aiua-10141	239	2	.	.	PUNCT
aiua-10141	240	1	malkin	malkin	PROPN
aiua-10141	240	2	cj	cj	PROPN
aiua-10141	240	3	,	,	PUNCT
aiua-10141	240	4	pugh	pugh	PROPN
aiua-10141	240	5	pj	pj	PROPN
aiua-10141	240	6	,	,	PUNCT
aiua-10141	240	7	jones	jones	PROPN
aiua-10141	240	8	rd	rd	PROPN
aiua-10141	240	9	,	,	PUNCT
aiua-10141	240	10	et	et	PROPN
aiua-10141	240	11	al	al	PROPN
aiua-10141	240	12	.	.	PUNCT
aiua-10141	241	1	the	the	DET
aiua-10141	241	2	effect	effect	NOUN
aiua-10141	241	3	of	of	ADP
aiua-10141	241	4	testosterone	testosterone	NOUN
aiua-10141	241	5	replacement	replacement	NOUN
aiua-10141	241	6	on	on	ADP
aiua-10141	241	7	endogenous	endogenous	ADJ
aiua-10141	241	8	inflammatory	inflammatory	ADJ
aiua-10141	241	9	cytokines	cytokine	NOUN
aiua-10141	241	10	and	and	CCONJ
aiua-10141	241	11	lipid	lipid	NOUN
aiua-10141	241	12	profiles	profile	NOUN
aiua-10141	241	13	in	in	ADP
aiua-10141	241	14	hypogonadal	hypogonadal	ADJ
aiua-10141	241	15	men	man	NOUN
aiua-10141	241	16	j	j	PROPN
aiua-10141	241	17	clin	clin	PROPN
aiua-10141	241	18	endocrinol	endocrinol	PROPN
aiua-10141	241	19	metab	metab	NOUN
aiua-10141	241	20	.	.	PUNCT
aiua-10141	242	1	2004	2004	NUM
aiua-10141	242	2	;	;	PUNCT
aiua-10141	242	3	89:3313	89:3313	NUM
aiua-10141	242	4	-	-	SYM
aiua-10141	242	5	8	8	NUM
aiua-10141	242	6	.	.	PUNCT
aiua-10141	243	1	32	32	NUM
aiua-10141	243	2	.	.	PUNCT
aiua-10141	244	1	chen	chen	PROPN
aiua-10141	244	2	j	j	PROPN
aiua-10141	244	3	,	,	PUNCT
aiua-10141	244	4	jiang	jiang	PROPN
aiua-10141	244	5	q	q	PROPN
aiua-10141	244	6	,	,	PUNCT
aiua-10141	244	7	xia	xia	PROPN
aiua-10141	244	8	x	x	PROPN
aiua-10141	244	9	,	,	PUNCT
aiua-10141	244	10	et	et	PROPN
aiua-10141	244	11	al	al	PROPN
aiua-10141	244	12	.	.	PUNCT
aiua-10141	245	1	individual	individual	ADJ
aiua-10141	245	2	variation	variation	NOUN
aiua-10141	245	3	of	of	ADP
aiua-10141	245	4	the	the	DET
aiua-10141	245	5	sarscov-2	sarscov-2	NUM
aiua-10141	245	6	receptor	receptor	NOUN
aiua-10141	245	7	ace2	ace2	NOUN
aiua-10141	245	8	gene	gene	NOUN
aiua-10141	245	9	expression	expression	NOUN
aiua-10141	245	10	and	and	CCONJ
aiua-10141	245	11	regulation	regulation	NOUN
aiua-10141	245	12	.	.	PUNCT
aiua-10141	246	1	aging	age	VERB
aiua-10141	246	2	cell	cell	NOUN
aiua-10141	246	3	.	.	PUNCT
aiua-10141	247	1	2020	2020	NUM
aiua-10141	247	2	;	;	PUNCT
aiua-10141	247	3	19	19	NUM
aiua-10141	247	4	:	:	PUNCT
aiua-10141	247	5	e13168	e13168	PROPN
aiua-10141	247	6	.	.	PROPN
aiua-10141	248	1	33	33	NUM
aiua-10141	248	2	.	.	PUNCT
aiua-10141	248	3	giagulli	giagulli	PROPN
aiua-10141	248	4	va	va	PROPN
aiua-10141	248	5	,	,	PUNCT
aiua-10141	248	6	guastamacchia	guastamacchia	NOUN
aiua-10141	248	7	e	e	NOUN
aiua-10141	248	8	,	,	PUNCT
aiua-10141	248	9	magrone	magrone	NOUN
aiua-10141	248	10	t	t	PROPN
aiua-10141	248	11	,	,	PUNCT
aiua-10141	248	12	et	et	PROPN
aiua-10141	248	13	al	al	PROPN
aiua-10141	248	14	.	.	PROPN
aiua-10141	249	1	worse	bad	ADJ
aiua-10141	249	2	progression	progression	NOUN
aiua-10141	249	3	of	of	ADP
aiua-10141	249	4	covid-19	covid-19	PROPN
aiua-10141	249	5	in	in	ADP
aiua-10141	249	6	men	man	NOUN
aiua-10141	249	7	:	:	PUNCT
aiua-10141	249	8	is	be	AUX
aiua-10141	249	9	testosterone	testosterone	NOUN
aiua-10141	249	10	a	a	DET
aiua-10141	249	11	key	key	ADJ
aiua-10141	249	12	factor	factor	NOUN
aiua-10141	249	13	?	?	PUNCT
aiua-10141	250	1	andrology	andrology	PROPN
aiua-10141	250	2	.	.	PUNCT
aiua-10141	251	1	2021	2021	NUM
aiua-10141	251	2	;	;	PUNCT
aiua-10141	251	3	9:53	9:53	NUM
aiua-10141	251	4	-	-	SYM
aiua-10141	251	5	64	64	NUM
aiua-10141	251	6	.	.	PUNCT
aiua-10141	252	1	34	34	NUM
aiua-10141	252	2	.	.	PUNCT
aiua-10141	252	3	çayan	çayan	PROPN
aiua-10141	252	4	s	s	PROPN
aiua-10141	252	5	,	,	PUNCT
aiua-10141	252	6	ug˘uz	ug˘uz	PROPN
aiua-10141	252	7	m	m	NOUN
aiua-10141	252	8	,	,	PUNCT
aiua-10141	252	9	saylam	saylam	PROPN
aiua-10141	252	10	b	b	PROPN
aiua-10141	252	11	,	,	PUNCT
aiua-10141	252	12	akbay	akbay	PROPN
aiua-10141	252	13	e.	e.	PROPN
aiua-10141	252	14	effect	effect	PROPN
aiua-10141	252	15	of	of	ADP
aiua-10141	252	16	serum	serum	NOUN
aiua-10141	252	17	total	total	ADJ
aiua-10141	252	18	testosterone	testosterone	NOUN
aiua-10141	252	19	and	and	CCONJ
aiua-10141	252	20	its	its	PRON
aiua-10141	252	21	relationship	relationship	NOUN
aiua-10141	252	22	with	with	ADP
aiua-10141	252	23	other	other	ADJ
aiua-10141	252	24	laboratory	laboratory	NOUN
aiua-10141	252	25	parameters	parameter	NOUN
aiua-10141	252	26	on	on	ADP
aiua-10141	252	27	the	the	DET
aiua-10141	252	28	prognosis	prognosis	NOUN
aiua-10141	252	29	of	of	ADP
aiua-10141	252	30	coronavirus	coronavirus	NOUN
aiua-10141	252	31	disease	disease	NOUN
aiua-10141	252	32	2019	2019	NUM
aiua-10141	252	33	(	(	PUNCT
aiua-10141	252	34	covid-19	covid-19	PROPN
aiua-10141	252	35	)	)	PUNCT
aiua-10141	252	36	in	in	ADP
aiua-10141	252	37	sarscov-2	sarscov-2	NUM
aiua-10141	252	38	infected	infected	ADJ
aiua-10141	252	39	male	male	ADJ
aiua-10141	252	40	patients	patient	NOUN
aiua-10141	252	41	:	:	PUNCT
aiua-10141	252	42	a	a	DET
aiua-10141	252	43	cohort	cohort	NOUN
aiua-10141	252	44	study	study	NOUN
aiua-10141	252	45	.	.	PUNCT
aiua-10141	253	1	aging	age	VERB
aiua-10141	253	2	male	male	NOUN
aiua-10141	253	3	.	.	PUNCT
aiua-10141	254	1	2020	2020	NUM
aiua-10141	254	2	;	;	PUNCT
aiua-10141	254	3	23:1493	23:1493	NUM
aiua-10141	254	4	-	-	SYM
aiua-10141	254	5	1503	1503	NUM
aiua-10141	254	6	.	.	PUNCT
aiua-10141	255	1	35	35	NUM
aiua-10141	255	2	.	.	PUNCT
aiua-10141	256	1	rastrelli	rastrelli	PROPN
aiua-10141	256	2	g	g	PROPN
aiua-10141	256	3	,	,	PUNCT
aiua-10141	256	4	di	di	PROPN
aiua-10141	256	5	stasi	stasi	PROPN
aiua-10141	256	6	v	v	PROPN
aiua-10141	256	7	,	,	PUNCT
aiua-10141	256	8	inglese	inglese	PROPN
aiua-10141	256	9	f	f	PROPN
aiua-10141	256	10	,	,	PUNCT
aiua-10141	256	11	et	et	PROPN
aiua-10141	256	12	al	al	PROPN
aiua-10141	256	13	.	.	PUNCT
aiua-10141	256	14	low	low	ADJ
aiua-10141	256	15	testosterone	testosterone	NOUN
aiua-10141	256	16	levels	level	NOUN
aiua-10141	256	17	predict	predict	VERB
aiua-10141	256	18	clinical	clinical	ADJ
aiua-10141	256	19	adverse	adverse	ADJ
aiua-10141	256	20	outcomes	outcome	NOUN
aiua-10141	256	21	in	in	ADP
aiua-10141	256	22	sars	sar	NOUN
aiua-10141	256	23	-	-	PUNCT
aiua-10141	256	24	cov-2	cov-2	NOUN
aiua-10141	256	25	pneumonia	pneumonia	NOUN
aiua-10141	256	26	patients	patient	NOUN
aiua-10141	256	27	.	.	PUNCT
aiua-10141	257	1	andrology	andrology	PROPN
aiua-10141	257	2	.	.	PUNCT
aiua-10141	258	1	2021	2021	NUM
aiua-10141	258	2	;	;	PUNCT
aiua-10141	258	3	9:88	9:88	NUM
aiua-10141	258	4	-	-	SYM
aiua-10141	258	5	98	98	NUM
aiua-10141	258	6	.	.	PUNCT
aiua-10141	259	1	36	36	NUM
aiua-10141	259	2	.	.	PUNCT
aiua-10141	260	1	li	li	PROPN
aiua-10141	260	2	w	w	PROPN
aiua-10141	260	3	,	,	PUNCT
aiua-10141	260	4	moore	moore	PROPN
aiua-10141	260	5	mj	mj	PROPN
aiua-10141	260	6	,	,	PUNCT
aiua-10141	260	7	vasilieva	vasilieva	PROPN
aiua-10141	260	8	n	n	CCONJ
aiua-10141	260	9	,	,	PUNCT
aiua-10141	260	10	et	et	PROPN
aiua-10141	260	11	al	al	PROPN
aiua-10141	260	12	.	.	PUNCT
aiua-10141	260	13	angiotensin	angiotensin	NOUN
aiua-10141	260	14	-	-	PUNCT
aiua-10141	260	15	converting	convert	VERB
aiua-10141	260	16	enzyme	enzyme	NOUN
aiua-10141	260	17	2	2	NUM
aiua-10141	260	18	is	be	AUX
aiua-10141	260	19	a	a	DET
aiua-10141	260	20	functional	functional	ADJ
aiua-10141	260	21	receptor	receptor	NOUN
aiua-10141	260	22	for	for	ADP
aiua-10141	260	23	the	the	DET
aiua-10141	260	24	sars	sars	PROPN
aiua-10141	260	25	coronavirus	coronavirus	PROPN
aiua-10141	260	26	.	.	PUNCT
aiua-10141	261	1	nature	nature	NOUN
aiua-10141	261	2	2003	2003	NUM
aiua-10141	261	3	;	;	PUNCT
aiua-10141	261	4	426:450	426:450	NUM
aiua-10141	261	5	-	-	SYM
aiua-10141	261	6	454	454	NUM
aiua-10141	261	7	.	.	PUNCT
aiua-10141	262	1	37	37	NUM
aiua-10141	262	2	.	.	PUNCT
aiua-10141	263	1	hoffmann	hoffmann	PROPN
aiua-10141	263	2	m	m	PROPN
aiua-10141	263	3	,	,	PUNCT
aiua-10141	263	4	kleine	kleine	PROPN
aiua-10141	263	5	-	-	PUNCT
aiua-10141	263	6	weber	weber	PROPN
aiua-10141	263	7	h	h	PROPN
aiua-10141	263	8	,	,	PUNCT
aiua-10141	263	9	schroeder	schroeder	PROPN
aiua-10141	263	10	s	s	PROPN
aiua-10141	263	11	,	,	PUNCT
aiua-10141	263	12	et	et	PROPN
aiua-10141	263	13	al	al	PROPN
aiua-10141	263	14	.	.	PUNCT
aiua-10141	264	1	sars	sars	PROPN
aiua-10141	264	2	-	-	PUNCT
aiua-10141	264	3	cov-2	cov-2	PART
aiua-10141	264	4	cell	cell	NOUN
aiua-10141	264	5	entry	entry	NOUN
aiua-10141	264	6	depends	depend	VERB
aiua-10141	264	7	on	on	ADP
aiua-10141	264	8	ace2	ace2	NOUN
aiua-10141	264	9	and	and	CCONJ
aiua-10141	264	10	tmprss2	tmprss2	ADV
aiua-10141	264	11	and	and	CCONJ
aiua-10141	264	12	is	be	AUX
aiua-10141	264	13	blocked	block	VERB
aiua-10141	264	14	by	by	ADP
aiua-10141	264	15	a	a	DET
aiua-10141	264	16	clinically	clinically	ADV
aiua-10141	264	17	proven	prove	VERB
aiua-10141	264	18	protease	protease	NOUN
aiua-10141	264	19	inhibitor	inhibitor	NOUN
aiua-10141	264	20	.	.	PUNCT
aiua-10141	265	1	cell	cell	NOUN
aiua-10141	265	2	.	.	PUNCT
aiua-10141	266	1	2020	2020	NUM
aiua-10141	266	2	;	;	PUNCT
aiua-10141	267	1	181:271	181:271	PROPN
aiua-10141	267	2	-	-	PUNCT
aiua-10141	267	3	280.e8	280.e8	NUM
aiua-10141	267	4	.	.	PUNCT
aiua-10141	268	1	38	38	NUM
aiua-10141	268	2	.	.	PUNCT
aiua-10141	269	1	heurich	heurich	PROPN
aiua-10141	269	2	a	a	PRON
aiua-10141	269	3	,	,	PUNCT
aiua-10141	269	4	hofmann	hofmann	PROPN
aiua-10141	269	5	-	-	PUNCT
aiua-10141	269	6	winkler	winkler	PROPN
aiua-10141	269	7	h	h	NOUN
aiua-10141	269	8	,	,	PUNCT
aiua-10141	269	9	gierer	gierer	NOUN
aiua-10141	269	10	s	s	PROPN
aiua-10141	269	11	,	,	PUNCT
aiua-10141	269	12	et	et	PROPN
aiua-10141	269	13	al	al	PROPN
aiua-10141	269	14	.	.	PUNCT
aiua-10141	270	1	tmprss2	tmprss2	PROPN
aiua-10141	270	2	and	and	CCONJ
aiua-10141	270	3	adam17	adam17	VERB
aiua-10141	270	4	cleave	cleave	PROPN
aiua-10141	270	5	ace2	ace2	PROPN
aiua-10141	270	6	differentially	differentially	ADV
aiua-10141	270	7	and	and	CCONJ
aiua-10141	270	8	only	only	ADV
aiua-10141	270	9	proteolysis	proteolysis	NOUN
aiua-10141	270	10	by	by	ADP
aiua-10141	270	11	tmprss2	tmprss2	PRON
aiua-10141	270	12	augments	augment	VERB
aiua-10141	270	13	entry	entry	NOUN
aiua-10141	270	14	driven	drive	VERB
aiua-10141	270	15	by	by	ADP
aiua-10141	270	16	the	the	DET
aiua-10141	270	17	severe	severe	ADJ
aiua-10141	270	18	acute	acute	ADJ
aiua-10141	270	19	respiratory	respiratory	ADJ
aiua-10141	270	20	syndrome	syndrome	NOUN
aiua-10141	270	21	coronavirus	coronavirus	NOUN
aiua-10141	270	22	spike	spike	ADJ
aiua-10141	270	23	protein	protein	NOUN
aiua-10141	270	24	.	.	PUNCT
aiua-10141	271	1	j	j	PROPN
aiua-10141	271	2	virol	virol	PROPN
aiua-10141	271	3	.	.	PUNCT
aiua-10141	272	1	2014	2014	NUM
aiua-10141	272	2	;	;	PUNCT
aiua-10141	272	3	88:1293	88:1293	NUM
aiua-10141	272	4	-	-	SYM
aiua-10141	272	5	1307	1307	NUM
aiua-10141	272	6	.	.	PUNCT
aiua-10141	273	1	39	39	NUM
aiua-10141	273	2	.	.	PUNCT
aiua-10141	274	1	wambier	wambi	ADJ
aiua-10141	274	2	cg	cg	PROPN
aiua-10141	274	3	,	,	PUNCT
aiua-10141	274	4	goren	goren	PROPN
aiua-10141	274	5	a.	a.	PROPN
aiua-10141	274	6	severe	severe	ADJ
aiua-10141	274	7	acute	acute	ADJ
aiua-10141	274	8	respiratory	respiratory	ADJ
aiua-10141	274	9	syndrome	syndrome	NOUN
aiua-10141	274	10	coronavirus	coronavirus	NOUN
aiua-10141	274	11	2	2	NUM
aiua-10141	274	12	(	(	PUNCT
aiua-10141	274	13	sars	sar	NOUN
aiua-10141	274	14	-	-	PUNCT
aiua-10141	274	15	cov-2	cov-2	NOUN
aiua-10141	274	16	)	)	PUNCT
aiua-10141	274	17	infection	infection	NOUN
aiua-10141	274	18	is	be	AUX
aiua-10141	274	19	likely	likely	ADJ
aiua-10141	274	20	to	to	PART
aiua-10141	274	21	be	be	AUX
aiua-10141	274	22	androgen	androgen	NOUN
aiua-10141	274	23	mediated	mediate	VERB
aiua-10141	274	24	.	.	PUNCT
aiua-10141	275	1	j	j	PROPN
aiua-10141	275	2	am	be	AUX
aiua-10141	275	3	acad	acad	ADJ
aiua-10141	275	4	dermatol	dermatol	NOUN
aiua-10141	275	5	.	.	PUNCT
aiua-10141	276	1	2020	2020	NUM
aiua-10141	276	2	;	;	PUNCT
aiua-10141	276	3	83:308	83:308	NUM
aiua-10141	276	4	-	-	SYM
aiua-10141	276	5	309	309	NUM
aiua-10141	276	6	.	.	PUNCT
aiua-10141	277	1	40	40	NUM
aiua-10141	277	2	.	.	PUNCT
aiua-10141	278	1	rozhivanov	rozhivanov	PROPN
aiua-10141	278	2	rv	rv	PROPN
aiua-10141	278	3	,	,	PUNCT
aiua-10141	278	4	andreeva	andreeva	VERB
aiua-10141	278	5	en	en	PROPN
aiua-10141	278	6	,	,	PUNCT
aiua-10141	278	7	melnichenko	melnichenko	PROPN
aiua-10141	278	8	ga	ga	PROPN
aiua-10141	278	9	,	,	PUNCT
aiua-10141	278	10	mokrysheva	mokrysheva	PROPN
aiua-10141	278	11	ng	ng	PROPN
aiua-10141	278	12	.	.	PROPN
aiua-10141	278	13	androgens	androgen	NOUN
aiua-10141	278	14	and	and	CCONJ
aiua-10141	278	15	antiandrogens	antiandrogen	NOUN
aiua-10141	278	16	influence	influence	NOUN
aiua-10141	278	17	on	on	ADP
aiua-10141	278	18	covid-19	covid-19	PROPN
aiua-10141	278	19	disease	disease	NOUN
aiua-10141	278	20	in	in	ADP
aiua-10141	278	21	men	man	NOUN
aiua-10141	278	22	.	.	PUNCT
aiua-10141	279	1	probl	probl	PROPN
aiua-10141	279	2	endokrinol	endokrinol	NOUN
aiua-10141	279	3	(	(	PUNCT
aiua-10141	279	4	mosk	mosk	PROPN
aiua-10141	279	5	)	)	PUNCT
aiua-10141	279	6	.	.	PUNCT
aiua-10141	280	1	2020	2020	NUM
aiua-10141	280	2	;	;	PUNCT
aiua-10141	280	3	66:77	66:77	NUM
aiua-10141	280	4	-	-	SYM
aiua-10141	280	5	81	81	NUM
aiua-10141	280	6	.	.	PUNCT
aiua-10141	281	1	correspondence	correspondence	NOUN
aiua-10141	281	2	kadir	kadir	PROPN
aiua-10141	281	3	karkin	karkin	PROPN
aiua-10141	281	4	,	,	PUNCT
aiua-10141	281	5	md	md	PROPN
aiua-10141	281	6	(	(	PUNCT
aiua-10141	281	7	corresponding	correspond	VERB
aiua-10141	281	8	author	author	NOUN
aiua-10141	281	9	)	)	PUNCT
aiua-10141	281	10	kadir_karkin@msn.com	kadir_karkin@msn.com	PROPN
aiua-10141	281	11	ergün	ergün	VERB
aiua-10141	281	12	alma	alma	PROPN
aiua-10141	281	13	,	,	PUNCT
aiua-10141	281	14	md	md	PROPN
aiua-10141	281	15	health	health	PROPN
aiua-10141	281	16	sciences	sciences	PROPN
aiua-10141	281	17	university	university	PROPN
aiua-10141	281	18	,	,	PUNCT
aiua-10141	281	19	adana	adana	PROPN
aiua-10141	281	20	city	city	PROPN
aiua-10141	281	21	training	training	NOUN
aiua-10141	281	22	and	and	CCONJ
aiua-10141	281	23	research	research	NOUN
aiua-10141	281	24	hospital	hospital	NOUN
aiua-10141	281	25	,	,	PUNCT
aiua-10141	281	26	department	department	NOUN
aiua-10141	281	27	of	of	ADP
aiua-10141	281	28	urology	urology	NOUN
aiua-10141	281	29	,	,	PUNCT
aiua-10141	281	30	01330	01330	NUM
aiua-10141	281	31	,	,	PUNCT
aiua-10141	281	32	adana	adana	PROPN
aiua-10141	281	33	(	(	PUNCT
aiua-10141	281	34	turkey	turkey	PROPN
aiua-10141	281	35	)	)	PUNCT